Disease of genetic or genomic mechanism
MONDO:7770009A grouping class for human diseases caused by genetic or genomic alterations, including chromosomal abnormalities and heritable mutations.
18330 clinical trials for this condition and its sub-types, 2 tagged with Disease of genetic or genomic mechanism itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Disease of genetic or genomic mechanism
-
Hereditary disease 193 trials · 18,187 incl. sub-types
1,925 sub-types
- Hereditary neurological disease 6 trials · 5,772 incl. sub-types Sub-types →
- Inborn errors of metabolism 48 trials · 2,228 incl. sub-types Sub-types →
- Autosomal genetic disease 0 trials · 1,665 incl. sub-types Sub-types →
- Hereditary disorder of connective tissue 0 trials · 1,311 incl. sub-types Sub-types →
- Inflammatory bowel disease 429 trials · 1,079 incl. sub-types Sub-types →
- Hereditary skin disorder 7 trials · 880 incl. sub-types Sub-types →
- Immunodeficiency disease 55 trials · 776 incl. sub-types Sub-types →
- Hereditary neoplastic syndrome 60 trials · 731 incl. sub-types Sub-types →
- Skeletal dysplasia 1 trial · 660 incl. sub-types Sub-types →
- Cardiogenetic disease 3 trials · 614 incl. sub-types Sub-types →
- Inherited hemoglobinopathy 38 trials · 439 incl. sub-types Sub-types →
- COPD, severe early onset 405 trials
- Hereditary skeletal muscle disorder 1 trial · 404 incl. sub-types Sub-types →
- X-linked disease 18 trials · 323 incl. sub-types Sub-types →
- Hereditary dementia 2 trials · 322 incl. sub-types Sub-types →
- Inherited blood coagulation disorder 8 trials · 321 incl. sub-types Sub-types →
- Inherited kidney disorder 1 trial · 317 incl. sub-types Sub-types →
- Cataract 294 trials · 305 incl. sub-types Sub-types →
- Myopia 258 trials · 273 incl. sub-types Sub-types →
- Preeclampsia 232 trials · 236 incl. sub-types Sub-types →
- Burkitt lymphoma 220 trials Sub-types →
- Gastroesophageal reflux disease 217 trials Sub-types →
- Intervertebral disk degenerative disorder 122 trials · 216 incl. sub-types Sub-types →
- Polycystic ovary syndrome 200 trials
- Classic Hodgkin lymphoma 147 trials · 149 incl. sub-types Sub-types →
- Ewing sarcoma 124 trials · 125 incl. sub-types Sub-types →
- Inherited auditory system disease 0 trials · 120 incl. sub-types Sub-types →
- Bronchiectasis 118 trials · 119 incl. sub-types Sub-types →
- Hereditary otorhinolaryngologic disease 0 trials · 102 incl. sub-types Sub-types →
- Osteonecrosis of genetic origin 0 trials · 102 incl. sub-types Sub-types →
- RASopathy 9 trials · 100 incl. sub-types Sub-types →
- Hypogonadotropic hypogonadism 19 trials · 99 incl. sub-types Sub-types →
- Lymphoproliferative syndrome 69 trials · 99 incl. sub-types Sub-types →
- Gastrointestinal stromal tumor 93 trials
- Familial polycythemia 1 trial · 92 incl. sub-types Sub-types →
- Familial colorectal cancer 3 trials · 91 incl. sub-types Sub-types →
- Celiac disease 79 trials Sub-types →
- Cirrhosis, familial 4 trials · 79 incl. sub-types Sub-types →
- Spondylolisthesis 77 trials Sub-types →
- Orofacial cleft 4 trials · 69 incl. sub-types Sub-types →
- Developmental dysplasia of the hip 62 trials Sub-types →
- Keratoconus 61 trials Sub-types →
- Anodontia 59 trials Sub-types →
- Enterocolitis 3 trials · 58 incl. sub-types Sub-types →
- Lymphatic malformation 17 trials · 55 incl. sub-types Sub-types →
- Inherited aplastic anemia 2 trials · 53 incl. sub-types Sub-types →
- Synovial sarcoma 53 trials Sub-types →
- Ciliopathy 2 trials · 49 incl. sub-types Sub-types →
- Hereditary glaucoma 0 trials · 49 incl. sub-types Sub-types →
- Bone marrow failure syndrome 48 trials Sub-types →
- Inherited primary ovarian failure 2 trials · 47 incl. sub-types Sub-types →
- Ehlers-Danlos syndrome 20 trials · 46 incl. sub-types Sub-types →
- Malocclusion due to protuberant upper front teeth 41 trials
- Craniosynostosis 17 trials · 39 incl. sub-types Sub-types →
- Chronic granulomatous disease 37 trials Sub-types →
- Hereditary hyperparathyroidism 1 trial · 35 incl. sub-types Sub-types →
- Hypospadias 35 trials Sub-types →
- Preterm premature rupture of the membranes 35 trials
- Fragile X syndrome 34 trials Sub-types →
- Fuchs' endothelial dystrophy 33 trials Sub-types →
- Spondylosis, cervical 33 trials
- Arteriovenous malformations of the brain 32 trials
- Pilonidal sinus 32 trials
- MALT lymphoma 30 trials · 31 incl. sub-types Sub-types →
- Hirschsprung disease 29 trials
- Deafness, unilateral 29 trials
- Inherited thrombocytopenia 2 trials · 29 incl. sub-types Sub-types →
- Pathological gambling 28 trials
- Familial hemolytic anemia 4 trials · 27 incl. sub-types Sub-types →
- Hereditary hypoparathyroidism 0 trials · 26 incl. sub-types Sub-types →
- Inherited bleeding disorder, platelet-type 6 trials · 26 incl. sub-types Sub-types →
- Oculocerebral hypopigmentation syndrome of Preus 26 trials
- Syncope, familial vasovagal 26 trials
- Laminopathy 3 trials · 25 incl. sub-types Sub-types →
- Hypogonadism, male 24 trials
- Diastasis recti and weakness of the linea alba 23 trials
- Trigger thumb 23 trials
- Speech-sound disorder 22 trials
- Tooth agenesis 22 trials Sub-types →
- Anterior segment dysgenesis 2 trials · 21 incl. sub-types Sub-types →
- Alveolar soft part sarcoma 20 trials Sub-types →
- Pectus excavatum 20 trials
- Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 16 trials · 19 incl. sub-types Sub-types →
- Familial clubfoot with or without associated lower limb anomalies 0 trials · 18 incl. sub-types Sub-types →
- Hereditary hypophosphatemic rickets 1 trial · 18 incl. sub-types Sub-types →
- Familial osteosclerosis 0 trials · 16 incl. sub-types Sub-types →
- Hereditary hemophagocytic lymphohistiocytosis 8 trials · 16 incl. sub-types Sub-types →
- Familial nonmedullary thyroid carcinoma 3 trials · 15 incl. sub-types Sub-types →
- Arts syndrome 14 trials
- Chiari malformation 13 trials · 14 incl. sub-types Sub-types →
- Klippel-Feil syndrome 14 trials Sub-types →
- Cryptorchidism 14 trials Sub-types →
- Essential hypertension, genetic 14 trials
- Periodontitis, chronic, adult 14 trials
- Pregnancy loss, recurrent, 4 14 trials
- Visceral leishmaniasis 14 trials
- Aorta coarctation 13 trials Sub-types →
- Familial spontaneous pneumothorax 13 trials
- Hereditary anemia 2 trials · 13 incl. sub-types Sub-types →
- SMAD6-related disease 0 trials · 12 incl. sub-types Sub-types →
- Familial thoracic aortic aneurysm and aortic dissection 11 trials · 12 incl. sub-types Sub-types →
- Ovarian hyperstimulation syndrome 12 trials
- Pleomorphic adenoma 12 trials
- Spermatogenic failure 1 trial · 12 incl. sub-types Sub-types →
- CDKL5 disorder 8 trials · 11 incl. sub-types Sub-types →
- CGF1 11 trials
- Ankyloglossia 11 trials
- Familial long QT syndrome 1 trial · 11 incl. sub-types Sub-types →
- Heritable pulmonary arterial hypertension 10 trials · 11 incl. sub-types Sub-types →
- Inherited interstitial lung disease 5 trials · 11 incl. sub-types Sub-types →
- Parasomnia, sleep bruxism type 11 trials
- Progeroid syndrome 3 trials · 11 incl. sub-types Sub-types →
- Syndromic microphthalmia 0 trials · 11 incl. sub-types Sub-types →
- Tardive dyskinesia 11 trials
- Thyroid Hurthle cell carcinoma 11 trials
- Trichotillomania 11 trials
- Phelan-McDermid syndrome 10 trials Sub-types →
- Raynaud disease 10 trials
- Arthritis, sacroiliac 10 trials
- Bile duct cyst 10 trials
- Central precocious puberty 9 trials · 10 incl. sub-types Sub-types →
- Erythromelalgia 3 trials · 10 incl. sub-types Sub-types →
- Fibrodysplasia ossificans progressiva 10 trials
- Hereditary breast carcinoma 10 trials Sub-types →
- Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome 10 trials
- Multinodular goiter 10 trials Sub-types →
- Myostatin-related muscle hypertrophy 10 trials
- IgE responsiveness, atopic 9 trials
- Familial pancreatic carcinoma 9 trials
- Immunodeficiency 32B 9 trials
- Impacted teeth, multiple 9 trials
- Inherited obesity 8 trials · 9 incl. sub-types Sub-types →
- Obesity-hypoventilation syndrome 9 trials
- Peripheral arterial occlusive disease 1 9 trials
- Polydactyly 2 trials · 9 incl. sub-types Sub-types →
- Syndactyly 3 trials · 9 incl. sub-types Sub-types →
- Central centrifugal cicatricial alopecia 8 trials
- Familial ovarian cancer 1 trial · 8 incl. sub-types Sub-types →
- Hyperhidrosis palmaris ET plantaris 8 trials
- Lower urinary tract obstruction, congenital 8 trials
- Masticatory muscles, hypertrophy of 8 trials
- Neuropathy, painful 8 trials
- Severe congenital neutropenia 5 trials · 8 incl. sub-types Sub-types →
- Spondylocostal dysostosis 5 trials · 8 incl. sub-types Sub-types →
- Van der Woude syndrome 8 trials Sub-types →
- Silver-Russell syndrome 7 trials Sub-types →
- Amelogenesis imperfecta 3 trials · 7 incl. sub-types Sub-types →
- Arterial calcification of infancy 7 trials Sub-types →
- Extraskeletal myxoid chondrosarcoma 7 trials Sub-types →
- Febrile seizures, familial 4 trials · 7 incl. sub-types Sub-types →
- Inherited sideroblastic anemia 2 trials · 7 incl. sub-types Sub-types →
- Malposition of teeth with or without hypodontia/oligodontia 7 trials
- Protein-losing enteropathy 7 trials
- Spermatic cord torsion 7 trials
- CSF1R-related disorder 0 trials · 6 incl. sub-types Sub-types →
- DICER1-related tumor predisposition 1 trial · 6 incl. sub-types Sub-types →
- Angioosteohypertrophic syndrome 6 trials
- Bundle branch block, familial isolated complete right 6 trials
- Channelopathy-associated congenital insensitivity to pain, autosomal recessive 6 trials
- Familial isolated congenital asplenia 6 trials
- Fibromuscular dysplasia 6 trials Sub-types →
- Hereditary chronic pancreatitis 6 trials Sub-types →
- Hereditary gastric cancer 1 trial · 6 incl. sub-types Sub-types →
- Hereditary pulmonary alveolar proteinosis 3 trials · 6 incl. sub-types Sub-types →
- Hypotrichosis 5 trials · 6 incl. sub-types Sub-types →
- Laryngeal adductor paralysis 6 trials
- Leukoencephalopathy, hereditary diffuse, with spheroids 1 trial · 6 incl. sub-types Sub-types →
- Periodontitis, aggressive 4 trials · 6 incl. sub-types Sub-types →
- Sclerosteosis 6 trials Sub-types →
- Uterine anomalies 6 trials
- COL4A1/A2-related disorder 2 trials · 5 incl. sub-types Sub-types →
- Cornelia de Lange syndrome 4 trials · 5 incl. sub-types Sub-types →
- Central hypoventilation syndrome, congenital 0 trials · 5 incl. sub-types Sub-types →
- Congenital diarrhea 0 trials · 5 incl. sub-types Sub-types →
- Hereditary Wilms tumor 1 trial · 5 incl. sub-types Sub-types →
- Hereditary narcolepsy 0 trials · 5 incl. sub-types Sub-types →
- Hydatidiform mole 3 trials · 5 incl. sub-types Sub-types →
- Oculoauriculovertebral spectrum with radial defects 0 trials · 5 incl. sub-types Sub-types →
- Primary failure of tooth eruption 5 trials
- Progesterone resistance 5 trials
- Pulmonic stenosis 5 trials
- CTNNB1-related neurodevelopmental disorder and/or vitreoretinopathy 3 trials · 4 incl. sub-types Sub-types →
- WHIM syndrome 3 trials · 4 incl. sub-types Sub-types →
- Alopecia universalis 4 trials
- Asthma, nasal polyps, and aspirin intolerance 4 trials
- Bile acid malabsorption, primary, 1 4 trials
- Diastema, dental medial 4 trials
- Familial juvenile hypertrophy of the breast 4 trials
- Fetal and neonatal alloimmune thrombocytopenia 4 trials Sub-types →
- Global developmental delay with or without impaired intellectual development 4 trials
- Growth delay due to insulin-like growth factor I resistance 4 trials
- Hernia, double inguinal 4 trials
- Hyperreflexia 4 trials
- Low density lipoprotein cholesterol, mild elevation of 4 trials
- Parathyroid gland carcinoma 4 trials
- Prostate cancer, hereditary 1 trial · 4 incl. sub-types Sub-types →
- Pulmonary atresia-intact ventricular septum syndrome 4 trials
- Urinary bladder, atony of 4 trials
- Volvulus of midgut 4 trials Sub-types →
- 7q11.23 microduplication syndrome 3 trials Sub-types →
- AP-4 deficiency syndrome 0 trials · 3 incl. sub-types Sub-types →
- Cushing syndrome due to macronodular adrenal hyperplasia 3 trials Sub-types →
- Pitt-Hopkins or Pitt-Hopkins-like syndrome 0 trials · 3 incl. sub-types Sub-types →
- Protrusio acetabuli 3 trials
- Capillary malformation-arteriovenous malformation syndrome 3 trials Sub-types →
- Delayed puberty, self-limited 3 trials
- Distal arthrogryposis 0 trials · 3 incl. sub-types Sub-types →
- Ear malformation 3 trials Sub-types →
- Epithelial-stromal TGFBI dystrophy 1 trial · 3 incl. sub-types Sub-types →
- Fibrinolytic defect 3 trials
- Genu valgum, st. Helena familial 3 trials
- Hematuria, benign familial 3 trials Sub-types →
- Lethal congenital contracture syndrome 0 trials · 3 incl. sub-types Sub-types →
- Patella, familial recurrent dislocation of 3 trials
- Pigment dispersion syndrome 3 trials
- Popliteal cyst 3 trials
- Portal hypertension, noncirrhotic 3 trials Sub-types →
- Retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome 3 trials
- Spatial visualization, aptitude for 3 trials
- Striae distensae, familial 3 trials
- Tooth ankylosis 3 trials
- Achoo syndrome 2 trials
- Kabuki syndrome 2 trials Sub-types →
- Kasabach-Merritt syndrome 2 trials
- POLR3A-related disorder 0 trials · 2 incl. sub-types Sub-types →
- Pseudofolliculitis barbae 2 trials
- Young syndrome 2 trials
- Alcohol sensitivity, acute 2 trials
- Anisomastia 2 trials
- Arthrogryposis multiplex congenita 1 trial · 2 incl. sub-types Sub-types →
- Arthropathy, erosive 2 trials
- Atrichia with papular lesions 2 trials
- Autoimmune disease, multisystem, infantile-onset 0 trials · 2 incl. sub-types Sub-types →
- Bone Paget disease 2 trials Sub-types →
- Breath-holding Spells 2 trials
- Capillary infantile hemangioma 2 trials
- Cardiac valvular defect 2 trials Sub-types →
- Celiac trunk compression syndrome 2 trials
- Congenital hereditary endothelial dystrophy of cornea 2 trials
- Congenital pseudoarthrosis of the limbs 1 trial · 2 incl. sub-types Sub-types →
- Cornea plana 0 trials · 2 incl. sub-types Sub-types →
- Cystic disease of lung 2 trials
- Dementia/parkinsonism with non-Alzheimer amyloid plaques 2 trials
- Dyskinesia with orofacial involvement 1 trial · 2 incl. sub-types Sub-types →
- Expansile bone lesions 2 trials
- Familial abdominal aortic aneurysm 0 trials · 2 incl. sub-types Sub-types →
- Familial hyperaldosteronism 0 trials · 2 incl. sub-types Sub-types →
- Familial thrombocytosis 2 trials Sub-types →
- Grouped pigmentation of the retina 2 trials
- Hereditary gingival fibromatosis 0 trials · 2 incl. sub-types Sub-types →
- Histiocytoma, Angiomatoid fibrous 2 trials
- Inherited cutis laxa 0 trials · 2 incl. sub-types Sub-types →
- Inosine triphosphatase deficiency 2 trials
- Insect Stings, hypersensitivity to 2 trials
- Insulin-resistance syndrome type A 2 trials
- Intussusception 2 trials
- Islet cell adenomatosis 0 trials · 2 incl. sub-types Sub-types →
- Juvenile arthritis due to defect in LACC1 2 trials
- Kyphoscoliosis 1 2 trials
- Multisystemic smooth muscle dysfunction syndrome 2 trials Sub-types →
- Muscular hypertonia, lethal 2 trials
- Myelodysplastic syndrome associated with isolated del(5q) 2 trials
- Nose, anomalous shape of 2 trials
- Platelet aggregation, spontaneous 2 trials
- Portal vein, cavernous transformation of 2 trials
- Primary pigmented nodular adrenocortical disease 2 trials Sub-types →
- Ragweed sensitivity 2 trials
- Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome 2 trials
- Teeth, supernumerary 2 trials
- 17q11.2 microduplication syndrome 1 trial
- A20 haploinsufficiency 1 trial
- ACAN-related short stature spectrum 0 trials · 1 incl. sub-types Sub-types →
- Axenfeld-Rieger syndrome 1 trial Sub-types →
- BENTA disease 1 trial
- CACNA1C-related disorder 0 trials · 1 incl. sub-types Sub-types →
- CFTR-related disorder 1 trial Sub-types →
- Caroli syndrome 1 trial
- Caronte 1 trial
- Charcot-Marie-Tooth disease-hearing loss-intellectual disability syndrome 1 trial
- Chopra-Amiel-Gordon syndrome 1 trial
- Coffin-Siris syndrome 1 trial Sub-types →
- Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency 1 trial
- DHDDS-CDG 1 trial Sub-types →
- ELANE-related neutropenia 0 trials · 1 incl. sub-types Sub-types →
- Koolen-de Vries syndrome 1 trial Sub-types →
- L-ferritin deficiency 1 trial
- Mazabraud syndrome 1 trial
- Mendelian encephalopathy 0 trials · 1 incl. sub-types Sub-types →
- NKX2-1 related choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction 0 trials · 1 incl. sub-types Sub-types →
- PLEC-related muscular dystrophy-epidermolysis bullosa simplex spectrum disorder 0 trials · 1 incl. sub-types Sub-types →
- Potocki-Lupski syndrome 1 trial
- RNU4ATAC spectrum disorder 1 trial Sub-types →
- Rombo syndrome 1 trial
- Shashi-Pena syndrome 1 trial
- Snijders Blok-Campeau syndrome 1 trial
- TOR1AIP1-related nuclear envelopathy 0 trials · 1 incl. sub-types Sub-types →
- Taqi polymorphism 1 trial
- WFS1-related disorder 0 trials · 1 incl. sub-types Sub-types →
- X-linked dominant chondrodysplasia, Chassaing-Lacombe type 1 trial
- Y-linked disease 0 trials · 1 incl. sub-types Sub-types →
- Yao syndrome 1 trial
- Acrofacial dysostosis 0 trials · 1 incl. sub-types Sub-types →
- Aganglionosis, total intestinal 1 trial
- Androgen insensitivity syndrome 1 trial Sub-types →
- Anisocoria 1 trial
- Arcus senilis 1 trial
- Autoinflammatory-pancytopenia syndrome due to DNASE2 deficiency 1 trial
- Beta-aminoisobutyric acid, urinary excretion of 1 trial
- Central areolar choroidal dystrophy 1 trial Sub-types →
- Chromosome 15q24 deletion syndrome 1 trial
- Congenital bilateral absence of vas deferens 1 trial Sub-types →
- Congenital insensitivity to pain syndrome, Marsili type 1 trial
- Contractures, pterygia, and variable skeletal fusions syndrome 0 trials · 1 incl. sub-types Sub-types →
- Coracoclavicular joint, anomalous 1 trial
- Coxa vara 1 trial
- Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy 1 trial
- Dysautonomia-like disorder 1 trial
- Early repolarization associated with ventricular fibrillation 1 trial
- Electroencephalographic peculiarity: fronto-precentral beta wave groups 1 trial
- Eosinophilia, familial 1 trial
- Epilepsy, early-onset 0 trials · 1 incl. sub-types Sub-types →
- Esophagitis, eosinophilic, 1 1 trial
- Familial male-limited precocious puberty 1 trial
- Familial melanoma 1 trial Sub-types →
- Familial vesicoureteral reflux 0 trials · 1 incl. sub-types Sub-types →
- Fleck corneal dystrophy 1 trial
- Focal dermal hypoplasia 1 trial
- Foveal hypoplasia 1 trial Sub-types →
- Frontonasal dysplasia 1 trial Sub-types →
- Gastrointestinal defect and immunodeficiency syndrome 0 trials · 1 incl. sub-types Sub-types →
- Graying of hair, precocious 1 trial
- Growth delay due to insulin-like growth factor type 1 deficiency 1 trial
- Growth hormone insensitivity syndrome with immune dysregulation 0 trials · 1 incl. sub-types Sub-types →
- Hereditary arterial and articular multiple calcification syndrome 1 trial
- Hereditary gallbladder disorder 0 trials · 1 incl. sub-types Sub-types →
- Horizontal gaze palsy with progressive scoliosis 1 trial Sub-types →
- Hyperpigmentation of eyelid 1 trial
- Hypoparathyroidism-deafness-renal disease syndrome 1 trial
- Hypothyroidism, congenital, nongoitrous 0 trials · 1 incl. sub-types Sub-types →
- Ichthyosis prematurity syndrome 1 trial
- Immunodysregulation with variable immunodeficiency and autoimmunity 1 trial
- Infantile liver failure 0 trials · 1 incl. sub-types Sub-types →
- Isolated congenital breast hypoplasia/aplasia 0 trials · 1 incl. sub-types Sub-types →
- Isolated microphthalmia 0 trials · 1 incl. sub-types Sub-types →
- Levator-medial rectus synkinesis 1 trial
- Lumbar stenosis, familial 1 trial
- Megalodactyly 1 trial
- Microtia with meatal atresia and conductive deafness 1 trial
- Modifier, X-linked, for Neurofunctional defects 1 trial
- Myeloperoxidase deficiency 1 trial
- Nasal alar collapse, bilateral 1 trial
- Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 0 trials · 1 incl. sub-types Sub-types →
- Neutropenia, chronic familial 1 trial
- Nocturnal enuresis, 2 1 trial
- Nonimmune chronic idiopathic neutropenia of adults 1 trial
- Pancreatic agenesis 0 trials · 1 incl. sub-types Sub-types →
- Papillomatosis, confluent and reticulated 1 trial
- Pernicious anemia 1 trial
- Platelet membrane fluidity 1 trial
- Posterior polymorphous corneal dystrophy 1 trial Sub-types →
- Premature centromere division 1 trial
- Progressive deafness with stapes fixation 1 trial
- Prolactin deficiency, isolated 1 trial
- Pulmonary atresia with ventricular septal defect 1 trial
- Pyropoikilocytosis, hereditary 1 trial
- Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency 1 trial
- Split hand-foot malformation 0 trials · 1 incl. sub-types Sub-types →
- Tarsal coalition 1 trial
- Taurodontism 1 trial
- Trichomegaly 1 trial Sub-types →
- Triphalangeal thumb, Nonopposable 1 trial
- Tune deafness 1 trial
- Urolithiasis, uric acid, autosomal dominant 1 trial
- Visceral heterotaxy 1 trial Sub-types →
- 3MC syndrome 0 trials Sub-types →
- 46,XX sex reversal 1 0 trials
- 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency 0 trials
- 46,xx sex reversal 5 0 trials
- 5-hydroxytryptamine oxygenase regulator 0 trials
- 6-phosphogluconolactonase deficiency 0 trials
- ACCES syndrome 0 trials
- ACD-related telomere biology disorder 0 trials Sub-types →
- ADNP-related blepharophimosis-intellectual disability syndrome 0 trials
- AKT3-related overgrowth spectrum 0 trials Sub-types →
- Abruzzo-Erickson syndrome 0 trials
- Achard syndrome 0 trials
- Acrodysplasia with ossification abnormalities, short stature, and fibular hypoplasia 0 trials
- Adams-Oliver syndrome 0 trials Sub-types →
- Alazami-Yuan syndrome 0 trials
- Alfadhel syndrome 0 trials
- Alkuraya-Kucinskas syndrome 0 trials
- Amobarbital, deficient N-hydroxylation of 0 trials
- Aphalangy-hemivertebrae-urogenital-intestinal dysgenesis syndrome 0 trials
- Armfield syndrome 0 trials
- Atelis syndrome 0 trials Sub-types →
- Athrombia, essential 0 trials
- Axenfeld-Rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities 0 trials
- Ayme-Gripp syndrome 0 trials
- B-cell immunodeficiency, distal limb anomalies, and urogenital malformations 0 trials
- BAFopathy 0 trials Sub-types →
- BMP4-related ocular growth disorder 0 trials Sub-types →
- Bamforth-Lazarus syndrome 0 trials
- Baralle-Macken syndrome 0 trials
- Basilicata-Akhtar syndrome 0 trials
- Beck-Fahrner syndrome 0 trials
- Birbeck granule deficiency 0 trials
- Boudin-Mortier syndrome 0 trials
- Bowen syndrome of multiple malformations 0 trials
- Brachmann-de Lange-like facial changes with microcephaly, metatarsus adductus, and developmental delay 0 trials
- Brachymetatarsus 4 0 trials
- Brachymorphism-onychodysplasia-dysphalangism syndrome 0 trials
- Braddock-Carey syndrome 0 trials Sub-types →
- Bryant-Li-Bhoj neurodevelopmental syndrome 0 trials Sub-types →
- Buratti-Harel syndrome 0 trials
- CCNK-related neurodevelopmental disorder-severe intellectual disability-facial dysmorphism syndrome 0 trials
- CEBALID syndrome 0 trials
- CHAND syndrome 0 trials
- CLAPO syndrome 0 trials
- CRYAB-related myofibrillar myopathy-cataract-cardiomyopathy spectrum disorder 0 trials Sub-types →
- Camptosynpolydactyly, complex 0 trials
- Car factor deficiency 0 trials
- Carabelli anomaly of maxillary molar teeth 0 trials
- Cardioneuromyopathy with hyaline masses and nemaline rods 0 trials
- Carey-Fineman-Ziter syndrome 0 trials Sub-types →
- Catifa syndrome 0 trials
- Charcot-Marie-Tooth peroneal muscular atrophy, X-linked, with aplasia cutis congenita 0 trials
- Chitayat syndrome 0 trials
- Chondronectin 0 trials
- Christianson syndrome 0 trials
- Chudley-McCullough syndrome 0 trials
- Cohen-Gibson syndrome 0 trials
- Crane-Heise syndrome 0 trials
- Cree intellectual disability syndrome 0 trials
- DEGCAGS syndrome 0 trials
- DNA, low-repetitive sequences of 0 trials
- DNA, satellite, 3 0 trials
- DONSON-related microcephaly-short stature-limb abnormalities spectrum 0 trials
- DOORS syndrome 0 trials
- Darwinian tubercle of pinna 0 trials
- Dauwerse-Peters syndrome 0 trials
- DeSanto-Shinawi syndrome due to WAC point mutation 0 trials
- Devriendt syndrome 0 trials
- Diamond-Blackfan anemia-like 0 trials
- Diets-Jongmans syndrome 0 trials
- Dohle bodies and leukemia 0 trials
- Dursun syndrome 0 trials
- Dyserythropoiesis, congenital, with ultrastructurally normal erythroblast heterochromatin 0 trials
- EDICT syndrome 0 trials
- EN1-related dorsoventral syndrome 0 trials Sub-types →
- EPHB4-associated vascular malformation spectrum 0 trials Sub-types →
- Elsahy-Waters syndrome 0 trials
- Emanuel syndrome 0 trials
- Eosinophilopenia 0 trials
- FDXR-related optic atrophy mitochondrial dysfunction syndrome 0 trials Sub-types →
- FG syndrome 0 trials Sub-types →
- FICUS syndrome 0 trials
- FRAXD syndrome 0 trials
- FRAXF syndrome 0 trials
- Fanconi-like syndrome 0 trials Sub-types →
- Faundes-Banka syndrome 0 trials
- Fliedner-Zweier syndrome 0 trials
- Floating-Harbor syndrome 0 trials
- Fowler syndrome 0 trials
- Fraser-like syndrome 0 trials
- Freesia Flowers, inability to smell 0 trials
- Friedreich ataxia and congenital glaucoma 0 trials
- Friedreich ataxia, so-called, with optic atrophy and sensorineural deafness 0 trials
- GATA1-Related X-Linked Cytopenia 0 trials Sub-types →
- GCGR-related hyperglucagonemia 0 trials
- GOMBO syndrome 0 trials
- GRACILE syndrome 0 trials
- Gabriele de Vries syndrome 0 trials
- Gamstorp-Wohlfart syndrome 0 trials
- Giacheti syndrome 0 trials
- Glucoglycinuria 0 trials
- Goldberg-Shprintzen syndrome 0 trials
- Grant syndrome 0 trials
- Guillouet-Gordon syndrome 0 trials
- Guttmacher syndrome 0 trials
- Halothane hepatitis 0 trials
- Hengel-Maroofian-Schols syndrome 0 trials
- Heyn-Sproul-Jackson syndrome 0 trials
- Hhhh syndrome 0 trials
- Hirschsprung disease with heart defects, laryngeal anomalies, and preaxial polydactyly 0 trials
- Hirschsprung disease with ulnar polydactyly, polysyndactyly of big toes, and ventricular septal defect 0 trials
- Hirschsprung disease, cardiac defects, and autonomic dysfunction 0 trials
- Hooft disease 0 trials
- Houge-Janssens syndrome 0 trials Sub-types →
- Hoxha-Aliu syndrome 0 trials
- Hunter-Macdonald syndrome 0 trials
- Huppke-Brendel syndrome 0 trials
- Hutterite cerebroosteonephrodysplasia syndrome 0 trials
- ICHAD syndrome 0 trials
- IVIC syndrome 0 trials
- Imagawa-Matsumoto syndrome 0 trials
- Jaberi-Elahi syndrome 0 trials
- Jalili syndrome 0 trials
- Jawad syndrome 0 trials
- Juberg-Hayward syndrome 0 trials
- Jumping Frenchmen of Maine 0 trials
- KLHL7-related Bohring-Opitz-like syndrome 0 trials
- Kallmann syndrome with spastic paraplegia 0 trials
- Karsch-Neugebauer syndrome 0 trials
- Kaya-Barakat-Masson syndrome 0 trials
- Keipert syndrome 0 trials
- Khan-Khan-Katsanis syndrome 0 trials
- Kifafa seizure disorder 0 trials
- Kleefstra syndrome 0 trials Sub-types →
- Kniest-like dysplasia with pursed lips and ectopia lentis 0 trials
- Kohlschutter-Tonz syndrome-like 0 trials
- Kury-Isidor syndrome 0 trials
- Kyrle disease 0 trials
- LTBP2-related ocular dysgenesis 0 trials Sub-types →
- Lamb-Shaffer syndrome 0 trials
- Lambotte syndrome 0 trials
- Lessel-Kreienkamp syndrome 0 trials
- Leydig cell hypoplasia, type 1 0 trials Sub-types →
- Li-Campeau syndrome 0 trials
- Li-Ghorbani-Weisz-Hubshman syndrome 0 trials
- Liang-Wang syndrome 0 trials
- Liberfarb syndrome 0 trials
- Lisch epithelial corneal dystrophy 0 trials
- Long-Olsen-Distelmaier syndrome 0 trials
- Lopes-Maciel-Rodan syndrome 0 trials
- Lui-Jee-Baron syndrome 0 trials
- Luo-Schoch-Yamamoto syndrome 0 trials
- Luscan-Lumish syndrome 0 trials
- MECOM-associated syndrome 0 trials Sub-types →
- MIRAGE syndrome 0 trials
- MOMO syndrome 0 trials
- MORM syndrome 0 trials
- MTOR-related overgrowth spectrum 0 trials
- Malan overgrowth syndrome 0 trials
- Mammastatin 0 trials
- Marinesco-Sjogren-like syndrome 0 trials
- Martinez-Frias syndrome 0 trials
- Meacham syndrome 0 trials
- Meckel diverticulum 0 trials
- Meesmann corneal dystrophy 0 trials Sub-types →
- Meester-Loeys syndrome 0 trials
- Megarbane syndrome 0 trials
- Megarbane-Jalkh syndrome 0 trials
- Melhem-Fahl syndrome 0 trials
- Menke-Hennekam syndrome 0 trials Sub-types →
- Monophalangy of great toe 0 trials
- Moynahan syndrome 0 trials
- Muggenthaler-Chowdhury-Chioza syndrome 0 trials
- Mullegama-Klein-Martinez syndrome 0 trials
- Mungan syndrome 0 trials
- N-acetylaspartate deficiency 0 trials
- NDUFB11-related disorders 0 trials Sub-types →
- NR2F2 related multiple congenital anomalies/dysmorphic syndrome 0 trials
- NR5A1-related sex development disorder 0 trials Sub-types →
- Nance-Horan syndrome 0 trials
- Nguyen syndrome 0 trials
- Nizon-Isidor syndrome 0 trials
- O'Donnell-Luria-Rodan syndrome 0 trials
- Okt4 epitope deficiency 0 trials
- Onychotrichodysplasia and neutropenia 0 trials
- Opitz G/BBB syndrome 0 trials Sub-types →
- Opticocochleodentate degeneration 0 trials
- Oroacral syndrome, Verloes-Koulischer type 0 trials
- Osebold skeletal dysplasia/osteolysis syndrome 0 trials
- PI4KA-related disorder 0 trials Sub-types →
- PIK3R1-related immunodeficiency and SHORT syndrome 0 trials Sub-types →
- PMP22-RAI1 contiguous gene duplication syndrome 0 trials
- POLR1C-related disorder 0 trials Sub-types →
- POLR3B-related disorder 0 trials Sub-types →
- PR interval, variation in 0 trials
- Paine syndrome 0 trials
- Pan-Chung-Bellen syndrome 0 trials
- Paramolar tubercle of bolk 0 trials
- Parotidomegaly, hereditary bilateral 0 trials
- Partington-Anderson syndrome 0 trials
- Passovoy factor defect 0 trials
- Pechet factor deficiency 0 trials
- Perlman syndrome 0 trials
- Pierre Robin syndrome-faciodigital anomaly syndrome 0 trials
- Pilotto syndrome 0 trials
- Polyosteolysis-hyperostosis syndrome 0 trials
- Prepapillary vascular loops 0 trials
- Primrose syndrome 0 trials
- Pseudoatrophoderma colli 0 trials
- Pseudopili annulati 0 trials
- Pseudouridinuria and mental defect 0 trials
- Rabin-Pappas syndrome 0 trials
- Rabson-Mendenhall syndrome 0 trials
- Radio-Tartaglia syndrome 0 trials
- Rahman syndrome 0 trials
- Ramon syndrome 0 trials
- Rauch-Steindl syndrome 0 trials
- Reese retinal dysplasia 0 trials
- Reynolds syndrome 0 trials
- Robin sequence-oligodactyly syndrome 0 trials
- Robinow-Sorauf syndrome 0 trials
- Roussy-Levy syndrome 0 trials
- Rowley-Rosenberg syndrome 0 trials
- SEC61A1 deficiency 0 trials Sub-types →
- STAD syndrome 0 trials
- SYCE1-related gametogenic failure 0 trials Sub-types →
- Sabinas brittle hair syndrome 0 trials
- Sakoda complex 0 trials
- Santos syndrome 0 trials
- Schnyder corneal dystrophy 0 trials
- Sener syndrome 0 trials
- Short stature, Dauber-Argente type 0 trials
- Shukla-Vernon syndrome 0 trials
- Siddiqi syndrome 0 trials
- Sifrim-Hitz-Weiss syndrome 0 trials
- Simpson-Golabi-Behmel syndrome type 1 0 trials
- Simpson-Golabi-Behmel syndrome type 2 0 trials
- Sjogren-Larsson-like ichthyosis without CNS or eye involvement 0 trials
- Skraban-Deardorff syndrome 0 trials
- Somatomedin, embryonic 0 trials
- Spondylospinal thoracic dysostosis 0 trials
- Stargardt macular degeneration, absent or hypoplastic corpus callosum, intellectual disability, and dysmorphic features 0 trials
- Stevenson-Carey syndrome 0 trials
- Stuve-Wiedemann syndrome 0 trials Sub-types →
- Suleiman-El-Hattab syndrome 0 trials
- Sweeney-Cox syndrome 0 trials
- T-cell Subgroups, non-HLA-linked 0 trials
- T-cell immunodeficiency with epidermodysplasia verruciformis 0 trials
- T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant 0 trials
- T-substance anomaly 0 trials
- THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome 0 trials
- TP63-related ectodermal dysplasia spectrum with limb and orofacial malformations 0 trials Sub-types →
- TPM4-related platelet disorder 0 trials
- TRAF3 haploinsufficiency 0 trials
- Tan-Almurshedi syndrome 0 trials
- Tayoun-Maawali syndrome 0 trials
- Teebi hypertelorism syndrome 0 trials Sub-types →
- Tenorio syndrome 0 trials
- Tented eyebrows 0 trials
- Tessadori-Van-Haaften neurodevelopmental syndrome 0 trials Sub-types →
- Thai symphalangism syndrome 0 trials
- Tn polyagglutination syndrome 0 trials
- Tolchin-Le Caignec syndrome 0 trials
- Tonoki syndrome 0 trials
- Tristichiasis 0 trials
- Tryptophanuria with dwarfism 0 trials
- Tuftsin deficiency 0 trials
- Tyrosinosis 0 trials
- Undritz anomaly 0 trials
- Upington disease 0 trials
- Usher syndrome, type 1M 0 trials
- Usmani-Riazuddin syndrome, autosomal dominant 0 trials
- Usmani-Riazuddin syndrome, autosomal recessive 0 trials
- VACTERL association, X-linked, with or without hydrocephalus 0 trials
- VISS syndrome 0 trials
- Valinemia 0 trials
- Ververi-Brady syndrome 0 trials Sub-types →
- Vissers-Bodmer syndrome 0 trials
- Warsaw breakage syndrome 0 trials
- Webb-Dattani syndrome 0 trials
- Weyers ulnar ray/oligodactyly syndrome 0 trials
- White-Kernohan syndrome 0 trials
- Wiedemann-Steiner syndrome 0 trials
- Wolfram syndrome 2 0 trials
- Woronets trait 0 trials
- X inactivation, familial skewed 0 trials Sub-types →
- X-linked complicated corpus callosum dysgenesis 0 trials
- Y chromosome infertility due to DAZ1 deletion 0 trials
- Yuksel-Vogel-Bauer syndrome 0 trials
- ZTTK syndrome 0 trials
- Zaki syndrome 0 trials
- Zimmermann-Laband syndrome 0 trials Sub-types →
- Ablepharon macrostomia syndrome 0 trials
- Absence deformity of leg-cataract syndrome 0 trials
- Absent radius-anogenital anomalies syndrome 0 trials
- Acetyl-CoA acetyltransferase-2 deficiency 0 trials
- Acetyl-coa carboxylase deficiency 0 trials
- Acetylation, slow 0 trials
- Achalasia, familial esophageal 0 trials
- Acinar dysplasia caused by mutation in FGF10 0 trials
- Acinar dysplasia caused by mutation in FGFR2 0 trials
- Acinar dysplasia caused by mutation in TBX4 0 trials
- Acroleukopathy, symmetric 0 trials
- Acromegaloid changes, cutis verticis gyrata, and corneal leukoma 0 trials
- Acromegaloid features, overgrowth, cleft palate, and hernia 0 trials
- Acromial dimples 0 trials
- Acroosteolysis-keloid-like lesions-premature aging syndrome 0 trials
- Acute insulin response 0 trials
- Adenosine triphosphatase deficiency, anemia due to 0 trials
- Advanced sleep phase syndrome 0 trials Sub-types →
- Agenesis of cerebral white matter 0 trials
- Agenesis of corpus callosum, cardiac, ocular, and genital syndrome 0 trials
- Agenesis of the corpus callosum and congenital lymphedema 0 trials
- Agnathia-otocephaly complex 0 trials
- Alar cleft, isolated 0 trials
- Alopecia - intellectual disability syndrome 0 trials Sub-types →
- Alopecia universalis congenita, 10Y gonadal dysgenesis, and laryngomalacia 0 trials
- Alopecia-epilepsy-pyorrhea-intellectual disability syndrome 0 trials
- Alpha-thalassemia-myelodysplastic syndrome 0 trials
- Amastia, bilateral, with ureteral triplication and dysmorphism 0 trials
- Amegakaryocytic thrombocytopenia, congenital, 2 0 trials
- Amelia and terminal transverse hemimelia 0 trials
- Amelia cleft lip palate hydrocephalus iris coloboma 0 trials
- Amenorrhea-galactorrhea syndrome 0 trials
- Amino aciduria with mental deficiency, dwarfism, muscular dystrophy, osteoporosis, and acidosis 0 trials
- Amyloidosis of gingiva and conjunctiva, with intellectual disability 0 trials
- Amyloidosis, cutaneous bullous 0 trials
- Amyotonia congenita 0 trials
- Amyotrophic dystonic paraplegia 0 trials
- Anal sphincter dysplasia 0 trials
- Anal sphincter myopathy, internal 0 trials
- Anemia, congenital hypoplastic, with multiple congenital anomalies/intellectual disability syndrome 0 trials
- Anemia, hypochromic microcytic with iron overload 0 trials Sub-types →
- Angiokeratoma corporis diffusum with arteriovenous fistulas 0 trials
- Angiomatosis, diffuse Corticomeningeal, of Divry and van Bogaert 0 trials
- Anhaptoglobinemia 0 trials
- Aniridia - intellectual disability syndrome 0 trials
- Aniridia, microcornea, and spontaneously Reabsorbed cataract 0 trials
- Aniridia-absent patella syndrome 0 trials
- Aniridia-renal agenesis-psychomotor retardation syndrome 0 trials
- Annular erythema 0 trials
- Anonychia-ectrodactyly 0 trials
- Anonychia-onychodystrophy with brachydactyly type b and ectrodactyly 0 trials
- Anosmia for isobutyric acid 0 trials
- Anterior chamber cleavage disorder, cerebellar hypoplasia, hypothyroidism, and tracheal stenosis 0 trials
- Antigen defined by monoclonal antibody Aj9 0 trials
- Antigen defined by monoclonal antibody T87 0 trials
- Antithrombin, familial hemorrhagic diathesis due to 0 trials
- Aortic arch interruption, facial palsy, and retinal coloboma 0 trials
- Aplasia of lacrimal and salivary glands 0 trials
- Apraxia of eyelid opening 0 trials
- Ariboflavinosis 0 trials Sub-types →
- Arms, malformation of 0 trials
- Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities 0 trials
- Arteries, anomalies of 0 trials
- Arteriosclerosis, severe juvenile 0 trials
- Arteritis, familial granulomatous, with juvenile polyarthritis 0 trials
- Arthrogryposis multiplex with deafness, inguinal hernias, and early death 0 trials
- Arthrogryposis, Perthes disease, and upward gaze palsy 0 trials
- Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development 0 trials
- Arthrogryposis, congenital, lower limb, X-linked 0 trials
- Arthrogryposis, distal, with intellectual disability and characteristic facies 0 trials
- Aspirin resistance 0 trials
- Asthma, short stature, and elevated IgA 0 trials
- Asymmetric short stature syndrome 0 trials
- Ataxia with myoclonic epilepsy and presenile dementia 0 trials
- Ataxia, deafness, and cardiomyopathy 0 trials
- Ataxia, intention tremor, and hypotonia syndrome, childhood-onset 0 trials
- Ataxia, spastic, childhood-onset, autosomal recessive, with optic atrophy and intellectual disability 0 trials
- Ataxia-microcephaly-cataract syndrome 0 trials
- Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome 0 trials
- Atonic-astatic syndrome of Foerster 0 trials
- Atrial septal defect, secundum, with various cardiac and Noncardiac defects 0 trials
- Atrophia maculosa varioliformis cutis, familial 0 trials
- Aurocephalosyndactyly 0 trials
- Autoinflammation with arthritis and dyskeratosis 0 trials
- Autoinflammation with arthritis and vasculitis 0 trials
- Autoinflammation with episodic fever and immune dysregulation 0 trials
- Autoinflammation with episodic fever and lymphadenopathy 0 trials
- Autoinflammation with pulmonary and cutaneous vasculitis 0 trials
- Autoinflammation, immune dysregulation, and eosinophilia 0 trials
- Autoinflammation, panniculitis, and dermatosis syndrome 0 trials Sub-types →
- Autosomal dominant deafness - onychodystrophy syndrome 0 trials
- Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome 0 trials
- Autosomal dominant wooly hair 0 trials
- Autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome 0 trials
- Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity 0 trials
- Azoospermia, obstructive, with nephrolithiasis 0 trials
- Azotemia, familial 0 trials
- Baculum, congenital absence of 0 trials
- Berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification 0 trials
- Beta-amino acids, renal transport of 0 trials
- Bilateral microtia-deafness-cleft palate syndrome 0 trials
- Bile acid conjugation defect 1 0 trials
- Bile acid malabsorption, primary, 2 0 trials
- Bile and pancreatic ducts, complete absence of 0 trials
- Biliary malformation with renal tubular insufficiency 0 trials
- Biliary, renal, neurologic, and skeletal syndrome 0 trials
- Bipartite talus 0 trials
- Bladder diverticulum 0 trials Sub-types →
- Blepharochalasis, superior 0 trials
- Blepharophimosis - intellectual disability syndrome, SBBYS type 0 trials
- Blepharophimosis-impaired intellectual development syndrome 0 trials
- Blistering, acantholytic, of oral and laryngeal mucosa 0 trials
- Blue nevi, familial multiple 0 trials
- Bone marrow failure and diabetes mellitus syndrome 0 trials
- Bone pain, periodic 0 trials
- Brachial palsy, familial congenital 0 trials
- Brachycephaly, trichomegaly, and developmental delay 0 trials
- Brachydactyly 0 trials Sub-types →
- Brachydactyly, coloboma, and anterior segment dysgenesis 0 trials
- Brachydactyly, intraventricular septal defect, and deafness 0 trials
- Brachydactyly, type A1, with short stature, scoliosis, microcephaly, ptosis, hearing loss, and intellectual disability 0 trials
- Brachydactyly, type A2, with microcephaly 0 trials
- Brachymesomelia-renal syndrome 0 trials
- Brachyphalangy, polydactyly, and tibial aplasia/hypoplasia 0 trials
- Brain malformation renal syndrome 0 trials
- Branchial myoclonus with spastic paraparesis and cerebellar ataxia 0 trials
- Branchiootic syndrome 0 trials Sub-types →
- Broad terminal phalanges, familial 0 trials
- Bronchiectasis and nasal polyposis 0 trials
- Bullous dystrophy, macular type 0 trials
- Butyrylesterase 1 0 trials
- Calcific aortic disease with immunologic abnormalities, familial 0 trials
- Camera-Marugo-Cohen syndrome 0 trials
- Camptodactyly syndrome, Guadalajara 0 trials Sub-types →
- Camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye 0 trials
- Camptodactyly-ichthyosis syndrome 0 trials
- Cancer, familial, with in vitro Radioresistance 0 trials
- Canine teeth, absence of upper permanent 0 trials
- Carboxypeptidase N deficiency 0 trials
- Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies 0 trials
- Cardiac septal defects with coarctation of the aorta 0 trials
- Cardiac, facial, and digital anomalies with developmental delay 0 trials
- Cardiac-urogenital syndrome 0 trials
- Cardioacrofacial dysplasia 0 trials Sub-types →
- Cardioauditory syndrome of Sanchez Cascos 0 trials
- Cardiofacioneurodevelopmental syndrome 0 trials
- Cardiomyopathy associated with myopathy and sudden death 0 trials
- Cardiomyopathy, fatal fetal, due to myocardial calcification 0 trials
- Cardiomyopathy, infantile hypertrophic 0 trials
- Carnitine acetyltransferase deficiency 0 trials
- Carnitine deficiency, myopathic 0 trials
- Carpal displacement 0 trials
- Cataract, alopecia, oral mucosal disorder, and psoriasis-like syndrome 0 trials
- Cataract, ataxia, short stature, and intellectual disability 0 trials
- Cataract, congenital, with mental impairment and dentate gyrus atrophy 0 trials
- Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 0 trials Sub-types →
- Caudal duplication 0 trials
- Cavernous hemangiomas of face-supraumbilical midline raphe syndrome 0 trials
- Celiac disease-epilepsy-cerebral calcification syndrome 0 trials
- Central incisors, absence of 0 trials
- Cephalin lipidosis 0 trials
- Cerebellar ataxia and neurosensory deafness 0 trials
- Cerebellar ataxia, benign, with thermoanalgesia 0 trials
- Cerebellar ataxia, brain abnormalities, and cardiac conduction defects 0 trials
- Cerebellar atrophy with seizures and variable developmental delay 0 trials
- Cerebellar atrophy, developmental delay, and seizures 0 trials
- Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism 0 trials
- Cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome 0 trials
- Cerebellar, ocular, craniofacial, and genital syndrome 0 trials
- Cerebelloparenchymal disorder 0 trials Sub-types →
- Cerebral angiopathy, dysphoric 0 trials
- Cerebral malformation, seizures, hypertrichosis, and overlapping fingers 0 trials
- Cerebral sclerosis, diffuse, scholz type 0 trials
- Cerebrocortical degeneration of infancy 0 trials
- Cervical hypertrichosis with underlying kyphoscoliosis 0 trials
- Cervical rib disease 0 trials
- Cervical ribs, Sprengel anomaly, anal atresia, and urethral obstruction 0 trials
- Cervical vertebrae, agenesis of 0 trials
- Cervical vertebral Bridge 0 trials
- Cervical vertebral dysplasia 0 trials
- Chemodectoma, intraabdominal, with cutaneous angiolipomas 0 trials
- Chloramphenicol toxicity 0 trials
- Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome 0 trials
- Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome 0 trials
- Cholestasis with gallstone, ataxia, and visual disturbance 0 trials
- Cholestasis-pigmentary retinopathy-cleft palate syndrome 0 trials
- Cholesteatoma, congenital 0 trials
- Cholesterol pneumonia 0 trials
- Chondrodysplasia-pseudohermaphroditism syndrome 0 trials
- Chondroitin-6-sulfaturia, defective cellular immunity, nephrotic syndrome 0 trials
- Chorea, childhood-onset, with psychomotor retardation 0 trials
- Choroidal osteoma, bilateral 0 trials
- Chromosomal instability with tissue-specific radiosensitivity 0 trials
- Chromosome 16 inversion, 0.45-Mb 0 trials
- Chromosome 18 pericentric inversion 0 trials
- Chromosome 1p32-p31 deletion syndrome 0 trials
- Chromosome 1p35 deletion syndrome 0 trials
- Chromosome 1p36.33 duplication syndrome, atad3 gene cluster, autosomal dominant 0 trials
- Chromosome 4Q32.1-q32.2 triplication syndrome 0 trials
- Chronic atrial and intestinal dysrhythmia 0 trials
- Chronic mast cell leukemia 0 trials
- Circumvallate placenta syndrome 0 trials
- Citrulline transport defect 0 trials
- Clavicular hypoplasia, zygomatic arch hypoplasia, and micrognathia 0 trials
- Cleft palate, midfacial hypoplasia, triangular facies, and sensorineural hearing loss 0 trials
- Cleft palate, proliferative retinopathy, and developmental delay 0 trials
- Cleft palate-large ears-small head syndrome 0 trials
- Cocoon syndrome 0 trials
- Cognitive impairment with or without cerebellar ataxia 0 trials
- Colloid cysts of third ventricle 0 trials
- Coloboma, ocular, autosomal dominant 0 trials Sub-types →
- Coloboma, ocular, autosomal recessive 0 trials
- Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness 0 trials
- Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome 0 trials
- Colonic varices without portal hypertension 0 trials
- Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia 0 trials
- Combined low LDL and fibrinogen 0 trials
- Combined oxidative phosphorylation deficiency 49 0 trials
- Combined oxidative phosphorylation deficiency 50 0 trials
- Comedones, familial Dyskeratotic 0 trials
- Commissural lip pits 0 trials
- Complement factor b deficiency 0 trials
- Conductive deafness-malformed external ear syndrome 0 trials
- Cone-rod dystrophy and hearing loss 0 trials Sub-types →
- Cone-rod synaptic disorder syndrome, congenital nonprogressive 0 trials
- Congenital analbuminemia 0 trials
- Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay 0 trials
- Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome 0 trials
- Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome 0 trials
- Congenital contractures of the limbs and face, hypotonia, and developmental delay 0 trials
- Congenital disorder of glycosylation, type i/IIx 0 trials
- Congenital enteropathy due to enteropeptidase deficiency 0 trials
- Congenital heart defects and ectodermal dysplasia 0 trials
- Congenital heart defects and skeletal malformations syndrome 0 trials
- Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 0 trials
- Congenital heart defects, multiple types, 7 0 trials
- Congenital hypotonia, epilepsy, developmental delay, and digital anomalies 0 trials
- Congenital osteogenesis imperfecta-microcephaly-cataracts syndrome 0 trials
- Congenital pseudoarthrosis of clavicle 0 trials
- Congenital short bowel syndrome, autosomal recessive 0 trials
- Congenital smooth muscle hamartoma, with or without hemihypertrophy 0 trials
- Congenital stromal corneal dystrophy 0 trials
- Congenital vertical talus 0 trials Sub-types →
- Convulsive disorder, familial, with prenatal or early onset 0 trials
- Cornea guttata with anterior polar cataracts 0 trials
- Corneal degeneration, band-shaped spheroid 0 trials
- Corneal degeneration, ribbonlike, with deafness 0 trials
- Corneal dystrophy, punctiform and polychromatic pre-descemet 0 trials
- Corneal dystrophy-perceptive deafness syndrome 0 trials
- Corpus callosum agenesis-abnormal genitalia syndrome 0 trials
- Corticosteroid-binding globulin deficiency 0 trials
- Corticosterone methyloxidase type 2 deficiency 0 trials
- Coumarin resistance 0 trials
- Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay 0 trials
- Cranial nerves, congenital paresis of 0 trials
- Cranial nerves, recurrent paresis of 0 trials
- Cranioacrofacial syndrome 0 trials
- Craniofacial anomalies and anterior segment dysgenesis syndrome 0 trials
- Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome 0 trials Sub-types →
- Craniofacial dysplasia - osteopenia syndrome 0 trials
- Craniofacial-deafness-hand syndrome 0 trials
- Craniofaciocardiohepatic syndrome 0 trials
- Craniolenticulosutural dysplasia 0 trials
- Craniometadiaphyseal osteosclerosis with hip dysplasia 0 trials
- Craniorhiny 0 trials
- Craniosynostosis with anomalies of the cranial base and digits 0 trials
- Craniosynostosis-intellectual disability syndrome of 51N and Gettig 0 trials
- Craniosynostosis-intellectual disability-clefting syndrome 0 trials
- Craniosynostosis-scoliosis syndrome 0 trials
- Creases, infra-auricular cutaneous, with tall stature and advanced bone age 0 trials
- Creatine phosphokinase, elevated serum 0 trials
- Crumpled helices and small mouth 0 trials
- Cryofibrinogenemia, familial primary 0 trials
- Cryptotia, familial 0 trials
- Curved nail of fourth toe 0 trials
- Cutis verticis gyrata and intellectual disability 0 trials
- Cutis verticis gyrata, thyroid aplasia, and intellectual disability 0 trials
- Cyanosis and hepatic disease 0 trials
- Cyanosis, transient neonatal 0 trials Sub-types →
- Cysteine Peptiduria 0 trials
- Dandy-walker malformation with occipital cephalocele, autosomal dominant 0 trials
- De Sanctis-Cacchione syndrome 0 trials
- Deafness with anhidrotic ectodermal dysplasia 0 trials
- Deafness with labyrinthine aplasia, microtia, and microdontia 0 trials
- Deafness, cataract, impaired intellectual development, and polyneuropathy 0 trials
- Deafness, cataract, retinitis pigmentosa, and sperm abnormalities 0 trials
- Deafness, congenital heart defects, and posterior embryotoxon 0 trials
- Deafness, congenital, and adult-onset progressive leukoencephalopathy 0 trials
- Deafness, congenital, and familial myoclonic epilepsy 0 trials
- Deafness, mid-tone neural 0 trials
- Deafness, neural, congenital moderate 0 trials
- Deafness, neural, with atypical atopic dermatitis 0 trials
- Deafness, sensorineural, with peripheral neuropathy and arterial disease 0 trials
- Deafness, unilateral, with delayed endolymphatic hydrops 0 trials
- Deafness-ear malformation-facial palsy syndrome 0 trials
- Deafness-epiphyseal dysplasia-short stature syndrome 0 trials
- Deafness-small bowel diverticulosis-neuropathy syndrome 0 trials
- Deafness-vitiligo-achalasia syndrome 0 trials
- Deeah syndrome 0 trials
- Dens evaginatus 0 trials
- Dens in dente and palatal invaginations 0 trials
- Dental radicular dysplasia 0 trials
- Dentin dysplasia type I 0 trials Sub-types →
- Dentin dysplasia type II 0 trials
- Dentin dysplasia-sclerotic bones syndrome 0 trials
- Dentinogenesis imperfecta type 2 0 trials Sub-types →
- Dentinogenesis imperfecta type 3 0 trials
- Deoxyribose-5-phosphate aldolase deficiency 0 trials
- Dermal Ridges, patternless 0 trials
- Developmental delay with dysmorphic facies and dental anomalies 0 trials
- Developmental delay with hypotonia, myopathy, and brain abnormalities 0 trials
- Developmental delay with or without dysmorphic facies and autism 0 trials
- Developmental delay with or without epilepsy 0 trials
- Developmental delay with or without intellectual impairment or behavioral abnormalities 0 trials
- Developmental delay with short stature, dysmorphic facial features, and sparse hair 0 trials Sub-types →
- Developmental delay with sleep apnea 0 trials
- Developmental delay with variable cardiac and renal congenital anomalies and dysmorphic facies 0 trials
- Developmental delay with variable intellectual disability and dysmorphic facies 0 trials
- Developmental delay with variable neurologic and brain abnormalities 0 trials
- Developmental delay, behavioral abnormalities, and neuropsychiatric disorders 0 trials
- Developmental delay, dysmorphic facies, and brain anomalies 0 trials
- Developmental delay, hypotonia, and impaired language 0 trials
- Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities 0 trials
- Developmental delay, impaired speech, and behavioral abnormalities 0 trials
- Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures 0 trials
- Developmental delay, language impairment, and ocular abnormalities 0 trials
- Dextrocardia with unusual facies and microphthalmia 0 trials
- Diabetes mellitus, congenital autoimmune 0 trials
- Diabetes, deafness, developmental delay, and short stature syndrome 0 trials
- Diaminopentanuria 0 trials
- Diarrhea, glucose-stimulated secretory, with common variable immunodeficiency 0 trials
- Diencephalic-mesencephalic junction dysplasia 0 trials Sub-types →
- Diffuse idiopathic skeletal hyperostosis 0 trials
- Dilution, pigmentary 0 trials
- Disabling pansclerotic morphea of childhood 0 trials
- Discrimination, Two-point, reduction 1N 0 trials
- Dislocated elbows, bowed tibias, scoliosis, deafness, cataract, microcephaly, and intellectual disability 0 trials
- Disseminated sclerosis with narcolepsy 0 trials
- Distal monosomy 10p 0 trials Sub-types →
- Distal osteosclerosis 0 trials
- Distal symphalangism 0 trials
- Distichiasis with congenital anomalies of the heart and peripheral vasculature 0 trials
- Double fingernail of fifth finger 0 trials
- Double nail for fifth toe 0 trials
- Duodenal ulcer due to antral G-cell hyperfunction 0 trials
- Duodenal ulcer, hyperpepsinogenemic 1 0 trials
- Duodenojejunal atresia with volvulus, absent dorsal mesentery, and absent superior mesenteric artery 0 trials
- Dwarfism with stiff joints and ocular abnormalities 0 trials
- Dwarfism with tall vertebrae 0 trials
- Dwarfism, Levi type 0 trials
- Dwarfism, familial, with muscle spasms 0 trials
- Dwarfism, intellectual disability, and eye abnormality 0 trials
- Dwarfism, low-birth-weight type, with unresponsiveness to growth hormone 0 trials
- Dwarfism, proportionate, with hip dislocation 0 trials
- Dyschromatosis, ichthyosis, deafness, and atopic disease 0 trials
- Dysmorphism-cleft palate-loose skin syndrome 0 trials
- Dysmyelination with jaundice 0 trials
- Dysostosis multiplex, Ain-Naz type 0 trials
- Dysraphism-cleft lip/palate-limb reduction defects syndrome 0 trials
- Dystelephalangy 0 trials
- Dystonia with Ringbinden 0 trials
- Dystonia with cerebellar atrophy 0 trials
- Dystonia, early-onset, and/or spastic paraplegia 0 trials
- Ear antitragus, tag at base of 0 trials
- Ear exostoses 0 trials
- Ear folding 0 trials
- Ear pits, posterior helical 0 trials
- Early response to neural induction gene 0 trials
- Early-onset familial hypoaldosteronism 0 trials
- Eccrine syringofibroadenomatosis with eyelid abnormalities 0 trials
- Ectodermal dysplasia syndrome with distinctive facial appearance and preaxial polydactyly of feet 0 trials
- Ectodermal dysplasia with adrenal cyst 0 trials
- Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies 0 trials
- Ectodermal dysplasia with intellectual disability and syndactyly 0 trials
- Ectodermal dysplasia, sensorineural hearing loss, and distinctive facial features 0 trials
- Ectopia lentis 1, isolated, autosomal dominant 0 trials
- Ectopia lentis 2, isolated, autosomal recessive 0 trials
- Ectopia lentis et pupillae 0 trials
- Ectopia pupillae 0 trials
- Ectrodactyly and ectodermal dysplasia without cleft lip/palate 0 trials
- Ectrodactyly of lower limbs, congenital heart defect, and micrognathia 0 trials
- Ectrodactyly-cleft palate syndrome 0 trials
- Edema, familial idiopathic, prepubertal 0 trials
- Electroencephalographic peculiarity: 14 and 6 per sec. positive spike phenomenon 0 trials
- Emphysema, congenital, with deafness, penoscrotal web, and intellectual disability 0 trials
- Emphysema, hereditary pulmonary 0 trials
- Enamel hypoplasia, cataracts, and aqueductal stenosis 0 trials
- Encephalitis, acute, infection-induced, susceptibility to, 12 0 trials
- Encephalomalacia, multilocular 0 trials
- Encephalomyopathy, mitochondrial, due to voltage-dependent anion channel deficiency 0 trials
- Endocardial fibroelastosis and coarctation of abdominal aorta 0 trials
- Endocrine-cerebro-osteodysplasia syndrome 0 trials
- Endothelial dystrophy, congenital hereditary, with nail hypoplasia 0 trials
- Enteropathy, familial, with villous edema and immunoglobulin G2 deficiency 0 trials
- Enuresis, nocturnal, 1 0 trials
- Epidermoid cysts 0 trials
- Epidermolysis bullosa with congenital localized absence of skin and deformity of nails 0 trials
- Epidermolysis bullosa with deficiency of galactosylhydroxylysyl glucosyltransferase 0 trials
- Epidermolysis bullosa with diaphragmatic hernia 0 trials
- Epilepsy, partial, with pericentral spikes 0 trials
- Epilepsy, photogenic, with spastic diplegia and intellectual disability 0 trials
- Epiphyseal dysplasia of femoral head, myopia, and deafness 0 trials
- Epiphyseal dysplasia, Baumann type 0 trials
- Episodic muscle weakness, X-linked 0 trials
- Epithelial basolateral chloride conductance regulator, rabbit, homolog of 0 trials
- Epithelial recurrent erosion dystrophy 0 trials
- Epithelial squamous dysplasia, keratinizing desquamative, of urinary tract 0 trials
- Erythema nodosum, familial 0 trials
- Erythema of acral regions 0 trials
- Esophageal ring, lower 0 trials
- Esophagitis, eosinophilic, 2 0 trials
- Estrogen resistance syndrome 0 trials
- Ethanolaminosis 0 trials
- Exchondrosis of pinna, posterior 0 trials
- Exercise intolerance, riboflavin-responsive 0 trials
- Exostoses-anetodermia-brachydactyly type E syndrome 0 trials
- Exostosis, Dupuytren subungual 0 trials
- Extraoral halitosis due to methanethiol oxidase deficiency 0 trials
- Facial abnormalities, kyphoscoliosis, and intellectual disability 0 trials
- Facial dysmorphism, cleft palate, hearing loss, and camptodactyly 0 trials
- Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome 0 trials
- Facial dysmorphism, selective tooth agenesis, and choroid calcification 0 trials
- Facial dysmorphism-immunodeficiency-livedo-short stature syndrome 0 trials
- Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome 0 trials
- Facial palsy, congenital, with ptosis and velopharyngeal dysfunction 0 trials
- Facial paresis, hereditary congenital, 3 0 trials
- Facial spasm 0 trials
- Faciocardiomelic syndrome 0 trials
- Faciothoracogenital syndrome 0 trials
- Factor 9 and Factor XI, combined deficiency of 0 trials
- Factor VIII and Factor IX, combined deficiency of 0 trials
- Factors VIII, IX and XI, combined deficiency of 0 trials
- Familial caudal dysgenesis 0 trials Sub-types →
- Familial cavitary optic disk anomaly 0 trials
- Familial cervical artery dissection 0 trials
- Familial gestational hyperthyroidism 0 trials
- Familial glucocorticoid deficiency 0 trials Sub-types →
- Familial hyperthyroidism due to mutations in TSH receptor 0 trials
- Familial lipochrome histiocytosis 0 trials
- Familial monosomy 7 syndrome 0 trials Sub-types →
- Familial parathyroid adenoma 0 trials
- Familial partial paralysis 0 trials
- Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome 0 trials
- Familial supernumerary nipples 0 trials
- Familial visceral myopathy 0 trials Sub-types →
- Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies 0 trials
- Fever, familial lifelong persistent 0 trials
- Fibromatosis, gingival, with hypertrichosis and intellectual disability 0 trials
- Fibromuscular dysplasia, multifocal 0 trials
- Fibrosclerosis, multifocal 0 trials
- Fibrosis, neurodegeneration, and cerebral angiomatosis 0 trials
- Fibula, recurrent dislocation of head of 0 trials
- Flushing of ears and somnolence 0 trials
- Focal epithelial hyperplasia 0 trials
- Focal epithelial hyperplasia of the oral mucosa 0 trials
- Focal segmental glomerulosclerosis and neurodevelopmental syndrome 0 trials
- Follicular atrophoderma, perioral pigmented, with milia and epidermoid cysts 0 trials
- Forsythe-wakeling syndrome 0 trials
- Fragile site 10Q23 0 trials
- Frontoocular syndrome 0 trials
- Fructose and galactose intolerance 0 trials
- Fucosidase regulator 0 trials
- Fucosyltransferase 6 deficiency 0 trials
- Fused mandibular incisors 0 trials
- Gamma-A-globulin, defect in assembly of 0 trials
- Gastric mucosal hypertrophy 0 trials
- Gastric volvulus, intrathoracic 0 trials
- Gelatinous drop-like corneal dystrophy 0 trials
- Genitourinary and/or brain malformation syndrome 0 trials
- Giant neutrophil leukocytes 0 trials
- Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome 0 trials
- Global developmental delay with speech and behavioral abnormalities 0 trials
- Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 0 trials
- Global developmental delay, progressive ataxia, and elevated glutamine 0 trials
- Globulin anomaly involving beta (2A)-globulin 0 trials
- Glomuvenous malformation 0 trials
- Glucocorticoid therapy, response to 0 trials
- Glucose-6-phosphate dehydrogenase-like 0 trials
- Glutamic acid decarboxylase, brain, membrane form 0 trials
- Glutamyl ribose-5-phosphate storage disease 0 trials
- Glutathione transferase activity toward trans-stilbene oxide 0 trials
- Gluteal muscles, absence of 0 trials
- Glycosylphosphatidylinositol biosynthesis defect 21 0 trials
- Gonadal agenesis 0 trials
- Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy 0 trials
- Granddad syndrome 0 trials
- Grange syndrome 0 trials
- Granulocytopenia with immunoglobulin abnormality 0 trials
- Granulomas, congenital cerebral 0 trials
- Granulosis rubra nasi 0 trials
- Growth and developintellectual disability, ocular ptosis, cardiac defect, and anal atresia 0 trials
- Growth failure, microcephaly, intellectual disability, cataracts, large joint contractures, osteoporosis, cortical dysplasia, and cerebellar atrophy 0 trials
- Growth restriction, hypoplastic kidneys, alopecia, and distinctive facies 0 trials
- Growth retardation-mild developmental delay-chronic hepatitis syndrome 0 trials
- Guanylate cyclase 2E 0 trials
- Guanylate kinase 3 0 trials
- Hairy ears, Y-linked 0 trials
- Hairy nose tip 0 trials
- Hairy palms and soles 0 trials
- Hamartoma, Precalcaneal congenital fibrolipomatous 0 trials
- Hand clasping pattern 0 trials
- Headache associated with sexual activity 0 trials
- Hearing loss, noise-induced, susceptibility to 0 trials
- Heart and brain malformation syndrome 0 trials
- Heart-hand syndrome 0 trials Sub-types →
- Hemangiomatosis, cutaneous, with associated features 0 trials
- Hemifacial myohyperplasia 0 trials
- Hemoglobin--variants for which the chain carrying the mutation 1S unknown or uncertain 0 trials
- Hemolytic poikilocytic anemia due to reduced ankyrin binding sites 0 trials
- Hemopoietic proliferation 0 trials
- Hepatic adenomas, familial 0 trials
- Hepatic veno-occlusive disease-immunodeficiency syndrome 0 trials
- Hepatorenocardiac degenerative fibrosis 0 trials
- Hereditary fallopian tube carcinoma 0 trials
- Hereditary hyperferritinemia with congenital cataracts 0 trials
- Hereditary hypotrichosis with recurrent skin vesicles 0 trials
- Hereditary neuro-ophthalmological disease 0 trials
- Hereditary neuroendocrine tumor of small intestine 0 trials
- Hereditary neutrophilia 0 trials
- Hereditary sensory and autonomic neuropathy with deafness and global delay 0 trials
- Heterochromia iridis 0 trials
- High myopia-sensorineural deafness syndrome 0 trials
- Histiocytic dermatoarthritis 0 trials
- Holoprosencephaly, recurrent infections, and monocytosis 0 trials
- Humero-radio-ulnar synostosis 0 trials Sub-types →
- Humerofemoral hypoplasia with radiotibial ray deficiency 0 trials
- Humeroradial synostosis 0 trials Sub-types →
- Humerus trochlea aplasia 0 trials
- Hyaluronan metabolism, defect 1N 0 trials
- Hydrocephalus, congenital communicating, 1 0 trials
- Hydrops fetalis, nonimmune, with gracile bones and dysmorphic features 0 trials
- Hydroxyacyl glutathione hydrolase deficiency 0 trials
- Hydroxyprolinemia 0 trials
- Hymen, imperforate 0 trials
- Hyperbiliverdinemia 0 trials
- Hypercalciuria, absorptive, 2 0 trials
- Hyperglycinuria 0 trials
- Hyperheparinemia 0 trials
- Hyperimmunoglobulin G1(A1) syndrome 0 trials
- Hyperleucine-Isoleucinemia 0 trials
- Hyperlipoproteinemia, type II, and deafness 0 trials
- Hyperlysinuria with hyperammonemia 0 trials
- Hypermetabolism due to defect in mitochondria 0 trials
- Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2 0 trials
- Hyperopia, high 0 trials
- Hyperostosis cranialis interna 0 trials
- Hyperparathyroidism, neonatal self-limited primary, with hypercalciuria 0 trials
- Hyperphosphatemia, polyuria, and seizures 0 trials
- Hyperpigmentation of Fuldauer and Kuijpers 0 trials
- Hyperproglucagonemia 0 trials
- Hyperproinsulinemia 0 trials
- Hypersecretion of adrenal androgens, familial 0 trials
- Hypersulfaturia 0 trials
- Hypertelorism and other facial dysmorphism, brachydactyly, genital abnormalities, intellectual disability, and recurrent inflammatory episodes 0 trials
- Hypertelorism and tetralogy of fallot 0 trials
- Hypertelorism-preauricular sinus-punctual pits-deafness syndrome 0 trials
- Hyperthermia, cutaneous, with headaches and nausea 0 trials
- Hyperthyroxinemia, dystransthyretinemic 0 trials
- Hyperthyroxinemia, euthyroid, caused by generalized 5-prime-deiodinase deficiency 0 trials
- Hyperthyroxinemia, familial dysalbuminemic 0 trials
- Hypertrophia musculorum vera 0 trials
- Hypertrophic neuropathy and cataract 0 trials
- Hyperuricemia, infantile, with abnormal behavior and normal hypoxanthine guanine phosphoribosyltransferase 0 trials
- Hypoglycemia, leucine-induced 0 trials
- Hypogonadism with low-grade mental deficiency and microcephaly 0 trials
- Hypohidrosis with abnormal palmar dermal Ridges 0 trials
- Hypoinsulinemic hypoglycemia and body hemihypertrophy 0 trials
- Hypokalemic alkalosis, familial, with specific renal tubulopathy 0 trials
- Hypokalemic tubulopathy and deafness 0 trials
- Hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial 0 trials
- Hypophosphatemia, renal, with intracerebral calcifications 0 trials
- Hypophosphatemic bone disease 0 trials
- Hypophosphatemic rickets and hyperparathyroidism 0 trials
- Hypopigmentation, organomegaly, and delayed myelination and development 0 trials
- Hypopituitarism, congenital, with central diabetes insipidus 0 trials
- Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome 0 trials
- Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration 0 trials
- Hypotaurinemic retinal degeneration and cardiomyopathy 0 trials
- Hypotonia, ataxia, and delayed development syndrome 0 trials
- Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome 0 trials
- Hypotonia, congenital nystagmus, ataxia, and abnormal auditory brainstem responses 0 trials
- Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities 0 trials
- Hypotonia, seizures, and precocious puberty 0 trials
- Hypotrichosis, progressive patterned scalp, with wiry hair, onycholysis, and cleft lip/palate 0 trials
- Hypoxanthine guanine phosphoribosyltransferase suppressor 0 trials
- Ichthyosis and male hypogonadism 0 trials
- Ichthyosis congenita with biliary atresia 0 trials
- Ichthyosis, split hairs, and amino aciduria 0 trials
- Ichthyosis-cheek-eyebrow syndrome 0 trials
- Ichthyosis-intellectual disability syndrome with large keratohyalin granules in the skin 0 trials
- Ichthyosis-intellectual disability-dwarfism-renal impairment syndrome 0 trials
- Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features 0 trials
- Immune dysregulation with immunodeficiency due to AIOLOS haploinsufficiency 0 trials
- Immune dysregulation, autoimmunity, and autoinflammation 0 trials
- Immune dysregulation, neurodevelopmental defects, and colitis 0 trials
- Immunodeficiency 28 0 trials
- Immunodeficiency 37 0 trials Sub-types →
- Immunodeficiency 39 0 trials
- Immunodeficiency 47 0 trials
- Immunodeficiency with defective T-cell response to interleukin 1 0 trials
- Immunodeficiency, X-linked, with deficiency of 115,000 Dalton surface glycoprotein 0 trials
- Immunodeficiency, developmental delay, and hypohomocysteinemia 0 trials
- Immunoglobulin M, level of 0 trials
- Immunoglobulin d level in plasma, low 0 trials
- Imperforate oropharynx-costo vetebral anomalies syndrome 0 trials
- Imprinting gene related to retinoblastoma 0 trials
- Incisors, lower central, absence of 0 trials
- Incisors, rotation of upper central 0 trials
- Incisors, shovel-shaped 0 trials
- Indolylacroyl glycinuria with intellectual disability 0 trials
- Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development 0 trials
- Inflammatory bowel disease, immunodeficiency, and encephalopathy 0 trials
- Inherited hypertrophic pyloric stenosis 0 trials Sub-types →
- Inherited isolated nail anomaly 0 trials Sub-types →
- Inherited oocyte maturation defect 0 trials Sub-types →
- Inosine phosphorylase deficiency, immune defect due to 0 trials
- Insensitivity to pain with hyperplastic Myelinopathy 0 trials
- Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature 0 trials
- Intellectual developmental disorder with autism and dysmorphic facies 0 trials
- Intellectual developmental disorder with autistic features and language delay, with or without seizures 0 trials
- Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures 0 trials
- Intellectual developmental disorder with cardiac defects and dysmorphic facies 0 trials
- Intellectual developmental disorder with hypertelorism and distinctive facies 0 trials
- Intellectual developmental disorder with hypotonia and behavioral abnormalities 0 trials
- Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies 0 trials
- Intellectual developmental disorder with impaired language and dysmorphic facies 0 trials
- Intellectual developmental disorder with macrocephaly, seizures, and speech delay 0 trials
- Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects 0 trials
- Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies 0 trials
- Intellectual developmental disorder with ocular anomalies and distinctive facial features 0 trials
- Intellectual developmental disorder with or without epilepsy or cerebellar ataxia 0 trials
- Intellectual developmental disorder with or without peripheral neuropathy 0 trials
- Intellectual developmental disorder with paroxysmal dyskinesia or seizures 0 trials
- Intellectual developmental disorder with poor growth and with or without seizures or ataxia 0 trials
- Intellectual developmental disorder with seizures and dysmorphic facies 0 trials
- Intellectual developmental disorder with seizures and language delay 0 trials
- Intellectual developmental disorder with short stature and behavioral abnormalities 0 trials
- Intellectual developmental disorder with short stature and variable skeletal anomalies 0 trials
- Intellectual developmental disorder with speech delay and axonal peripheral neuropathy 0 trials
- Intellectual developmental disorder with speech delay, autism, and dysmorphic facies 0 trials
- Intellectual developmental disorder, autosomal dominant 77 0 trials
- Intellectual developmental disorder, autosomal recessive 84 0 trials
- Intellectual disability and myopathy syndrome 0 trials
- Intellectual disability with optic atrophy, facial dysmorphism, microcephaly, and short stature 0 trials
- Intellectual disability, FRA12A type 0 trials
- Intellectual disability, anterior maxillary protrusion, and strabismus 0 trials
- Intellectual disability, keratoconus, febrile seizures, and sinoatrial block 0 trials
- Intellectual disability, microcephaly, growth retardation, joint contractures, and facial dysmorphism 0 trials
- Intellectual disability, severe, with spasticity and pigmentary tapetoretinal degeneration 0 trials
- Intellectual disability, short stature, facial anomalies, and joint dislocations 0 trials
- Intellectual disability-brachydactyly-Pierre Robin syndrome 0 trials
- Intellectual disability-strabismus syndrome 0 trials
- Interferon antiviral depressor 0 trials
- Internal carotid arteries, hypoplasia of 0 trials
- Internal carotid artery, spontaneous dissection of 0 trials
- Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency 0 trials
- Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked 0 trials
- Iridogoniodysgenesis and skeletal anomalies 0 trials
- Iris pattern 0 trials
- Iris pigment epithelium anomalies 0 trials
- Iris pigment layer, cleavage of 0 trials
- Ischio-vertebral syndrome 0 trials
- Isolated aniridia 0 trials Sub-types →
- Isolated cryptophthalmia 0 trials Sub-types →
- Isolated hyperferritinemia 0 trials
- Isolated neonatal sclerosing cholangitis 0 trials
- Isolated right ventricular hypoplasia 0 trials
- Isoproterenol-mediated vasodilatation 0 trials
- Isovaleric acid, inability to smell 0 trials
- Jaundice, familial obstructive, of infancy 0 trials Sub-types →
- Jejunal atresia with renal adysplasia 0 trials
- Joint contractures, osteochondromas, and B-cell lymphoma 0 trials
- Kallikrein, decreased urinary activity of 0 trials
- Keloid formation 0 trials
- Keratitis fugax hereditaria 0 trials
- Keratoconus and congenital hip dysplasia 0 trials
- Keratoconus posticus circumscriptus 0 trials
- Keratoderma hereditarium mutilans 0 trials
- Keratoderma-ichthyosis-deafness syndrome, autosomal recessive 0 trials
- Keratosis, familial actinic 0 trials
- Knuckle pads 0 trials
- Labia minora, incomplete adhesion of 0 trials
- Lactic acidosis, chronic adult form 0 trials
- Language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia 0 trials
- Laryngeal abductor paralysis with cerebellar ataxia and motor neuropathy 0 trials
- Laryngeal atresia, encephalocele, and limb deformities 0 trials
- Lateral semicircular canal malformation, familial, with external and middle ear abnormalities 0 trials
- Lattice degeneration of retina leading to retinal detachment 0 trials
- Leg ulcers, familial, of juvenile onset 0 trials
- Lentiginosis, centrofacial neurodysraphic 0 trials
- Lessel-kubisch syndrome 0 trials
- Lethal faciocardiomelic dysplasia 0 trials
- Lethal polymalformative syndrome, Boissel type 0 trials
- Lethal recessive chondrodysplasia 0 trials
- Leukemia, acute myelocytic, with polyposis coli and colon cancer 0 trials
- Leukocyte nuclear appendages, hereditary prevalence of 0 trials
- Leukodystrophy and acquired microcephaly with or without dystonia; 0 trials
- Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate 0 trials
- Leukoencephalopathy, arthritis, colitis, and hypogammaglobulinema 0 trials
- Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome 0 trials
- Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome 0 trials
- Leukoencephalopathy, progressive, infantile-onset, with or without deafness 0 trials
- Limb transversal defect-cardiac anomaly syndrome 0 trials
- Lip, hamartomatous 0 trials
- Lipodystrophy, partial, acquired, with low complement component c3, with or without glomerulonephritis 0 trials
- Lipoprotein types--Lt system 0 trials
- Lipoprotein, variant of beta 0 trials
- Lissencephaly, familial, with cleft palate and cerebellar hypoplasia 0 trials
- Lithium transport 0 trials
- Liver disease, severe congenital 0 trials
- Liver fibrocystic disease and polydactyly 0 trials
- Long chain fatty acids, defect in transport of 0 trials
- Low density lipoprotein, variation in molecular weight of 0 trials
- Lung disease, immunodeficiency, and chromosome breakage syndrome; 0 trials
- Lymphedema-posterior choanal atresia syndrome 0 trials
- Lymphoid system deterioration, progressive 0 trials
- Lymphopenic hypergammaglobulinemia, antibody deficiency, autoimmune hemolytic anemia, and glomerulonephritis 0 trials
- Lysine malabsorption syndrome 0 trials
- Macrocephaly, acquired, with impaired intellectual development 0 trials
- Macrocephaly, benign familial 0 trials
- Macrocephaly, dysmorphic facies, and psychomotor retardation 0 trials Sub-types →
- Macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin 0 trials
- Macrocephaly-developmental delay syndrome 0 trials
- Macrocytosis, familial 0 trials
- Macroepiphyseal dysplasia with osteoporosis, wrinkled skin, and aged appearance 0 trials
- Macrosomia adiposa congenita 0 trials
- Magnesium, elevated red cell 0 trials
- Maleylacetoacetate isomerase deficiency 0 trials
- Malocclusion and short stature 0 trials
- Mammary-digital-nail syndrome 0 trials
- Mandibulofacial dysostosis syndrome, Bauru type 0 trials
- Mandibulofacial dysostosis with alopecia 0 trials
- Mandibulofacial dysostosis with mental deficiency 0 trials
- Mandibulofacial dysostosis with ptosis, autosomal dominant 0 trials
- Mannose 6-phosphate receptor recognition defect, Lebanese type 0 trials
- Marfanoid habitus with situs inversus 0 trials
- Marfanoid hypermobility syndrome 0 trials
- Maxillofacial dysostosis 0 trials
- Mediosternal depigmentation line 0 trials
- Medium chain 3-ketoacyl-Coa thiolase deficiency 0 trials
- Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations 0 trials
- Megabladder, congenital 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 0 trials Sub-types →
- Megaepiphyseal dwarfism 0 trials
- Megalencephaly with dysmyelination 0 trials
- Megalencephaly-polydactyly syndrome 0 trials
- Megalocornea 0 trials Sub-types →
- Melanoma tumor antigen Gp90 0 trials
- Menstrual cycle-dependent periodic fever 0 trials
- Mental and growth retardation with amblyopia 0 trials
- Mesoaxial hexadactyly and cardiac malformation 0 trials
- Mesomelic dwarfism of hypoplastic tibia and radius type 0 trials
- Mesomelic dysplasia, camera type 0 trials
- Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression 0 trials
- Metachondromatosis 0 trials
- Metachromasia of fibroblasts 0 trials
- Metaphyseal chondrodysplasia with cone-shaped epiphyses, normal hair, and normal hands 0 trials
- Metaphyseal chondrodysplasia, Pena type 0 trials
- Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria 0 trials
- Metaphyseal dysplasia, anetoderma, and optic atrophy 0 trials
- Metaphyseal modeling abnormality, skin lesions, and spastic paraplegia 0 trials
- Metaphyseal undermodeling, spondylar dysplasia, and overgrowth 0 trials
- Metatarsus varus, type 1 0 trials
- Methionine malabsorption syndrome 0 trials
- Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum 0 trials
- Microcephaly, corpus callosum dysgenesis, and cleft lip/palate 0 trials
- Microcephaly, developmental delay, and brittle hair syndrome 0 trials
- Microcephaly, epilepsy, and diabetes syndrome 0 trials Sub-types →
- Microcephaly, facial abnormalities, micromelia, and intellectual disability 0 trials
- Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome 0 trials
- Microcephaly, growth deficiency, seizures, and brain malformations 0 trials
- Microcephaly, growth restriction and increased sister chromatid exchange 0 trials Sub-types →
- Microcephaly, growth retardation, cataract, hearing loss, and unusual appearance 0 trials
- Microcephaly, macrotia, and intellectual disability 0 trials
- Microcephaly, retinitis pigmentosa, and sutural cataract 0 trials
- Microcephaly, severe, with skeletal anomalies including posterior rib-Gap defects 0 trials
- Microcephaly, short stature, and impaired glucose metabolism 0 trials Sub-types →
- Microcephaly, short stature, and limb abnormalities 0 trials
- Microcephaly-brachydactyly-kyphoscoliosis syndrome 0 trials
- Microcephaly-capillary malformation syndrome 0 trials
- Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome 0 trials
- Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome 0 trials
- Microcephaly-micromelia syndrome 0 trials
- Microcephaly-thin corpus callosum-intellectual disability syndrome 0 trials
- Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1 0 trials
- Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2 0 trials
- Microphthalmia with cyst, bilateral facial clefts, and limb anomalies 0 trials
- Microphthalmia with hyperopia, retinal degeneration, macrophakia, and dental anomalies 0 trials
- Microphthalmia, isolated, with corectopia 0 trials
- Microspherophakia with hernia 0 trials
- Microspherophakia-metaphyseal dysplasia syndrome 0 trials
- Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis 0 trials
- Midface hypoplasia, obesity, developmental delay, and neonatal hypotonia 0 trials
- Midline malformations, multiple, with limb abnormalities and hypopituitarism 0 trials
- Milia, multiple eruptive 0 trials
- Mitochondrial complex 1 deficiency, nuclear type 35 0 trials
- Mitochondrial import-stimulating factor 0 trials
- Mitochondrial intermembrane space protein Tim12, yeast, homolog of 0 trials
- Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency 0 trials
- Monosodium glutamate sensitivity 0 trials
- Mucocutaneous ulceration, chronic 0 trials
- Mucus inspissation of respiratory tract 0 trials
- Mullerian aplasia and hyperandrogenism 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 0 trials Sub-types →
- Multiple congenital anomalies-neurodevelopmental syndrome, X-linked 0 trials
- Multiple exostoses with spastic tetraparesis 0 trials
- Multiple fibroadenoma of the breast 0 trials
- Multiple synostoses syndrome 0 trials Sub-types →
- Muscle cramps, familial 0 trials
- Muscular atrophy, malignant neurogenic 0 trials
- Muscular dystrophy, adult-onset, with leukoencephalopathy 0 trials
- Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome 0 trials
- Muscular dystrophy, congenital, with cerebellar atrophy 0 trials
- Muscular dystrophy, congenital, with or without seizures 0 trials
- Muscular dystrophy, congenital, with severe central nervous system atrophy and absence of large myelinated fibers 0 trials
- Muscular hypoplasia, congenital universal, of Krabbe 0 trials
- Musk, inability to smell 0 trials
- Myelinated optic nerve fibers 0 trials
- Myelodysplasia, immunodeficiency, facial dysmorphism, short stature, and psychomotor delay 0 trials
- Myelofibrosis, congenital, with anemia, neutropenia, developmental delay, and ocular abnormalities 0 trials
- Myeloid tumor suppressor 0 trials
- Myelolymphatic insufficiency 0 trials
- Myoclonic epilepsy, congenital deafness, macular dystrophy, and psychiatric disorders 0 trials
- Myopathy due to malate-aspartate shuttle defect 0 trials
- Myopathy with giant abnormal mitochondria 0 trials
- Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1 0 trials
- Myopathy with storage of glycoproteins and Glycosaminoglycans 0 trials
- Myopathy, congenital, with excess of muscle spindles 0 trials
- Myopathy, granulovacuolar lobular, with electrical myotonia 0 trials
- Nanophthalmia 0 trials Sub-types →
- Nasal bones, absence of 0 trials
- Nasal groove, familial transverse 0 trials
- Nasal hyperpigmentation, familial transverse 0 trials
- Nephropathy - deafness - hyperparathyroidism syndrome 0 trials
- Nephropathy, chronic tubulointerstitial 0 trials
- Nephropathy, progressive, with deafness 0 trials
- Neurocardiofaciodigital syndrome 0 trials
- Neurodegeneration, infantile-onset, with optic atrophy and brain abnormalities 0 trials
- Neurodevelopmental, jaw, eye, and digital syndrome 0 trials
- Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities 0 trials
- Neuroectodermal melanolysosomal disease 0 trials
- Neuroendocrine carcinoma of salivary glands, sensorineural hearing loss, and enamel hypoplasia 0 trials
- Neurofacioskeletal syndrome with or without renal agenesis 0 trials
- Neurofibromatosis-pheochromocytoma-duodenal carcinoid syndrome 0 trials
- Neurologic disease, infantile multisystem, with osseous fragility 0 trials
- Neuromuscular disease and ocular or auditory anomalies with or without seizures 0 trials
- Neurooculocardiogenitourinary syndrome 0 trials
- Neurooculorenal syndrome 0 trials
- Neuropathy, congenital, with arthrogryposis multiplex 0 trials
- Neuropathy, hereditary motor and sensory, with excessive myelin folding complex, autosomal recessive 0 trials
- Neuropathy, hereditary sensory and autonomic, adult-onset, with anosmia 0 trials
- Neuropathy, with paraprotein in serum, cerebrospinal fluid and urine 0 trials
- Nevus anemicus 0 trials
- Nevus flammeus of nape of neck 0 trials
- Nipples inverted 0 trials
- Noduli Cutanei, multiple, with urinary tract abnormalities 0 trials
- Nondisjunction 0 trials
- Nuclear ribonucleic acid 0 trials
- Obesity and hypopigmentation 0 trials
- Obesity, hyperphagia, and developmental delay 0 trials
- Occipital hair, white lock of 0 trials
- Ocular myopathy with curare sensitivity 0 trials
- Ocular pterygium-digital keloid dysplasia syndrome 0 trials
- Oculocerebrofacial syndrome, Kaufman type 0 trials
- Oculogastrointestinal-neurodevelopmental syndrome 0 trials
- Oculomaxillofacial dysostosis 0 trials Sub-types →
- Oculomotor-abducens synkinesis 0 trials
- Oculopharyngeal myopathy with leukoencephalopathy 1 0 trials
- Oculorenocerebellar syndrome 0 trials
- Oculotrichoanal syndrome 0 trials
- Oculovertebral syndrome 0 trials
- Odontoid hypoplasia 0 trials
- Oligodontia-cancer predisposition syndrome 0 trials
- Olivopontocerebellar atrophy II, autosomal recessive 0 trials
- Omphalocele, X-linked 0 trials
- Omphalocele, autosomal 0 trials
- Omphalocele, diaphragmatic hernia, and radial ray defects 0 trials
- Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome 0 trials
- Onychogryposis, pedal, with keratosis plantaris and coarse hair 0 trials
- Ophthalmomandibulomelic dysplasia 0 trials
- Ophthalmoplegia totalis with ptosis and miosis 0 trials
- Ophthalmoplegia, external, and myopia 0 trials
- Ophthalmoplegia, external, with rib and vertebral anomalies 0 trials
- Ophthalmoplegia, familial static 0 trials
- Ophthalmoplegia, familial total, with iris transillumination 0 trials
- Ophthalmoplegic neuromuscular disorder with abnormal mitochondria 0 trials
- Optic atrophy, hearing loss, and peripheral neuropathy, autosomal recessive 0 trials
- Optic atrophy--spastic paraplegia syndrome 0 trials
- Oral sensibility, disturbance of 0 trials
- Orofaciodigital syndrome 0 trials Sub-types →
- Oromandibular-limb hypogenesis syndrome 0 trials Sub-types →
- Orthostatic hypotensive disorder, Streeten type 0 trials
- Ossicular malformations, familial 0 trials
- Ossified ear cartilages 0 trials
- Osteochondrodysplasia, brachydactyly, and overlapping malformed digits 0 trials
- Osteochondrodysplasia, rhizomelic, with callosal agenesis, thrombocytopenia, hydrocephalus, and hypertension 0 trials
- Osteochondrodysplatic nanism-deafness-retinitis pigmentosa syndrome 0 trials
- Osteodysplasty, precocious, of Danks, Mayne, and Kozlowski 0 trials
- Osteoma of cranial vault, familial 0 trials
- Osteoma of middle ear 0 trials
- Osteootohepatoenteric syndrome 0 trials
- Osteoporosis, childhood- or juvenile-onset, with developmental delay 0 trials
- Osteoporosis-oculocutaneous hypopigmentation syndrome 0 trials
- Osteosclerosis with ichthyosis and fractures 0 trials
- Osteosclerotic chondrodysplasia, lethal, with intracellular inclusions 0 trials
- Otofaciocervical syndrome 0 trials Sub-types →
- Otofacioosseous-gonadal syndrome 0 trials
- Otoonychoperoneal syndrome 0 trials
- Ovalocytosis, hereditary hemolytic, with defective erythropoiesis 0 trials
- Ovarian dysgenesis, hypergonadotropic, with short stature and recurrent metabolic acidosis 0 trials
- Pachydermodactyly, familial 0 trials
- Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures 0 trials
- Palant cleft palate syndrome 0 trials
- Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome 0 trials
- Palmaris longus muscle, absence of 0 trials
- Pancreatic beta cell agenesis with neonatal diabetes mellitus 0 trials
- Pancreatic hypoplasia-diabetes-congenital heart disease syndrome 0 trials
- Pancreatic lymphoma, familial 0 trials
- Pancreatitis, sclerosing cholangitis, and sicca complex 0 trials
- Pancytopenia and occlusive vascular disease 0 trials
- Papillomatosis, florid, of nipple 0 trials
- Parotid salivary glands, polycystic dysgenetic disease of 0 trials
- Parotitis, juvenile recurrent 0 trials
- Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome 0 trials
- Patella aplasia/hypoplasia 0 trials Sub-types →
- Patent ductus venosus 0 trials
- Peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome 0 trials
- Pellagra-like syndrome 0 trials
- Pelvic lipomatosis with crossed renal ectopia 0 trials
- Periodic fever, immunodeficiency, and thrombocytopenia syndrome 0 trials
- Peripapillary atrophy, beta type 0 trials
- Peripheral cone dystrophy 0 trials
- Peripheral neuropathy, ataxia, focal necrotizing encephalopathy, and spongy degeneration of brain 0 trials
- Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development 0 trials
- Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome 0 trials
- Peroneal nerve, accessory deep 0 trials
- Peroneus tertius muscle, absence of 0 trials
- Peroxidase, salivary 0 trials
- Phagocytosis, plasma-related defect 1N 0 trials
- Phenformin 4-hydroxylation 0 trials
- Pheochromocytoma-islet cell tumor syndrome 0 trials
- Phlebectasia of lips 0 trials
- Phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome 0 trials
- Phosphatase, acid, of tissues 0 trials
- Phosphoglucomutase 4 0 trials
- Phosphoglycoprotein 1 0 trials
- Phosphohydroxylysinuria 0 trials
- Phosphoribosylaminoimidazole carboxylase deficiency 0 trials
- Photomyoclonus, diabetes mellitus, deafness, nephropathy, and cerebral dysfunction 0 trials
- Pigmented purpuric eruption 0 trials
- Pituitary dwarfism with large sella turcica 0 trials
- Plasma clot retraction factor, deficiency of 0 trials
- Plasma fibronectin deficiency 0 trials
- Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease 0 trials
- Platelet adenylate cyclase activity 0 trials
- Platelet disorder, undefined 0 trials
- Platelet factor 3 deficiency 0 trials
- Platelet prostacyclin receptor defect 0 trials
- Platelet responsiveness to adrenaline, depressed 0 trials
- Platelet signal processing defect 0 trials
- Platelet-activating factor acetylhydrolase deficiency 0 trials
- Pleoconial myopathy with salt craving 0 trials
- Polycystic bone disease 0 trials
- Polycystic kidney, cataract, and congenital blindness 0 trials
- Polydactyly-macrocephaly syndrome 0 trials
- Polyhydramnios, chronic idiopathic 0 trials
- Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome 0 trials
- Polymyoclonus, infantile 0 trials
- Polyneuropathy, lethal neonatal, axonal sensorimotor, autosomal recessive 0 trials
- Polyposis of gastric fundus without polyposis coli 0 trials
- Polyposis, intestinal, scattered and discrete 0 trials
- Polyposis, intestinal, with multiple exostoses 0 trials
- Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal 0 trials
- Polysaccharide, storage of unusual 0 trials
- Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal 0 trials Sub-types →
- Porencephaly-microcephaly-bilateral congenital cataract syndrome 0 trials
- Postaxial tetramelic oligodactyly 0 trials
- Posterior column ataxia 0 trials
- Preauricular fistulae, congenital 0 trials
- Preauricular tag, isolated, autosomal dominant, 1 0 trials
- Premature chromatid separation trait 0 trials
- Presenile dementia, Kraepelin type 0 trials
- Priapism, familial idiopathic 0 trials
- Primary hypertrophic osteoarthropathy 0 trials Sub-types →
- Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection 0 trials
- Primary intraosseous venous malformation 0 trials
- Primordial dwarfism-immunodeficiency-lipodystrophy syndrome 0 trials
- Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome 0 trials
- Progressive non-infectious anterior vertebral fusion 0 trials
- Prolactin deficiency with obesity and enlarged testes 0 trials
- Pronation-supination of the forearm, impairment of 0 trials
- Properdin deficiency, X-linked 0 trials
- Prostate cancer aggressiveness quantitative trait locus on chromosome 19 0 trials
- Protein Z deficiency 0 trials
- Proteinuria, chronic benign 0 trials
- Proteolytic capacity of plasma 0 trials
- Protocadherin 3 0 trials
- Prune belly syndrome with pulmonic stenosis, intellectual disability, and deafness 0 trials
- Pruritus, hereditary localized 0 trials
- Pseudoacromegaly with severe insulin resistance 0 trials
- Pseudoarthrogryposis 0 trials
- Pseudohyperaldosteronism type 2 0 trials
- Pseudomonilethrix 0 trials
- Pseudoxanthoma elasticum, forme fruste 0 trials
- Psychomotor retardation, epilepsy, and craniofacial dysmorphism 0 trials
- Pterygium colli, isolated 0 trials
- Pubic bone dysplasia 0 trials
- Pulmonary alveolar microlithiasis 0 trials
- Pulmonary alveolar proteinosis with hypogammaglobulinemia 0 trials
- Pulmonary bullae causing pneumothorax 0 trials
- Pulmonary venoocclusive disease 0 trials Sub-types →
- Pulmonic stenosis and congenital nephrosis 0 trials
- Pulmonic stenosis and deafness 0 trials
- Pulmonic stenosis, atrial septal defect, and unique electrocardiographic abnormalities 0 trials
- Pupillary membrane, persistence of 0 trials
- Purpura simplex 0 trials
- Pyloric atresia 0 trials
- Radial deficiency-tibial hypoplasia syndrome 0 trials
- Radial heads, posterior dislocation of 0 trials
- Radial ray deficiency, X-linked 0 trials
- Radiation sensitivity of natural killer activity 0 trials
- Radiculoneuropathy, fatal neonatal 0 trials
- Radio-renal syndrome 0 trials
- Radioulnar synostosis, radial ray abnormalities, and severe malformations in the male 0 trials
- Radius, aplasia of, with cleft lip/palate 0 trials
- Raindrop hypopigmentation 0 trials
- Recombinant 8 syndrome 0 trials
- Recurrent infections associated with rare immunoglobulin isotypes deficiency 0 trials
- Red cell permeability defect 0 trials
- Red cell phospholipid defect with hemolysis 0 trials
- Red skin pigment anomaly of new guinea 0 trials
- Renal and mullerian duct hypoplasia 0 trials
- Renal tubular acidosis, distal, with nephrocalcinosis, short stature, intellectual disability, and distinctive facies 0 trials
- Renal-hepatic-pancreatic dysplasia 0 trials Sub-types →
- Respiratory infections, recurrent, and failure to thrive with or without diarrhea 0 trials
- Respiratory papillomatosis, juvenile recurrent, congenital 0 trials
- Respiratory underresponsiveness to hypoxia and hypercapnia 0 trials
- Restrictive dermopathy 0 trials Sub-types →
- Reticuloendotheliosis, X-linked 0 trials
- Retinal degeneration and epilepsy 0 trials
- Retinal dystrophy and microvillus inclusion disease 0 trials
- Retinal dystrophy with leukodystrophy 0 trials
- Retinal dystrophy with or without macular staphyloma 0 trials
- Retinal telangiectasia and hypogammaglobulinemia 0 trials
- Retinal venous beading 0 trials
- Retinitis pigmentosa 89 0 trials
- Retinitis pigmentosa and erythrocytic microcytosis 0 trials
- Retinitis pigmentosa inversa with deafness 0 trials
- Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome 0 trials
- Retinitis pigmentosa-intellectual disability-deafness-hypogenitalism syndrome 0 trials
- Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome 0 trials
- Retinopathy, pigmentary, and intellectual disability 0 trials
- Rhabdomyosarcoma, embryonal, 2 0 trials
- Rhiny 0 trials
- Rhizomelic dysplasia, scoliosis, and retinitis pigmentosa 0 trials
- Rhizomelic limb shortening with dysmorphic features 0 trials
- Ribbing disease 0 trials
- Right pulmonary artery, anomalous origin of, familial 0 trials
- Ring dermoid of cornea 0 trials
- Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction 0 trials
- Salivary duct calculi 0 trials
- Salivary substance, Clostridium botulinum type 0 trials
- Sandestig-stefanova syndrome 0 trials
- Scimitar anomaly, multiple cardiac malformations, and craniofacial and central nervous system abnormalities 0 trials
- Sebaceous gland hyperplasia, familial presenile 0 trials
- Second metatarsal-metacarpal syndrome 0 trials
- Secretory diarrhea, myopathy, and deafness 0 trials
- Seizures, early-onset, with neurodegeneration and brain calcifications 0 trials
- Sella turcica, bridged 0 trials
- Senile plaque formation 0 trials
- Sensorineural hearing loss, retinal pigment epithelium lesions, discolored teeth 0 trials
- Serpinopathy 0 trials
- Setting-Sun phenomenon, familial benign 0 trials
- Severe dermatitis-multiple allergies-metabolic wasting syndrome 0 trials
- Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome 0 trials
- Sex-linked disease 0 trials
- Short stature and Facioauriculothoracic malformations 0 trials
- Short stature and microcephaly with genital anomalies 0 trials
- Short stature due to GHSR deficiency 0 trials
- Short stature due to primary acid-labile subunit deficiency 0 trials
- Short stature with nonspecific skeletal abnormalities 0 trials Sub-types →
- Short stature, Brussels type 0 trials
- Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis 0 trials
- Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 0 trials Sub-types →
- Short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies 0 trials
- Short stature, intellectual disability, callosal agenesis, Heminasal hypoplasia, microphthalmia, and atypical clefting 0 trials
- Short stature, oligodontia, dysmorphic facies, and motor delay 0 trials
- Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay 0 trials
- Short stature-obesity syndrome 0 trials
- Shoulder and thorax deformity-congenital heart disease syndrome 0 trials
- Sister chromatid exchange, frequency of 0 trials
- Skeletal defects, genital hypoplasia, and intellectual disability 0 trials
- Skeletal dysplasia and progressive central nervous system degeneration, lethal 0 trials
- Skeletal dysplasia with delayed epiphyseal and carpal bone ossification 0 trials
- Skeletal dysplasia, mild, with joint laxity and advanced bone age 0 trials
- Skeletal dysplasia, rhizomelic, with retinitis pigmentosa 0 trials
- Snijders blok-fisher syndrome 0 trials
- Sodium-potassium-ATPase activity of red cell 0 trials
- Spastic diplegia and intellectual disability 0 trials
- Spastic paraparesis-cataracts-speech delay syndrome 0 trials
- Spastic paraparesis-deafness syndrome 0 trials
- Spastic paraplegia and Evans syndrome 0 trials
- Spastic paraplegia with associated extrapyramidal signs 0 trials
- Spastic paraplegia with myoclonic epilepsy 0 trials
- Spastic paraplegia, ataxia, and intellectual disability 0 trials
- Spastic paraplegia, mitochondrial 0 trials
- Spastic paraplegia, optic atrophy, and dementia 0 trials
- Spastic paraplegia, optic atrophy, microcephaly, and 10Y sex reversal 0 trials
- Spastic tetraplegia and axial hypotonia, progressive 0 trials
- Spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome 0 trials
- Specific granule deficiency 0 trials Sub-types →
- Sperm protamine P4 0 trials
- Sperm-specific antigen 1 0 trials
- Spinal dysplasia, Anhalt type 0 trials
- Spinal muscular atrophy with intellectual disability 0 trials
- Spinal muscular atrophy with microcephaly and mental subnormality 0 trials
- Spinal muscular atrophy, infantile, James type 0 trials
- Spinocerebellar ataxia with rigidity and peripheral neuropathy 0 trials
- Spinocerebellar atrophy with pupillary paralysis 0 trials
- Splenogonadal fusion-limb defects-micrognathia syndrome 0 trials
- Splenomegaly syndrome with splenic Germinal center hypoplasia and reduced circulating T helper cells 0 trials
- Splenoportal vascular anomalies 0 trials
- Split lower lip 0 trials
- Split-foot malformation-mesoaxial polydactyly syndrome 0 trials
- Split-hand and split-foot with hypodontia 0 trials
- Spondylocostal dysostosis-anal and genitourinary malformations syndrome 0 trials
- Spondylocostal dysostosis-hypospadias-intellectual disability syndrome 0 trials
- Spondylomegaepiphyseal dysplasia with upper limb mesomelia, punctate calcifications, and deafness 0 trials
- Spondylometaphyseal dysplasia with corneal dystrophy 0 trials
- Sternum, premature obliteration of sutures of 0 trials
- Storm syndrome 0 trials
- Streptococcus, group A, severity of infection by 0 trials
- Structural brain anomalies with impaired intellectual development and craniosynostosis 0 trials
- Structural heart defects and renal anomalies syndrome 0 trials
- Subaortic stenosis, membranous 0 trials
- Succinic acidemia 0 trials
- Sucrosuria, hiatus hernia and intellectual disability 0 trials
- Sudden cardiac failure, alcohol-induced 0 trials
- Sudden cardiac failure, infantile 0 trials
- Sudden infant death-dysgenesis of the testes syndrome 0 trials
- Superior transverse scapular ligament, calcification of, familial 0 trials
- Supernumerary der(22)t(8;22) syndrome 0 trials
- Suppressor of tumorigenicity 3 0 trials
- Surface antigen, glycoprotein 75 0 trials
- Surface polypeptides, anonymous 0 trials
- Symphalangism of toes 0 trials
- Symphalangism with multiple anomalies of hands and feet 0 trials
- Symphalangism, C. S. Lewis type 0 trials
- Symphalangism, distal, with microdontia, dental pulp stones, and narrowed zygomatic arch 0 trials
- Syndesmodysplasic dwarfism 0 trials
- Syndromic multisystem autoimmune disease due to ITCH deficiency 0 trials
- Syngnathia multiple anomalies 0 trials
- Syngnathia-cleft palate syndrome 0 trials
- Synovial chondromatosis, familial, with dwarfism 0 trials
- Syringomas, multiple 0 trials
- Tall stature-intellectual disability-renal anomalies syndrome 0 trials
- Talonavicular coalition 0 trials
- Taurodontism, microdontia, and dens invaginatus 0 trials
- Tear protein, anodal 0 trials
- Teeth present at birth 0 trials
- Teeth, fused 0 trials
- Teeth, odd shapes of 0 trials
- Telangiectasia, impaired intellectual development, microcephaly, metaphyseal dysplasia, eye abnormalities, and short stature 0 trials
- Temperature-sensitive lethal mutation 0 trials
- Temtamy syndrome 0 trials
- Testes, rudimentary 0 trials
- Testicular anomalies with or without congenital heart disease 0 trials
- Testicular microlithiasis 0 trials
- Tetraamelia with ectodermal dysplasia and lacrimal duct abnormalities 0 trials
- Tetraamelia-multiple malformations syndrome 0 trials Sub-types →
- Tetralogy of fallot and glaucoma 0 trials
- Tetralogy of fallot syndrome, autosomal recessive 0 trials
- Tetramelic monodactyly 0 trials
- Tetrasomy 18p 0 trials
- Thalamic degeneration, symmetric infantile 0 trials
- Thickened earlobes-conductive deafness syndrome 0 trials
- Thoracic dysostosis, isolated 0 trials
- Thrombocytopenia with elevated serum IgA and renal disease 0 trials
- Thrombocytopenia, anemia, and myelofibrosis 0 trials
- Thrombocytopenia-Robin sequence syndrome 0 trials
- Thumb deformity 0 trials
- Thumb, distal hyperextensibility of 0 trials
- Thumbs, congenital Clasped 0 trials
- Thymic aplasia with fetal death 0 trials
- Thymoma, familial 0 trials
- Thyroid hormone metabolism, abnormal 0 trials Sub-types →
- Thyroid hormone plasma membrane transport defect 0 trials
- Tibia, absence of, with congenital deafness 0 trials
- Tibial aplasia-ectrodactyly syndrome 0 trials Sub-types →
- Tibial torsion, bilateral medial 0 trials
- Tiglic acidemia 0 trials
- Toe, fifth, number of phalanges 1N 0 trials
- Toe, misshapen 0 trials
- Toe, rotated fifth 0 trials
- Toes, relative length of first and second 0 trials
- Toes, space between first and second 0 trials
- Tongue, pigmented fungiform papillae of 0 trials
- Torus palatinus and torus mandibularis 0 trials
- Transient infantile hypertriglyceridemia and hepatosteatosis 0 trials
- Tremor of intention, ataxia, and lipofuscinosis 0 trials
- Tremor, hereditary essential, and idiopathic normal pressure hydrocephalus 0 trials
- Trichilemmal cyst 0 trials
- Trichoepitheliomas, multiple desmoplastic 0 trials
- Trichohepatoneurodevelopmental syndrome 0 trials
- Trichoscyphodysplasia 0 trials
- Triokinase and FMN cyclase deficiency syndrome 0 trials
- Triphalangeal thumb with double phalanges 0 trials
- Triphalangeal thumb-polysyndactyly syndrome 0 trials
- Trisomy 18-like syndrome 0 trials
- Trypsinogen deficiency 0 trials
- Tuberculin skin test reactivity, absence of 0 trials
- Tubulin, beta 0 trials
- Tumor suppressor gene on chromosome 11 0 trials
- Turnpenny-fry syndrome 0 trials
- Ubiquitin-activating enzyme, Y-linked 0 trials
- Ulna hypoplasia-intellectual disability syndrome 0 trials
- Ulnar agenesis and endocardial fibroelastosis 0 trials
- Ulnar hypoplasia-split foot syndrome 0 trials
- Ulnar ray dysgenesis with postaxial polydactyly and renal cystic dysplasia 0 trials
- Umbilicus, familial flat 0 trials
- Uncombable hair syndrome 1 0 trials
- Uncombable hair syndrome 2 0 trials
- Uncombable hair syndrome 3 0 trials
- Unique green phenomenon 0 trials
- Ureter, bifid or double 0 trials
- Ureterocele 0 trials
- Urogenital adysplasia 0 trials
- Uveal coloboma-cleft lip and palate-intellectual disability 0 trials
- Vacuolar Neuromyopathy 0 trials
- Van Bogaert-Hozay syndrome 0 trials
- Van Maldergem syndrome 0 trials Sub-types →
- Varicella, severe recurrent 0 trials
- Vascular helix of umbilical cord 0 trials
- Vascular hyalinosis 0 trials
- Vasculitis, lymphocytic, cutaneous small vessel 0 trials
- Veins, pattern of, on anterior thorax 0 trials
- Ventriculomegaly and arthrogryposis 0 trials
- Ventriculomegaly with defects of the radius and kidney 0 trials
- Ventriculomegaly-cystic kidney disease 0 trials
- Venular insufficiency, systemic 0 trials
- Vertebral anomalies and variable endocrine and T-cell dysfunction 0 trials
- Vertebral hypersegmentation and orofacial anomalies 0 trials
- Vertebral hypoplasia with lumbar kyphosis 0 trials
- Vertebral, cardiac, tracheoesophageal, renal, and limb defects 0 trials
- Vestibulocochlear dysfunction, progressive 0 trials
- Visceral neuropathy, familial 0 trials Sub-types →
- Visual impairment and progressive phthisis bulbi 0 trials
- Vitamin D-dependent rickets, type 3 0 trials
- Vitiligo, progressive, with intellectual disability and urethral duplication 0 trials
- Vitreoretinopathy with phalangeal epiphyseal dysplasia 0 trials
- Warburg-cinotti syndrome 0 trials
- Widow's peak syndrome 0 trials
- Woolly hair-skin fragility syndrome 0 trials
- Wooly hair, autosomal recessive 3 0 trials
- Wormian bone-multiple fractures-dentinogenesis imperfecta-skeletal dysplasia 0 trials
- Xerosis and growth failure with immune and pulmonary dysfunction syndrome 0 trials
- Xylosidase deficiency 0 trials
- Yakut short stature syndrome 0 trials
- Zinc deficiency, transient neonatal 0 trials
-
Chromosomal disorder 13 trials · 276 incl. sub-types
18 sub-types
- Autosomal anomaly 0 trials · 194 incl. sub-types Sub-types →
- Syndrome caused by partial chromosomal deletion 0 trials · 57 incl. sub-types Sub-types →
- Aneuploidy 14 trials · 36 incl. sub-types Sub-types →
- Syndrome caused by partial chromosomal duplication 0 trials · 32 incl. sub-types Sub-types →
- Prader-Willi syndrome 31 trials Sub-types →
- Gonosome anomaly 6 trials · 20 incl. sub-types Sub-types →
- Silver-Russell syndrome 7 trials Sub-types →
- Chromosome inversion disorder 1 trial Sub-types →
- Polyploidy 0 trials · 1 incl. sub-types Sub-types →
- Uniparental disomy 0 trials · 1 incl. sub-types Sub-types →
- Bloom syndrome 0 trials
- FRAXD syndrome 0 trials
- Chromosome 16q12 duplication syndrome 0 trials
- Chromosome 1p36 deletion syndrome, proximal 0 trials
- Chromosome Xq13 duplication syndrome 0 trials
- Duplication/inversion 15q11 0 trials
- Mosaic variegated aneuploidy syndrome 0 trials Sub-types →
- Ring chromosome disorder 0 trials Sub-types →
Most studied deeper sub-types
Showing the 400 most recently updated of 6763 trials in this tab.
-
Radical new schedule aims to cure High-Risk ewing sarcoma
Cure Recruiting nowThis study tests a new treatment schedule for people with metastatic Ewing sarcoma, a rare and aggressive cancer. The approach uses an intense first attack on cancer cells, followed by targeted strikes and long-term maintenance to wipe out remaining cells. The goal is a cure. The…
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
Gene therapy aims to cure inherited immune disorder
Cure Recruiting nowChronic granulomatous disease (CGD) caused by p47phox deficiency is a rare, life-threatening genetic disorder that leaves people vulnerable to severe infections. Standard treatments include daily antibiotics and antifungal drugs, but they do not fix the underlying genetic defect.…
Phase 1/2 • Sponsor: Somagenetix AG • Aim: Cure
Last updated Sep 19, 2026 00:00 UTC
-
Lab-Grown gut patches made from Patients' own cells tested against Crohn's ulcers
Cure Recruiting nowResearchers are testing ATORM-C, a treatment made from a patient's own adult stem cells grown into tiny intestinal organoids, in adults with Crohn's disease who have not responded well to standard therapies. During a colonoscopy, a single dose of these organoids is applied direct…
Phase 1 • Sponsor: ORGANOIDSCIENCES LTD. • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Half-Matched stem cells tested as a cure for severe aplastic anemia
Cure Recruiting nowResearchers are testing a stem cell transplant from a half-matched family member in children and young adults with severe aplastic anemia, a condition where the bone marrow stops making enough blood cells. Participants receive chemotherapy and radiation to prepare their body, the…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Can stem cells restore vision in stargardt disease? a First-in-Human trial aims to find out
Cure Recruiting nowThis early-phase trial tests a single injection of ASP2020, stem cells turned into retinal cells, placed under the retina in people with Stargardt disease or similar inherited macular dystrophies. The main goal is to check safety and tolerability, while also looking for signs tha…
Phase 1 • Sponsor: Astellas Institute for Regenerative Medicine • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Can a single infusion rewrite the genetic code behind wilson disease?
Cure Recruiting nowThis trial tests an experimental therapy called PM577a, which uses prime editing to correct a common genetic mutation that causes Wilson disease. The treatment is given as a single intravenous infusion and aims to restore the liver's ability to remove excess copper. The study inc…
Phase 1/2 • Sponsor: Prime Medicine, Inc. • Aim: Cure
Last updated Sep 17, 2026 00:00 UTC
-
Off-the-Shelf immune cells target solid tumors
Cure Recruiting nowResearchers are testing a new cell therapy called CAR001 in adults with solid tumors that have come back or stopped responding to standard treatment. CAR001 uses donor gamma-delta T cells engineered with a chimeric antigen receptor to recognize and attack cancer cells. The trial …
Phase 1/2 • Sponsor: Ever Supreme Bio Technology Co., Ltd. • Aim: Cure
Last updated Sep 11, 2026 00:00 UTC
-
New hope for uncontrolled muscle movements: valbenazine trial targets stubborn TD symptoms
Disease control Recruiting nowThis study tests whether valbenazine can reduce involuntary muscle movements (tardive dyskinesia) in adults who still have symptoms while taking or after stopping another similar drug. About 50 people with schizophrenia, bipolar disorder, or major depression will take valbenazine…
Phase 4 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could Two-Drug cocktails tame stubborn inflammatory bowel disease?
Disease control Recruiting nowThis study tests whether combining risankizumab with either trosunilimab or ABBV-701 can safely reduce inflammation and improve symptoms in adults with moderately to severely active Crohn's disease or ulcerative colitis. Participants are randomly assigned to one of the combinatio…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Hope for stargardt patients: new drug aims to slow blindness
Disease control Recruiting nowThis Phase 3 trial tests an oral drug called gildeuretinol acetate (ALK 001) in 230 people aged 8 to 45 with Stargardt disease, a genetic condition that causes progressive vision loss. Participants take the drug or a placebo daily for 24 months. The goal is to see if the drug can…
Phase 3 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Watch and wait: could immunotherapy let some GI cancer patients avoid surgery?
Disease control Recruiting nowThis study looks at people with early-stage gastrointestinal cancers that have a mismatch repair deficiency, a feature that can make tumors respond well to immunotherapy. Part A is a registry that tracks all such patients, whether they have surgery or immunotherapy. Part B follow…
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New shot aims to tame ulcerative colitis Flare-Ups
Disease control Recruiting nowThis study tests whether MK-8690, a drug given as a shot, can help people with moderate-to-severe ulcerative colitis achieve remission. About 100 adults who haven't responded well to other treatments will receive either MK-8690 or a placebo. The main goal is to see if more people…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug trial aims to shrink painful lymphatic growths in kids and adults
Disease control Recruiting nowThis study tests alpelisib, a drug that targets a specific gene mutation (PIK3CA), in people with lymphatic malformations—abnormal growths of lymph vessels. The trial includes children and adults and compares alpelisib to a placebo to see if it can shrink the growths and ease sym…
Phase 2/3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a weekly shot fix hormone chaos in teens with PCOS?
Disease control Recruiting nowThis study tests whether a weekly injection of semaglutide (a GLP-1 drug used for obesity) can improve the brain's reproductive hormone signals in obese adolescent girls with polycystic ovary syndrome (PCOS). Twenty girls aged 12–18 will receive the drug plus lifestyle advice for…
Sponsor: Nemours Children's Clinic • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Poop pills? stool transplants may ease immunotherapy side effects
Disease control Recruiting nowThis early-stage trial tests whether a stool transplant (FMT) can help cancer patients who develop severe diarrhea or colon inflammation from immune-checkpoint inhibitor drugs. About 40 patients with various cancers will receive the transplant via colonoscopy. The main goal is to…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a common arthritis drug tame rare immune disease symptoms?
Disease control Recruiting nowThis early study tests baricitinib, a drug already approved for other immune conditions, in 20 people with Job syndrome who also have lupus-like disease or eczema. Participants take the pill daily for 6 months. The main goal is to see if it is safe and tolerable, while also check…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Tiny implant aims to restore sight in eyes that resist standard AMD therapy
Disease control Recruiting nowResearchers are testing a new treatment called PAL-222 for people with neovascular age-related macular degeneration (AMD) whose disease has not responded to existing therapies. The study will enroll up to 10 adults aged 18 to 85 with this condition. Each participant will have a s…
Sponsor: PharmaBio Corporation • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a higher dose of this pill regrow hair in severe alopecia?
Disease control Recruiting nowThis study tests two daily doses (50 mg and 100 mg) of the medicine ritlecitinib in about 550 people aged 12 and older with severe alopecia areata, a condition causing significant hair loss on the scalp and body. The 50 mg dose is already approved, and researchers want to see if …
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New cell therapy trial aims to tame stubborn autoimmune diseases
Disease control Recruiting nowThis early-phase trial is testing an injection called GT719 in 10 adults with moderate to severe autoimmune diseases that haven't responded to other treatments. The main goal is to check safety and find the right dose. Researchers will also look for signs that the therapy might h…
Early phase 1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Radiation boosts cancer drug in Tough-to-Treat myeloma
Disease control Recruiting nowThis study tests whether adding low-dose radiation to the drug elranatamab can better kill cancer cells in people with multiple myeloma that has come back or not responded to treatment and has spread outside the bone. About 34 adults will receive the combination. The goal is to s…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Injectable hydrogel could ease back pain without surgery
Disease control Recruiting nowThis study tests a hydrogel implant injected into damaged spinal discs to treat degenerative disc disease. About 225 adults with chronic low back pain will receive either the implant or standard care like physical therapy. The goal is to see if the implant safely improves pain an…
Sponsor: ReGelTec, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New Immune-Targeting drug surovatamig enters first human tests for arthritis and lupus
Disease control Recruiting nowThis Phase 1 trial tests surovatamig, a bispecific T-cell engager, in 48 adults with rheumatoid arthritis or systemic lupus erythematosus. The study gives the drug as injections in increasing doses to check safety, side effects, and how the body processes it. It is too early to k…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill could transform leukemia treatment, phase 3 trial begins
Disease control Recruiting nowThis study tests a new oral drug, QTX-2101, combined with standard ATRA therapy for adults newly diagnosed with a low-risk form of acute promyelocytic leukemia (APL). The goal is to see if the oral capsule works as well as the current intravenous treatment. About 150 participants…
Phase 3 • Sponsor: Quetzal Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New injection aims to tackle Alzheimer's at its roots
Disease control Recruiting nowThis study tests a new drug called ARO-MAPT-SC in healthy people and those with early Alzheimer's. The goal is to check if it is safe and how the body processes it. Participants receive either the drug or a placebo by injection under the skin. The trial is still in early stages, …
Phase 1/2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New study to track gene Therapy's Real-World impact on spinal muscular atrophy
Disease control Recruiting nowThis study will follow 36 people with spinal muscular atrophy (SMA) who receive a gene therapy called onasemnogene abeparvovec (ITVISMA) injected into the spinal fluid. The goal is to see how well it works and how safe it is in everyday medical practice. Participants must be at l…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Boosting transplants with donor immune cells to fight blood cancer relapse
Disease control Recruiting nowThis study tests whether giving donor white blood cells (lymphocytes) soon after a stem cell transplant can lower the chance of cancer returning in people with high-risk blood cancers like leukemia or lymphoma. Participants receive chemotherapy, a stem cell transplant, and then a…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for HIV patients with blood cancer: safer bone marrow transplants on the horizon?
Disease control Recruiting nowThis study tests whether a combination of three drugs (cyclophosphamide, bortezomib, and maraviroc) can safely prevent graft-versus-host disease after a half-matched bone marrow transplant in people living with HIV who also have a blood cancer. The trial involves 265 participants…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for leukemia patients: olverembatinib trial launches
Disease control Recruiting nowThis phase 2 trial tests whether the drug olverembatinib can safely control chronic myeloid leukemia (CML) in people who are newly diagnosed. About 50 adults will take the drug by mouth. Researchers will track side effects and how well the drug works. The study is currently recru…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New cocktail of 5 drugs targets tough leukemia
Disease control Recruiting nowThis phase 2 trial is testing a combination of five drugs (fludarabine, cytarabine, filgrastim-sndz, gemtuzumab ozogamicin, and idarubicin) in 270 people with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome that have specific genetic changes. The goal…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill for duchenne MD enters Mid-Stage trial in young boys
Disease control Recruiting nowThis study tests an oral drug called SAT-3247 in 51 boys aged 7 to 10 with Duchenne muscular dystrophy who can still walk. The goal is to find the best dose, check safety, and see if it helps muscle strength. Participants take the drug or a placebo for 12 weeks, and all continue …
Phase 2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Lupus drug may shield heart and arteries
Disease control Recruiting nowThis study tests whether anifrolumab, a drug that blocks certain immune signals, can improve blood vessel function and reduce inflammation in people with lupus. About 45 adults with lupus will receive either the drug or a placebo over 8 months. Researchers will measure changes in…
Phase 2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to boost survival in hodgkin lymphoma
Disease control Recruiting nowThis phase 3 trial is testing whether adding immunotherapy drugs (brentuximab vedotin and nivolumab) to standard chemotherapy (with or without radiation) improves survival for people aged 5 to 60 with newly diagnosed stage I or II classical Hodgkin lymphoma. About 1,875 participa…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for blood disorder patients: Long-Term safety check for etavopivat
Disease control Recruiting nowThis study looks at the long-term safety and effectiveness of etavopivat, an experimental medicine for sickle cell disease and thalassemia. It involves 480 adults, adolescents, and children who have already benefited from etavopivat in a previous study. Participants will continue…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill hopes to slow rare brain disease in kids
Disease control Recruiting nowThis study tests an oral drug called nizubaglustat in children and teens aged 4 and older with Niemann-Pick type C disease, a rare genetic disorder that affects movement and thinking. Participants will take the drug or a placebo for 18 months to see if it slows the disease and im…
Phase 3 • Sponsor: Azafaros B.V. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for rare blood cancers: first human trial of PRT12396 begins
Disease control Recruiting nowThis early-stage study tests a new drug, PRT12396, in about 100 people with polycythemia vera or myelofibrosis—rare blood cancers. The main goals are to find a safe dose and check for side effects. Researchers will also look for signs that the drug controls the disease, but this …
Phase 1 • Sponsor: Prelude Therapeutics Incorporated • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New study tests Long-Term safety of Cholesterol-Lowering injection for kids
Disease control Recruiting nowThis study looks at the long-term safety of inclisiran, a cholesterol-lowering injection, in children with a genetic condition that causes very high cholesterol. About 195 kids who completed earlier inclisiran studies will receive the drug for an extended period. Researchers will…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a compound in grapes help Parkinson's? new trial launches
Disease control Recruiting nowThis early-phase trial will test whether a special form of resveratrol (JOTROL) is safe and tolerable for people with Parkinson's disease. About 30 participants will receive either a low dose, high dose, or placebo daily for three months. The study will also measure how the drug …
Phase 2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a daily pill replace needles for hemophilia a?
Disease control Recruiting nowThis study tests an experimental oral medicine called Inno8 in 30 adults with hemophilia A. The goal is to see if it is safe and how the body processes it. Participants will take multiple doses over about 11 weeks. If successful, Inno8 could offer a more convenient way to control…
Phase 1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
One-Shot hope for blinding eye disease? new trial underway
Disease control Recruiting nowThis study tests a single injection into the eye of a new drug (SAR446597) for people with geographic atrophy, a progressive form of age-related macular degeneration that causes vision loss. About 104 participants aged 60 and older will be followed for 2 years, with an optional 3…
Phase 1/2 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
CRISPR therapy takes aim at stubborn high cholesterol in first human trial
Disease control Recruiting nowThis early-stage trial tests a new CRISPR-based treatment called CTX310 for people with severe cholesterol and triglyceride problems that don't improve with standard therapies. The treatment uses a tiny fat bubble to deliver gene-editing tools that turn off a gene linked to high …
Phase 1 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill aims to cut dangerous lung Flare-Ups in bronchiectasis
Disease control Recruiting nowThis study tests a daily pill called BI 1291583 (Verducatib) in 1755 adults and teens with bronchiectasis, a lung condition causing frequent infections and coughing. Participants take either the drug or a placebo for up to 76 weeks. The main goal is to see if the drug reduces the…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Targeted pill takes on rare skull base cancers
Disease control Recruiting nowThis phase 2 trial tests enasidenib, a daily pill that targets the IDH2 gene mutation, in 40 adults with rare cancers of the nasal cavity or skull base that have spread or come back. Participants take the drug once daily in 28-day cycles, and researchers will track how long the c…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New eye drug tiespectus takes on aflibercept in major wet AMD trial
Disease control Recruiting nowThis study tests a new medicine called tiespectus (EYE201) for wet age-related macular degeneration, a leading cause of vision loss. About 960 people will receive either tiespectus or the standard treatment aflibercept via eye injections. The goal is to see if tiespectus can impr…
Phase 2/3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Sleep pill may shield brain from Alzheimer's damage
Disease control Recruiting nowThis study tests whether the insomnia medication lemborexant (Dayvigo) can lower blood markers of brain damage in adults aged 40–65 with insomnia. Twenty participants will take the drug or a placebo for two weeks each, then have their blood tested for proteins linked to Alzheimer…
Phase 2 • Sponsor: Woolcock Institute of Medical Research • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a Gene-Silencing drug tame a rare heart disease?
Disease control Recruiting nowThis trial tests an investigational medicine called ATR 1072 in adults with PRKAG2 syndrome, a genetic condition that causes abnormal heart muscle thickening and rhythm problems. The drug is designed to reduce the activity of the faulty PRKAG2 gene. Researchers are evaluating its…
Phase 1/2 • Sponsor: Atrium Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Lung cancer vaccine trial aims to stop tumors from coming back
Disease control Recruiting nowThis study tests whether adding an experimental mRNA vaccine (V940) to the immunotherapy drug pembrolizumab (Keytruda) can keep lung cancer from returning after surgery. It includes 680 people with stage II to IIIB non-small cell lung cancer whose tumors did not fully respond to …
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a cementless hip stem hold up in asian patients?
Disease control Recruiting nowResearchers at a Korean hospital are following 210 adults who receive a cementless total hip replacement using the collarless Actis femoral stem. The study focuses on Asian patients, who tend to be younger at surgery and more often need the operation because of lost blood supply …
Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New daily pill could ease sickle cell pain for kids
Disease control Recruiting nowThis study tests a once-daily pill called etavopivat in children (6 months to 18 years) with sickle cell disease. The main goals are to check safety and how the drug works in the body, and to see if it can raise hemoglobin levels and reduce painful crises. About 95 children will …
Phase 2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Scientists train immune cells to hunt down mutated blood cancers
Disease control Recruiting nowThis early-phase trial tests a personalized treatment for people with blood cancers like leukemia. Doctors take a patient's own T cells, modify them in the lab to recognize unique cancer mutations, and infuse them back after a short course of chemotherapy. The goal is to see if t…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a donor stem cell transplant fix broken immune systems?
Disease control Recruiting nowThis study tests whether a stem cell transplant from a healthy donor can help people with severe primary immunodeficiencies. Participants aged 4 to 75 receive chemotherapy before the transplant to prepare their body. The goal is to see if the procedure is safe and can improve imm…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo aims to halt blinding eye disease
Disease control Recruiting nowThis phase 3 trial tests two injectable drugs, pozelimab and cemdisiran, alone or together, to slow the growth of geographic atrophy—an advanced form of dry age-related macular degeneration that causes central vision loss. About 975 participants will receive either the drugs or a…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could detoxing metals boost chemo for leukemia?
Disease control Recruiting nowThis early-stage trial is testing whether two drugs that lower metal levels in the body can help people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) respond better to chemotherapy. The study will enroll 58 adults and aims to find the safest dose and check f…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Brain pacemaker trial aims to tame Parkinson's symptoms
Disease control Recruiting nowThis study follows 300 adults with Parkinson's disease, essential tremor, or dystonia who receive deep brain stimulation (DBS). DBS uses a device implanted in the chest to send electrical pulses to brain areas controlling movement. Researchers will track symptom severity, medicat…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo aims to tackle bipolar depression and suicidal thoughts
Disease control Expanded accessThis study offers NRX-101, a combination of two drugs, to adults aged 18-65 with treatment-resistant bipolar depression and suicidal thoughts. Participants receive the medication from their own psychiatrist and undergo regular check-ins on mood, suicidal ideation, and side effect…
Sponsor: NeuroRx, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Special lenses may curb worsening eyesight in children
Disease control Recruiting nowThis study tests two types of modified spectacle lenses designed to slow the progression of myopia (nearsightedness) in children aged 6 to 13. Over one year, researchers will measure changes in the back of the eye (choroid), eye length, and prescription strength. The goal is to s…
Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new drug ease the joint pain of psoriatic arthritis?
Disease control Recruiting nowThis trial tests an experimental drug called DDY391 in about 220 adults with moderate to severe psoriatic arthritis, a condition that causes joint pain, swelling, and skin patches. Researchers want to see whether DDY391 can reduce joint symptoms better than a placebo and at what …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could your own bone marrow cells save your hip from collapse?
Disease control Recruiting nowThis study tests whether adding a patient's own concentrated bone marrow cells to a standard hip surgery (core decompression) can prevent the hip ball from collapsing and delay or avoid the need for a hip replacement. It includes 192 adults with early-stage osteonecrosis (before …
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Promising new combo aims to beat aggressive leukemia
Disease control Recruiting nowThis phase 2 trial is testing a combination of blinatumomab (an immune-boosting drug) with dasatinib or imatinib (targeted pills) and standard chemotherapy for people with a specific type of leukemia called Philadelphia chromosome-positive or Philadelphia chromosome-like B-ALL. T…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for kids with colitis: risankizumab trial launches
Disease control Recruiting nowThis phase 3 study tests the drug risankizumab in about 120 children aged 2 to 18 with moderate to severe ulcerative colitis. The trial has three parts: an initial 12-week IV treatment period, a 52-week maintenance phase where patients get one of two doses by injection, and a lon…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for kids with tough cancers: targeted radiation trial launches
Disease control Recruiting nowThis early-stage trial tests a radioactive drug (Lu-177 edotreotide) in children aged 2 to 17 with cancers that have a specific marker (SSTR-positive). The goal is to find the right dose and check safety. About 20 children whose cancer has returned or not responded to prior treat…
Phase 1 • Sponsor: ITM Solucin GmbH • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New contact lenses aim to curb childhood myopia epidemic
Disease control Recruiting nowThis study tests two types of daily disposable contact lenses designed to slow the progression of myopia (nearsightedness) in children aged 7 to 12. Over two years, 126 Hong Kong Chinese children will wear either a special lens or a standard single-vision lens, with their eyes me…
Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo aims to boost transplant success in rare blood cancer
Disease control Recruiting nowThis study tests whether giving a chemotherapy drug (decitabine) plus a targeted therapy (ruxolitinib, fedratinib, or pacritinib) before a stem cell transplant helps people with advanced myeloproliferative neoplasms (MPN) get to transplant and have better outcomes. About 25 adult…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a cancer drug ease rett syndrome? early trial launches
Disease control Recruiting nowThis early-stage trial is testing the drug vorinostat in 15 girls and young women with Rett syndrome, a rare genetic disorder that affects brain development. Each participant will receive placebo and two different doses of vorinostat, acting as their own control. The study aims t…
Phase 1 • Sponsor: Unravel Biosciences, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a tailored diet boost brain and body health in denture-wearers?
Disease control Recruiting nowThis study tests a 6-month nutritional program for adults aged 60–80 who wear complete dentures. Participants receive personalized dietary advice, meal plans, cooking workshops, and a mobile app. The goal is to see if the program improves diet quality, chewing ability, muscle str…
Sponsor: Universidad de La Frontera • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New shot aims to help kids with rare heart-muscle disease move easier
Disease control Recruiting nowThis study tests a daily injection called elamipretide in 48 people with genetically confirmed Barth syndrome, a rare condition that causes muscle weakness and heart problems. Participants will receive either the drug or a placebo for 72 weeks. The main goal is to see if the drug…
Phase 4 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for tough leukemia: MK-1045 takes on standard therapy
Disease control Recruiting nowThis study compares a new immunotherapy, MK-1045, to the standard drug blinatumomab in people whose B-cell acute lymphoblastic leukemia has returned or stopped responding to treatment. About 340 adults with CD19-positive leukemia will receive one of the two treatments. The goal i…
Phase 2/3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Experimental drug velzatinib offered to GIST patients who have run out of options
Disease control Expanded accessThis expanded access program provides velzatinib (GSK6042981) to patients with gastrointestinal stromal tumors (GIST) that have a KIT mutation and have already tried at least three prior treatments. The program is for people who have no satisfactory alternative, including approve…
Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
A pill to stop the bleeding? new hope for HHT nosebleeds
Disease control Recruiting nowThis phase 3 trial tests whether an experimental oral drug called engasertib can reduce the number of nosebleeds in adults with moderate to severe hereditary hemorrhagic telangiectasia (HHT), a genetic condition that causes abnormal blood vessels and frequent bleeding. About 240 …
Phase 3 • Sponsor: Vaderis Therapeutics AG • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Engineered immune cells take on rare solid tumors in first human trial
Disease control Recruiting nowThis early-phase study tests a new treatment called GCAR1, which uses a patient's own immune cells (T-cells) that have been modified to recognize and attack cancer cells carrying a specific marker (GPNMB). The study enrolls 30 adults in Canada with advanced alveolar soft part sar…
Phase 1 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Gut check: probiotic may sharpen memory and tame blood sugar in prediabetes
Disease control Recruiting nowThis study tests whether taking a daily probiotic (Lab4P) for 12 weeks can improve memory, thinking speed, and blood sugar control in overweight adults aged 18-40 with prediabetes (mildly high blood sugar). Seventy participants will be randomly assigned to receive either the prob…
Sponsor: Leeds Beckett University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill aims to tackle Huntington's at its source
Disease control Recruiting nowThis clinical trial tests an oral drug called SKY-0515 in 400 adults with Huntington's disease. The goal is to see if it can lower harmful proteins linked to the disease and improve symptoms like movement and thinking. Participants take the drug or a placebo daily for 18 months.
Phase 2/3 • Sponsor: Skyhawk Therapeutics, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo therapy aims to extend life in advanced lung cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding the experimental drug MK-2870 to the standard immunotherapy pembrolizumab helps people with advanced non-small cell lung cancer live longer compared to pembrolizumab alone. The study enrolls about 614 adults whose tumors have high PD-L1 lev…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for Crohn's? large trial tests tulisokibart
Disease control Recruiting nowThis phase 3 trial is testing a drug called tulisokibart in about 1,200 people with moderate-to-severe Crohn's disease who haven't had success with other treatments. The drug is given by IV or injection and aims to reduce symptoms and heal the gut lining. The study compares tulis…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill aims to slow kidney damage in FSGS patients
Disease control Recruiting nowThis study tests an oral medication called BI 764198 for people with a kidney condition called focal segmental glomerulosclerosis (FSGS). About 286 adults and teens will take either the study drug or a placebo daily for up to 2 years, while continuing their usual FSGS treatments.…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New Triple-Drug attack on cervical cancer enters final testing
Disease control Recruiting nowThis phase 3 trial tests whether adding the experimental drug sacituzumab tirumotecan (sac-TMT) to standard immunotherapy (pembrolizumab) and a targeted therapy (bevacizumab) helps people with metastatic cervical cancer live longer. About 1,000 participants whose cancer has sprea…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Triple-Drug cholesterol attack aims to strike within 72 hours of a heart attack
Disease control Recruiting nowResearchers are testing whether adding bempedoic acid to high-intensity statin and ezetimibe therapy within 72 hours after a heart procedure helps adults with acute coronary syndrome reach very low LDL cholesterol. Participants receive either the three-drug combination or the sta…
Phase 4 • Sponsor: Taipei Medical University Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
3D printed dentures face off against traditional milled ones in new trial
Disease control Recruiting nowThis study compares two types of full dentures: 3D printed ones and milled ones. Researchers want to see which lasts longer and causes fewer problems over five years. Sixty-eight adults who need complete dentures will take part, and the main focus is how many dentures are still w…
Sponsor: Dentsply Sirona Implants and Consumables • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can weekly Finger-Prick tests improve PKU control?
Disease control Recruiting nowResearchers are testing whether measuring phenylalanine at home once a week, rather than once a month, helps adults with classic phenylketonuria keep their levels in a healthier range. The trial enrolls 36 adults aged 18 to 65 who follow a low-protein diet and use special amino a…
Sponsor: Michał Kania • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Gut bacteria trial aims to slow ALS and dementia
Disease control Recruiting nowThis study tests whether a special probiotic supplement can change fat-related molecules in the blood of people with ALS and frontotemporal dementia (FTD). Researchers will compare those taking the probiotic to those taking a placebo over 24 weeks. The goal is to see if the probi…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug cocktail targets Virus-Linked cancers in early trial
Disease control Recruiting nowThis phase 1 study tests a combination of two drugs, pomalidomide (a pill) and nivolumab (an infusion), in adults with cancers caused by viruses like Epstein-Barr, HPV, or hepatitis. The goal is to find a safe dose and see if the drugs can shrink tumors. Up to 58 people with Kapo…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Which drug first? trial tests sequence of carboplatin and olaparib in aggressive prostate cancer
Disease control Recruiting nowResearchers are comparing two sequences of treatment for metastatic castration-resistant prostate cancer that carries certain DNA repair gene mutations. Participants receive either carboplatin first and olaparib second, or olaparib first and carboplatin second, switching after th…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill could slow blindness in inherited eye disease
Disease control Recruiting nowThis early-stage trial tests a new oral drug called OCT-980 for people with a specific inherited eye disease (autosomal dominant retinitis pigmentosa) that causes gradual vision loss and blindness. The study first gives a single dose to healthy volunteers to check safety, then mu…
Phase 1/2 • Sponsor: Octant, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Personalized chemo boosts CAR T-Cell success in young leukemia patients
Disease control Recruiting nowThis study tests whether giving a personalized dose of the chemotherapy drug fludarabine before CAR T-cell therapy can improve outcomes for children and young adults with relapsed or hard-to-treat B-cell acute lymphoblastic leukemia. About 130 participants will be randomly assign…
Phase 3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two drugs aim to restore energy factories in rare muscle disease
Disease control Recruiting nowResearchers are testing a combination of two drugs, doxecitine and doxribtimine, in adults with thymidine kinase 2 (TK2) deficiency, a rare genetic condition that causes muscle weakness and breathing problems. The study will enroll about 15 adults with moderate to severe disease.…
Phase 2 • Sponsor: Cristina Domínguez González • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New lupus pill enters Mid-Stage trial – hope for better control?
Disease control Recruiting nowThis study tests an experimental oral drug called BI 3000202 in 405 adults with moderate to severe systemic lupus erythematosus (SLE). Participants are randomly assigned to one of four doses of the drug or a placebo, taken daily for a year alongside their usual lupus treatments. …
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill aims to slow kidney disease in IgA nephropathy patients
Disease control Recruiting nowThis study tests an experimental drug called STL303 for people with IgA nephropathy, a kidney disease. About 15 adults will receive either STL303 or a placebo to see if the drug is safe and can reduce protein in the urine, a sign of kidney damage. Possible side effects include na…
Phase 2 • Sponsor: Sitala Bio LTD • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New eye drug aims to offer cheaper option for blinding disease
Disease control Recruiting nowThis phase 3 trial tests whether a new drug called ABP 938 works as well as the approved treatment Eylea HD for wet age-related macular degeneration, a leading cause of vision loss. About 304 people aged 50 and older with untreated wet AMD will receive injections of either drug i…
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Botox injections studied for movement disorder relief
Disease control Recruiting nowThis study uses botulinum toxin (Botox) injections to treat movement disorders such as dystonia, tremor, and spasticity. Up to 2,000 participants aged 2 and older will receive tailored injections, with doctors trained in proper techniques. The goal is to manage symptoms and build…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill aims to slow Parkinson's progression in early stages
Disease control Recruiting nowThis study tests whether a daily pill called BHV-8000 can slow the worsening of motor skills in people recently diagnosed with Parkinson's disease. About 550 adults aged 40 to 85 with early Parkinson's will receive either BHV-8000 (10 mg or 20 mg) or a placebo for up to 48 weeks.…
Phase 2/3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat lupus
Disease control Recruiting nowThis early-phase trial tests a new type of cell therapy called BCMA-CD19-IL-15/IL15sushi compound CAR T cells in 20 people with severe lupus that hasn't improved with standard treatments. The therapy aims to reset the immune system by targeting and eliminating faulty immune cells…
Phase 2 • Sponsor: iCell Gene Therapeutics • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a common arthritis drug help sickle cell patients?
Disease control Recruiting nowThis early-stage trial is testing the safety of fostamatinib, a drug already used for arthritis, in 25 adults with stable sickle cell disease. Participants take the pill twice daily for up to 6 weeks, with close monitoring for side effects. The goal is to see if the drug is safe …
Phase 1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a simple pill shield HAE patients from Procedure-Triggered attacks?
Disease control Recruiting nowThis trial tests whether the drug sebetralstat can prevent swelling attacks in people with hereditary angioedema (HAE) when taken before a medical procedure. Participants aged 12 and older with HAE type I or II will take sebetralstat just before their scheduled procedure. The mai…
Phase 4 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug trial hopes to shrink tumors in kids with Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a drug called zilovertamab vedotin in children and young adults whose blood cancers (like certain leukemias and lymphomas) or solid tumors (neuroblastoma, Ewing sarcoma) have come back or not responded to treatment. The goal is to see if the drug is safe and can …
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Hope for Huntington's: new drug aims to slow decline in major trial
Disease control Recruiting nowThis study tests whether the drug pridopidine can slow the worsening of Huntington's disease (HD) in adults. About 400 participants will take either pridopidine or a placebo twice daily for one year, then everyone can receive pridopidine for two more years. The goal is to see if …
Phase 3 • Sponsor: Prilenia • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for myelofibrosis patients: experimental pill targets resistant disease
Disease control Recruiting nowThis early-stage study tests an experimental oral drug, AJ1-11095, in about 76 adults with myelofibrosis (a type of bone marrow cancer) whose disease has stopped responding to standard JAK2 inhibitor therapy. The main goals are to check the drug's safety, find the best dose, and …
Phase 1 • Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for womb cancer: drug duo aims to slow tumor growth
Disease control Recruiting nowThis study tests whether adding sacituzumab tirumotecan (Sac-TMT) to pembrolizumab helps people with advanced or recurrent endometrial cancer live longer without the cancer getting worse. About 1,100 participants with a specific type of endometrial cancer (pMMR) will receive eith…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a cancer drug help kids with rare brain disorder?
Disease control Recruiting nowThis study is testing whether a drug called vorinostat is safe and helpful for people with Pitt Hopkins syndrome, a rare genetic condition that affects development. Five participants will each receive a placebo and two different doses of the drug in a special 'N-of-1' design, mea…
Phase 1 • Sponsor: Unravel Biosciences, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New lupus shot aims to tame flares in phase 2 trial
Disease control Recruiting nowThis phase 2 trial tests a new drug called SG301, given as a shot under the skin, for people with systemic lupus erythematosus (SLE). About 120 participants whose lupus is not well controlled by standard treatments will receive either SG301 or a placebo over several months. The g…
Phase 2 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill aims to cut sickle cell pain crises in half
Disease control Recruiting nowThis global phase 3 trial is testing whether a daily pill called etavopivat can reduce the number of painful sickle cell crises in adolescents and adults with sickle cell disease. About 408 participants will be randomly assigned to receive either etavopivat or a placebo for aroun…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New sickle cell drug DISC-3405 enters early human safety trial
Disease control Recruiting nowThis early-stage study tests a new drug, DISC-3405, in 24 adults with sickle cell disease to see if it is safe and how the body processes it. Participants will receive increasing doses of the drug, and researchers will monitor side effects and changes in blood counts. The goal is…
Phase 1 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New spinal device aims to improve back surgery outcomes
Disease control Recruiting nowThis study tests a new device called CORUS-LX for spinal fusion surgery in people with degenerative disc disease in the lower back. About 250 adults will either get the new device or standard surgery. The goal is to see if the device helps bones fuse better and reduces the need f…
Sponsor: Providence Medical Technology, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Clear braces take on classic overbite treatment in Head-to-Head trial
Disease control Recruiting nowThis study tests a new clear-plate version of the Twin-Block brace against the traditional metal one for children aged 10.5-13 with a receding lower jaw and overbite. The goal is to see if the clear plates work as well at correcting jaw position and bite. Thirty-two participants …
Sponsor: Hama University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Cancer drug nivolumab takes on EBV-Linked tumors in new trial
Disease control Recruiting nowThis phase 2 trial tests whether the drug nivolumab can slow or stop the growth of Epstein-Barr virus (EBV)-positive lymphoproliferative disorders and non-Hodgkin lymphomas. About 40 people aged 12 and older whose cancers have not responded to standard therapy will receive nivolu…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
One-Time gene shot could free teens from bleeding disorder
Disease control Recruiting nowThis study tests a single-dose gene therapy called CSL222 in 20 teenage boys with severe hemophilia B, a bleeding disorder. The goal is to see if the treatment reduces bleeding episodes and improves quality of life. Participants must already be on regular factor IX replacement th…
Phase 3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New 5-Drug combo aims to tackle tough lymphoma
Disease control Recruiting nowThis study tests a combination of five drugs (venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide, called ViPOR) in adults with B-cell lymphoma that has come back or not responded to prior treatment. The main goal is to check the safety of this drug mix. Up to 155 p…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
One pill to tackle three heart risks: could a polypill cut cardiovascular disease?
Disease control Recruiting nowThis trial tests whether a single daily pill that combines treatments for high blood pressure, high cholesterol, and type 2 diabetes can lower the risk of heart disease and dementia. The study involves over 8,000 adults aged 50 to 75 in China who have all three conditions. Partic…
Sponsor: China Medical University, China • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New pill aims to ease fatigue in rare mitochondrial disease
Disease control Recruiting nowThis study is for people who completed a previous trial of KL1333 (napazimone) for primary mitochondrial disease. It will test the drug's long-term safety and whether it helps with fatigue and daily activities. About 140 participants will take the pill twice daily for an extended…
Phase 2 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Milder chemo may make stem cell transplants safer for Non-Cancer patients
Disease control Recruiting nowThis phase 2 trial tests a combination of three chemotherapy drugs (treosulfan, fludarabine, thiotepa) plus an immune-suppressing antibody before a donor stem cell transplant in up to 40 people under 50 with non-cancerous blood disorders. The goal is to see if this milder conditi…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug aims to protect kidneys in IgA nephropathy patients
Disease control Recruiting nowThis Phase 3 trial tests whether mezagitamab, an injectable drug, can reduce protein in the urine and preserve kidney function in adults with IgA nephropathy, a condition where immune complexes damage the kidneys. About 347 participants will receive either mezagitamab or a placeb…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for glioblastoma? drug combo trial targets aggressive brain tumors
Disease control Recruiting nowThis Phase 2 trial tests whether adding the experimental drug silevertinib to standard chemotherapy (temozolomide) helps people with a specific type of newly diagnosed glioblastoma live longer without their cancer worsening. The study includes 162 participants whose tumors have c…
Phase 2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New spinal injection aims to tame Huntington's
Disease control Recruiting nowThis early-stage study tests an experimental drug called ALN-HTT02 in 66 adults with Huntington's disease. The drug is given as a single injection into the spine to see if it is safe and how it affects the body. The goal is to reduce levels of the harmful protein that causes the …
Phase 1 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New pill hopes to tame rare childhood brain diseases
Disease control Recruiting nowThis Phase 3 trial tests an oral drug called nizubaglustat (AZ-3102) in people aged 4 and older with Niemann-Pick type C disease, GM1 gangliosidosis, or GM2 gangliosidosis. The study lasts 18 months and compares the drug to a placebo to see if it is safe and can slow disease prog…
Phase 3 • Sponsor: Azafaros B.V. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for leukemia patients who failed standard treatments
Disease control Recruiting nowThis study tests a drug called ponatinib in 50 adults with chronic myeloid leukemia (CML) whose cancer did not respond to or they could not tolerate other targeted therapies. The goal is to see if ponatinib can control the disease by blocking a protein that helps cancer cells gro…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a stem cell transplant fix a rare genetic immune disorder?
Disease control Recruiting nowThis study tests whether a stem cell transplant from a healthy donor can treat GATA2 deficiency, a rare genetic condition that weakens the immune system and raises the risk of leukemia. Participants aged 6 to 70 with GATA2 mutations will receive chemotherapy or radiation before t…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New kidney drug shows promise in reducing protein leakage
Disease control Recruiting nowThis study tests an experimental tablet, BI 764198, in adults and some teens with four types of kidney disease that cause protein in the urine. Participants take the drug or a placebo daily for 20 weeks while continuing their usual care. The main goal is to see if the drug lowers…
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a drink replace daily shots for growth hormone deficiency?
Disease control Recruiting nowThis study tests an oral medicine called GS3-007a for children with growth hormone deficiency. In the first part, kids receive different doses or a placebo for 14 days to check safety. In the second part, they take the chosen dose or a standard injection for 52 weeks to see how w…
Phase 1/2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for toddlers with rare hormone disorder?
Disease control Recruiting nowThis study tests a drug called crinecerfont in 20 children aged 3 months to 4 years with classic congenital adrenal hyperplasia (CAH). The goal is to see if the drug is safe and tolerable. Participants must already be on stable hydrocortisone treatment. The study is not yet recru…
Phase 2 • Sponsor: Neurocrine Switzerland GmbH • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New pill could ease iron overload for thousands with genetic disorder
Disease control Recruiting nowThis phase 2 trial tests an experimental drug called vamifeport in 84 adults with HFE-related hereditary hemochromatosis, a genetic condition causing iron buildup. The drug aims to reduce liver iron levels, potentially offering an alternative to regular blood removal. Participant…
Phase 2 • Sponsor: CSL Behring • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Gut bacteria and minerals: a new hope for ulcerative colitis remission?
Disease control Recruiting nowThis trial is testing whether adding a Lactobacillus probiotic or a trace element supplement to standard ulcerative colitis treatment can help keep the disease in remission. About 132 adults with mild to moderate ulcerative colitis will be randomly assigned to one of three groups…
Phase 4 • Sponsor: National Hepatology & Tropical Medicine Research Institute • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Clear aligners take on braces in overbite showdown
Disease control Recruiting nowThis study tests whether clear aligners with rubber bands can correct a mild overbite (Class II malocclusion) as well as traditional braces. Twenty-four people aged 15-20 will be randomly assigned to either clear aligners or braces, both with elastics. Researchers will measure ch…
Sponsor: Hama University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New antibody drug aims to tame ulcerative colitis
Disease control Recruiting nowThis study tests a new antibody drug called XmAb942 for moderate-to-severe ulcerative colitis, a chronic inflammatory bowel disease. First, healthy volunteers will receive the drug to check safety. Then, about 270 people with ulcerative colitis will get either XmAb942 or a placeb…
Phase 1/2 • Sponsor: Xencor, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New combo therapy aims to outperform standard drugs for rare blood cancer
Disease control Recruiting nowThis phase II trial is testing whether a combination of venetoclax and rituximab works better than current standard treatments (ibrutinib plus rituximab or zanubrutinib alone) for people with previously untreated Waldenstrom's macroglobulinemia, a rare type of blood cancer. The s…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Engineered immune cells take on childhood blood cancers in early trial
Disease control Recruiting nowThis early-phase trial is testing a new CAR T-cell therapy called AUTO1 (obe-cel) in up to 30 children with B-cell acute lymphoblastic leukemia or B-cell non-Hodgkin lymphoma that has returned or not responded to treatment. The therapy uses the child's own immune cells, which are…
Phase 1 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New pill targets tough cancers with genetic flaw
Disease control Recruiting nowThis study tests an experimental oral drug, GSK5460025, alone or with other cancer drugs, in adults whose solid tumors have specific genetic changes (dMMR or MSI-H). The goal is to see if the drug can shrink tumors and to check its safety. About 47 people with advanced cancers th…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Eye drops could replace injections for wet AMD
Disease control Recruiting nowResearchers are testing a new eye drop called NT-101 in people with wet age-related macular degeneration, a condition where abnormal blood vessels leak fluid into the retina and damage central vision. The trial enrolls 66 adults aged 50 and older who have active leaking vessels u…
Phase 2 • Sponsor: NexThera Co., Ltd. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New antibody aims to cut lung attacks in bronchiectasis patients
Disease control Recruiting nowThis study tests an experimental drug called AZD0292 in 435 people aged 12 and older who have bronchiectasis and a long-term lung infection with Pseudomonas aeruginosa. The goal is to see if the drug can reduce the number of moderate-to-severe lung flare-ups compared to a placebo…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Brain pacemaker registry tracks Real-Life results for Parkinson's patients
Disease control Recruiting nowThis registry is collecting information from 1,500 people with Parkinson's disease who are receiving deep brain stimulation (DBS) with the Vercise system. The goal is to see how DBS affects quality of life in everyday practice, and to evaluate new programming tools. Participants …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug aims to slow kidney damage in IgA nephropathy
Disease control Recruiting nowThis study tests a drug called felzartamab in people with IgA nephropathy, a kidney disease where abnormal antibodies build up and damage the kidneys. The goal is to see if felzartamab can reduce protein in the urine, a sign of kidney damage. About 454 adults will receive either …
Phase 3 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a cancer drug rescue kidneys harmed by rogue antibodies?
Disease control Recruiting nowResearchers are testing whether the drug daratumumab can treat kidney diseases caused by monoclonal gammopathy of renal significance (MGRS), a group of conditions where abnormal antibody proteins damage the kidneys. The trial enrolls 30 adults with biopsy-confirmed MGRS. Particip…
Phase 2 • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for Crohn's: phase 3 trial of afimkibart launches
Disease control Recruiting nowThis phase 3 study tests a drug called afimkibart in 600 people with moderate-to-severe Crohn's disease. Participants receive either the drug or a placebo to see if it can reduce symptoms and gut inflammation. The trial is double-blind, meaning neither patients nor doctors know w…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Cystinosis drug under Long-Term watch: could cysteamine be key?
Disease control Recruiting nowCystinosis is a rare inherited disease that causes kidney failure and poor growth due to cystine buildup in cells. This study follows 330 patients taking cysteamine, a drug that lowers cystine levels, to track long-term effects, detect new complications, and support genetic resea…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could less be more? new study tests lower doses of cancer drug
Disease control Recruiting nowThis study is testing whether giving lower, less frequent doses of the cancer drug atezolizumab can still keep enough drug in the blood to fight cancer. About 30 adults with certain advanced cancers (like lung cancer or melanoma) will start with standard doses, then switch to a l…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Blood test may help doctors Fine-Tune kidney disease therapy
Disease control Recruiting nowResearchers are testing whether regularly checking a marker called Gd-IgA1 can help doctors adjust treatment for IgA nephropathy, a kidney disease. Adults with biopsy-confirmed IgA nephropathy or IgA vasculitis-associated nephritis receive Nefecon or telitacicept. Half have Gd-Ig…
Sponsor: Hong Zhang • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Promising new combo therapy for infant leukemia shows potential
Disease control Recruiting nowThis study tests whether adding two targeted drugs, blinatumomab and venetoclax, to standard chemotherapy can improve outcomes for infants with a type of leukemia called acute lymphoblastic leukemia (ALL). About 153 infants will participate. The goal is to see if these combinatio…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a pill shrink nerve tumors in NF1? new trial aims to find out
Disease control Recruiting nowThis study tests the drug abemaciclib, typically used for cancer, in people with neurofibromatosis type 1 (NF1) who have atypical neurofibromas that cannot be surgically removed. The goal is to find a safe dose and see if it can shrink or stabilize these tumors. Participants take…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Gentler transplant offers hope for blood disorders without cancer
Disease control Recruiting nowThis study is testing a milder type of stem cell transplant for people with non-cancerous blood, immune, or metabolic disorders. The goal is to safely get donor cells to grow in the patient's body while reducing harsh side effects. About 220 participants will receive a reduced-in…
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for rare brain disease: platform trial targets PSP
Disease control Recruiting nowThis study tests several experimental treatments for progressive supranuclear palsy (PSP), a rare brain disease that affects movement and thinking. About 440 people with early-stage PSP will receive one of the treatments or a placebo. The goal is to see if any of the treatments c…
Phase 2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New antibody WIN378 aims to tame COPD lung inflammation
Disease control Recruiting nowThis phase 2 trial is testing a new medicine called WIN378 for people with moderate to severe COPD. WIN378 is a long-acting antibody that blocks a protein involved in lung inflammation. The study will test different doses in 105 adults who are former smokers and already on standa…
Phase 2 • Sponsor: Windward Bio • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could your Donor's gut bacteria decide whether a stool transplant works?
Disease control Recruiting nowResearchers are testing fecal microbiota transplantation (FMT) for ulcerative colitis, a chronic inflammatory bowel disease. They will compare stool from healthy Han donors with stool from healthy Dai donors, a Yunnan ethnic group with distinct diets, to see if donor background a…
Phase 2 • Sponsor: First Affiliated Hospital of Kunming Medical University • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill takes on brain tumors and metastases in early trial
Disease control Recruiting nowThis study tests an oral drug called NEO212 in people with specific brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it helps control tumor growth. About 134 adults will take NEO212 alone or with sta…
Phase 1/2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
One-Shot gene therapy could slash eye injections for wet AMD
Disease control Recruiting nowThis study tests a gene therapy called ABBV-RGX-314 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if a single treatment can reduce the need for frequent eye injections while keeping vision stable. About 561 adults a…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a Once-Daily form of tacrolimus spare liver transplant patients from side effects?
Disease control Recruiting nowAfter a liver transplant, patients take tacrolimus to stop their immune system from rejecting the new organ, but the drug can cause kidney problems, high blood pressure, diabetes, and other side effects. Researchers at the University of Alberta are comparing a once-daily extended…
Phase 4 • Sponsor: University of Alberta • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for PBC patients: phase 3 trial of saroglitazar launches
Disease control Recruiting nowThis study tests a new drug, saroglitazar magnesium, in 89 adults with primary biliary cholangitis (PBC) who did not get enough benefit from or could not tolerate standard treatment (UDCA). The goal is to see if the drug can lower a key liver enzyme (alkaline phosphatase) to norm…
Phase 3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for ulcerative colitis: Long-Term remission trial begins
Disease control Recruiting nowThis study tests an investigational drug called duvakitug in people with moderate-to-severe ulcerative colitis who have already responded to treatment. The goal is to see if duvakitug can help maintain remission better than a placebo over 40 weeks, with an optional long-term exte…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for cancer patients with autoimmune conditions: immune checkpoint inhibitor trial expands access
Disease control Recruiting nowThis study is for people who have both an autoimmune disease (like rheumatoid arthritis, lupus, or multiple sclerosis) and an advanced cancer that has spread or cannot be removed by surgery. It tests the safety and effectiveness of the immunotherapy drug nivolumab, given alone or…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
A reversible gut sleeve could offer a new way to treat obesity
Disease control Recruiting nowThis pilot study tests a temporary, flexible tube called a duodenal-jejunal bypass sleeve. It is placed in the upper intestine using an endoscope and left for 3 months to help with weight loss and improve metabolic syndrome. The study involves 20 adults with obesity or excess wei…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug shows promise for rare, severe childhood epilepsy
Disease control Recruiting nowThis study tests whether clemizole HCl (EPX-100) can safely reduce seizures when added to current treatments for Lennox-Gastaut syndrome, a severe form of epilepsy. About 260 children and adults aged 2 to 55 will receive either the drug or a placebo. The main goal is to measure c…
Phase 3 • Sponsor: Epygenix • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Hope for duchenne: new drug targets rare gene mutation in phase 3 trial
Disease control Recruiting nowThis study tests an experimental drug called AOC 1044 for boys with Duchenne muscular dystrophy (DMD) who have a specific genetic change (exon 44 skipping). About 70 boys aged 7 to 16 who can still walk will receive either the drug or a placebo. The main goal is to see if the dru…
Phase 3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug AZD5492 tested for autoimmune diseases in first human study
Disease control Recruiting nowThis Phase 1 trial tests the safety and tolerability of a new drug called AZD5492 in 72 adults with lupus, myositis, or rheumatoid arthritis. Participants receive one or two doses under the skin and are monitored for side effects and how the drug moves through the body. The study…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New shot every 6 months could slow rare nerve disease
Disease control Recruiting nowThis Phase 3 trial tests a new drug called nucresiran in 125 people with a rare inherited condition that damages nerves (hATTR-PN). The drug is given as a shot under the skin every 6 months and aims to slow nerve damage and improve quality of life. Researchers will compare it to …
Phase 3 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug MTX325 enters first human tests for Parkinson's
Disease control Recruiting nowThis early-stage study tests a new drug called MTX325 in healthy volunteers and people with mild to moderate Parkinson's disease. The main goals are to check safety, how the body processes the drug, and whether it reaches the brain. If successful, MTX325 might one day slow the pr…
Phase 1 • Sponsor: Mission Therapeutics • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug aims to cut blood transfusions for bone marrow disease patients
Disease control Recruiting nowThis study tests an experimental drug called DISC-0974 in about 150 adults with myelofibrosis or myelodysplastic syndrome (MDS) who also have anemia. The goal is to see if the drug can reduce the need for blood transfusions and increase red blood cell levels. The study is in earl…
Phase 1/2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Electric zaps to the gut could tame diabetes and fatty liver
Disease control Recruiting nowThis study tests a procedure called pulsENDO that uses mild electric pulses to regenerate the lining of the duodenum (the first part of the small intestine). The goal is to improve blood sugar control and reduce fat buildup in the liver for people with type 2 diabetes and fatty l…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for sickle cell patients: drug aims to cut painful crises
Disease control Recruiting nowThis study tests a drug called crizanlizumab in people aged 12 and older with sickle cell disease who have frequent pain crises. The goal is to see if the drug can reduce the number of these crises compared to a placebo. Participants may also continue taking their usual treatment…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug aims to stop liver decline in PBC patients with cirrhosis
Disease control Recruiting nowThis Phase 3 trial tests whether seladelpar, a daily pill, can improve outcomes for people with primary biliary cholangitis (PBC) who also have compensated cirrhosis. About 318 adults will receive either seladelpar or a placebo for up to 36 months. The study tracks serious events…
Phase 3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New study tests switch from IV to At-Home shots for gut disease
Disease control Recruiting nowThis study is testing the drug vedolizumab (Entyvio) in 400 adults with moderate to severe ulcerative colitis or Crohn's disease. Participants first receive the drug through an IV for 6 weeks, then switch to injections under the skin for the rest of the year. The main goal is to …
Phase 4 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could a simple injection dissolve painful calcium lumps in rare diseases?
Disease control Recruiting nowThis study tests whether injecting sodium thiosulfate directly into abnormal calcium deposits can shrink them and reduce pain. It includes people with three rare conditions: systemic sclerosis, dermatomyositis, and a genetic disorder called iPPSD2. Participants receive up to 11 i…
Phase 2 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
A pill that could let people with rare sunlight disorder step outside without pain
Disease control Recruiting nowResearchers are testing an oral drug called PORT-77 in people with erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), rare conditions that cause severe pain after sunlight exposure. The trial enrolls about 225 adults and adolescents aged 12 and older. It compa…
Phase 2/3 • Sponsor: Portal Therapeutics, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could a Low-Dose arthritis drug ease a dangerous sickle cell complication?
Disease control Recruiting nowThis phase 2 trial is testing whether a single low dose of tocilizumab, a drug that blocks inflammation, can help people with sickle cell disease who develop acute chest syndrome—a serious lung complication. Researchers will enroll 200 patients aged 12 and older and track their o…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New glasses aim to balance unequal vision in nearsighted kids
Disease control Recruiting nowThis study tests whether special research glasses can reduce the difference in prescription between the two eyes in children aged 6 to 13 with myopic anisometropia (when one eye is much more nearsighted than the other). Twenty children will wear the study glasses and have their e…
Sponsor: Essilor International • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Drug cocktail may save tiniest Babies' hearts and lungs
Disease control Recruiting nowThis study tests whether giving two medicines (acetaminophen and ibuprofen) together works better than ibuprofen alone to close a common heart blood vessel in extremely premature infants (born before 27 weeks). About 310 babies will take part. The goal is to see if the combo redu…
Phase 2 • Sponsor: Mount Sinai Hospital, Canada • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for dravet syndrome: phase 3 trial of EPX-100 aims to cut seizures
Disease control Recruiting nowThis study tests an experimental drug called EPX-100 (clemizole) in 150 children and adults with Dravet syndrome, a severe form of epilepsy. The goal is to see if adding EPX-100 to current treatments can safely reduce the number of motor seizures. Participants will be randomly as…
Phase 3 • Sponsor: Epygenix • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Cell therapy trial aims to halt vision loss in dry AMD
Disease control Recruiting nowThis study tests a cell therapy called OpRegen for people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes blind spots. About 60 participants will receive a one-time injection of retinal cells under the retina during eye surgery. The m…
Phase 2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Real-World study tracks Ravulizumab's impact on rare kidney disease
Disease control Recruiting nowThis study will follow about 80 Polish patients with atypical hemolytic uremic syndrome (aHUS) who are receiving ravulizumab (Ultomiris) as part of routine care. Researchers will collect data from medical records and follow patients over time to see how well the drug controls the…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug takes aim at Treatment-Resistant leukemia
Disease control Recruiting nowResearchers are comparing olverembatinib, an experimental drug, with bosutinib, an approved drug, in adults with chronic phase chronic myeloid leukemia (CML-CP). The trial enrolls patients whose disease has not responded well to at least two prior targeted treatments. A separate …
Phase 3 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a simple antibody infusion shield myeloma patients from infections?
Disease control Recruiting nowThis study tests whether IgPro20 (HIZENTRA), a concentrated antibody solution given under the skin, can prevent infections in people with multiple myeloma who have low antibody levels due to bispecific antibody therapy. About 100 participants will either receive IgPro20 plus stan…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Second-Chance CAR-T: could Off-Spec cells still fight cancer?
Disease control Recruiting nowThis phase 3 trial is testing a CAR-T cell therapy called tisagenlecleucel that didn't quite meet commercial release standards. It's for people with B-cell acute lymphoblastic leukemia or diffuse large B-cell lymphoma who have no other approved options. The study will check if th…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could a natural supplement calm ulcerative colitis?
Disease control Recruiting nowThis study tests whether a supplement called palmitoylethanolamide (PEA) can help people with mild-to-moderate ulcerative colitis. Researchers will measure changes in disease activity, quality of life, and inflammation markers in 60 participants. The goal is to see if adding PEA …
Sponsor: Ain Shams University • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug aims to shrink polyps in inherited colon cancer condition
Disease control Recruiting nowThis phase 2 trial tests whether the drug TPST-1495 can reduce the number and size of polyps in the small bowel and colon of people with familial adenomatous polyposis (FAP), an inherited condition that greatly raises colon cancer risk. About 38 participants will take the drug by…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Engineered immune cells take on lupus kidney disease
Disease control Recruiting nowThis phase 2 trial is testing a new treatment called FT819 for people with lupus nephritis, a serious kidney complication of lupus. FT819 is made from donor immune cells that are engineered to target and destroy faulty B cells. The study will enroll 53 participants and aims to se…
Phase 2 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New pill targets rosacea inflammation at its source
Disease control Recruiting nowThis study tests an oral medication called remibrutinib for adults with moderate-to-severe papulopustular rosacea, a skin condition causing red bumps and pustules on the face. The drug works by blocking a protein involved in inflammation. Researchers will measure whether it reduc…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New antibody cocktail takes on tough lupus kidney disease
Disease control Recruiting nowThis early-stage trial is testing two experimental drugs, vonsetamig and odronextamab, in people with lupus nephritis that has not responded to standard treatments. The main goal is to check safety and side effects over the long term. Researchers will also see if the drugs can he…
Phase 1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New injection could ease back pain without surgery
Disease control Recruiting nowThis study tests a one-time injection called VIA Disc NP for people with long-term low-back pain caused by disc disease. The injection adds material to the damaged disc to help cushion it. About 496 adults will receive either the real injection or a sham procedure, and researcher…
Sponsor: VIVEX Biologics, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New hope for kids with SMA: experimental drug ARGX-119 enters Mid-Stage trial
Disease control Recruiting nowThis study tests a new biologic drug called ARGX-119 in children aged 5 to 17 with spinal muscular atrophy (SMA). About 60 participants will receive either ARGX-119 or a placebo by IV infusion for 24 weeks, alongside their usual SMA therapy. The goal is to find the best dose and …
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New cream could ease painful skin condition lichen sclerosus
Disease control Recruiting nowThis study tests a cream called delgocitinib for lichen sclerosus, a skin condition that causes itching, pain, and scarring in the genital area. About 652 adults with mild to severe disease will apply the cream twice daily for up to 52 weeks. Researchers will check if the cream i…
Phase 3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug targets Alzheimer's proteins in Early-Onset patients
Disease control Recruiting nowThis early-stage trial tests a drug called ALN-APP (mivelsiran) in 60 adults with mild cognitive impairment or mild dementia due to early-onset Alzheimer's disease. The drug is given via a spinal injection to see if it safely lowers certain proteins linked to Alzheimer's in the b…
Phase 1 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Could a cocktail of good bacteria break the cycle of c. diff?
Disease control Recruiting nowThis large Phase 3 trial tests whether VE303, a capsule containing 8 harmless bacteria, can prevent repeat Clostridioides difficile (C. diff) infections. About 852 people who have had at least one prior C. diff infection will take VE303 or a placebo for 14 days. The main goal is …
Phase 3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New hope for rare cancers: drug combo trial launches
Disease control Recruiting nowThis study tests a combination of two drugs, nilotinib (a pill) and paclitaxel (given by IV), for people with rare advanced cancers that have not responded to standard treatments. The goal is to see if the drugs can shrink or stop tumor growth. About 82 adults with specific rare …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New immune cell therapy aims to stop blood cancer relapse after transplant
Disease control Recruiting nowThis early-phase trial tests whether giving patients a special infusion of donor immune cells (with certain T and B cells removed) after a stem cell transplant is safe and can help prevent their blood cancer from coming back. The study enrolls high-risk patients with hard-to-trea…
Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New ventilator aims to help patients breathe easier in the ICU
Disease control Recruiting nowThis trial is testing a new ventilator called INBENTUS VERSATILE in 81 adults who need help breathing. The study checks if the device is safe and works well for conditions like ARDS, pneumonia, and COPD. Participants will use the ventilator for 3 to 48 hours and be monitored unti…
Sponsor: Iconic Solutions By Murcia SL • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug ABBV-519 enters first human tests for lupus and arthritis
Disease control Recruiting nowThis early-stage study tests a single dose of ABBV-519 in 30 adults with moderate lupus or rheumatoid arthritis. Researchers will check how the drug moves through the body, how it affects immune cells, and whether it is safe. Participants will be followed for about a year to moni…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Smart brain pacemaker learns to adjust itself for Parkinson's patients
Disease control Recruiting nowThis study tests a new automated method to fine-tune adaptive deep brain stimulation (aDBS) for people with Parkinson's disease. aDBS uses brain signals to adjust stimulation in real time, but setting it up is complex. The trial will compare automated aDBS to standard continuous …
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Hormone blockers and letrozole tested to spare uterus in early endometrial cancer
Disease control Recruiting nowResearchers are testing a combination of a gonadotropin-releasing hormone agonist injection and the drug letrozole in obese women with early-stage endometrial cancer that has not responded to progestin. The goal is to see if this hormone-blocking approach can shrink tumors and al…
Phase 2/3 • Sponsor: Xiaojun Chen • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Antibiotic flush directly into the lungs tested against bronchiectasis Flare-Ups
Disease control Recruiting nowBronchiectasis damages the airways and causes repeated flare-ups of cough and breathlessness. Researchers are testing whether washing the affected lung areas with saline through a bronchoscope, then injecting the antibiotic amikacin directly into those areas, can delay the next f…
Sponsor: First Affiliated Hospital of Ningbo University • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Sound waves aimed at the brain may quiet temporal lobe seizures
Disease control Recruiting nowResearchers are testing a non-invasive device that uses focused ultrasound to target the hippocampus, a brain region involved in temporal lobe epilepsy. The study enrolls adults whose seizures continue despite medication. Participants receive ultrasound treatments twice a week fo…
Sponsor: Genovate-NaviFUS (Australia) Pty Ltd. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Hormone combo tested as Fertility-Sparing option for early uterine cancer
Disease control Recruiting nowResearchers test whether a combination of GnRHa and letrozole can shrink early endometrial cancer or atypical hyperplasia in non-obese patients who have not responded to progestin therapy. The trial compares this regimen with Diane-35 plus metformin. About 80 participants receive…
Phase 2/3 • Sponsor: Xiaojun Chen • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Which dental framework keeps bacteria at bay?
Disease control Recruiting nowResearchers compare two materials for making fixed full-arch dental prostheses supported by four implants in people with no natural teeth in the lower jaw. Each participant receives a prosthesis with either a Zantex (fiber-reinforced polymer) or zirconia (ceramic) framework. The …
Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Stent graft showdown: which device best tames aortic aneurysms?
Disease control Recruiting nowThe JAGUAR trial compares two approaches to endovascular aneurysm repair (EVAR) in adults with abdominal aortic aneurysms. Participants are randomly assigned to receive either the Alto Abdominal Stent Graft System or another FDA-approved stent graft. Researchers track complicatio…
Sponsor: Endologix • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can AI learn to spot endometriosis and fibroids on ultrasound?
Diagnosis Recruiting nowResearchers at Semmelweis University are building and testing artificial intelligence algorithms that read standardized transvaginal ultrasound images. The study includes women aged 18 to 45 who have suspected endometriosis or adenomyosis, a confirmed uterine mass scheduled for s…
Sponsor: Semmelweis University • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
New 3D ultrasound aims to improve breast cancer diagnosis without radiation
Diagnosis Recruiting nowThis study is testing a new 3D automated ultrasound system called ATUSA to see how well it can image suspicious breast lesions. Up to 800 women with suspicious findings on standard imaging will get an ATUSA scan before their biopsy. The goal is to collect images and compare them …
Sponsor: iSono Health, Inc. • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Gut bacteria and genes eyed as keys to predicting repeat c. diff
Diagnosis Recruiting nowResearchers are studying adults with Clostridioides difficile infection to learn why some people get a repeat infection. The trial follows 750 patients across multiple hospitals, collecting blood for genetic testing and stool samples to examine gut bacteria. The goal is to build …
Sponsor: Hospital Universitario de Valme • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can a gentle eye scan replace stressful exams for preterm infants?
Diagnosis Recruiting nowThis study tests whether a handheld, ultra-widefield eye scanner (OCT) can accurately identify preterm infants with severe retinopathy of prematurity (ROP), a condition that can harm vision. The scanner takes detailed images of the retina without touching the eye, potentially red…
Sponsor: Duke University • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can a Chest-Strap wearable match the gold standard for heart monitoring?
Diagnosis Recruiting nowThis study tests whether a chest-strap ECG wearable, the Frontier X Plus, can accurately detect heart rhythm problems compared to the standard MoMe ARC patch monitor. About 15 active adults who are already prescribed a heart monitor will wear both devices at the same time. Resear…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can a simple blood draw map a Baby's genetic risks?
Diagnosis Recruiting nowResearchers are testing two cell-free DNA blood tests to see how well they detect chromosomal and single-gene conditions in pregnancies with higher genetic risk, such as those with increased nuchal translucency or fetal structural anomalies. The study plans to enroll at least 1,6…
Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can advanced imaging reveal hidden swallowing muscle damage in IBM?
Diagnosis Recruiting nowResearchers at Johns Hopkins University are studying whether neuromuscular ultrasound and MRI can serve as reliable markers of swallowing muscle problems in people with inclusion body myositis (IBM). The study compares imaging and clinical findings in 30 participants, including p…
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can a weekly dipstick at home catch lupus kidney damage early?
Diagnosis Recruiting nowPeople with lupus can develop kidney inflammation called lupus nephritis, which is easier to treat when caught early. This study enrolls adults with lupus who are at higher risk for kidney problems and assigns them by chance to either standard care alone or standard care plus wee…
Sponsor: NYU Langone Health • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
New scan spots hidden thyroid tumors that resist standard treatment
Diagnosis Recruiting nowThis study tests whether a special PET scan using a radioactive tracer called 68Gallium-DOTATATE can better detect thyroid cancer that has spread and no longer responds to standard radioactive iodine therapy. About 54 adults with metastatic thyroid cancer will receive one injecti…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Acne may signal hidden hormonal disorder in young women
Diagnosis Recruiting nowResearchers at Sohag University Hospital want to know how many women with acne also have polyendocrine metabolic ovarian syndrome, a hormonal and metabolic condition. The study enrolls 90 women aged 15 to 49 who have been diagnosed with acne. Doctors will check each participant f…
Sponsor: Sohag University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Simple balloon test could catch hidden esophagus cancer risk
Diagnosis Recruiting nowThis study aims to see if a new office-based test (EsoCheck balloon and EsoGuard lab test) can accurately detect Barrett's esophagus in people who do not have chronic heartburn. Barrett's esophagus is a condition that can lead to esophageal cancer, but it is often missed in peopl…
Sponsor: Case Comprehensive Cancer Center • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC
-
Ear device could spot seizures without wires
Diagnosis Recruiting nowThis study is testing a small device that fits in the ear to detect seizures by measuring brain waves. Researchers will first test it on 5 healthy people, then on 10 people with epilepsy who are already scheduled for a standard scalp EEG. The goal is to see if the in-ear device i…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Microbes in the mouth and gut may hold clues to a common kidney disease
Diagnosis Recruiting nowIgA nephropathy is a kidney disease where immune proteins build up in the kidney's filtering units. Researchers in China are collecting samples from 600 people aged 16 and older, including those with biopsy-confirmed IgA nephropathy, to study the bacteria living in their mouths, …
Sponsor: Guangdong Provincial People's Hospital • Aim: Diagnosis
Last updated Sep 16, 2026 00:00 UTC
-
Hearing loss in children may hide a balance problem, and doctors are testing for it
Diagnosis Recruiting nowResearchers are studying how often children with sensorineural hearing loss also have problems with their balance system. The study enrolls 48 children aged 3 to 10 with hearing loss in one or both ears. Children complete questionnaires and a series of balance and inner-ear tests…
Sponsor: Gødstrup Hospital • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Swallow a camera pill to diagnose Crohn's? trial puts it to the test
Diagnosis Recruiting nowResearchers are testing whether a camera pill that travels through the whole bowel can diagnose Crohn's disease without the need for colonoscopy and a separate small bowel exam. The trial enrolls people aged 18 to 40 who have symptoms and lab signs suggesting Crohn's disease. Par…
Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
A simple blood draw could one day detect down syndrome in pregnancy
Diagnosis Recruiting nowResearchers are collecting blood samples from pregnant women at higher risk of having a baby with a chromosomal condition. The goal is to develop a noninvasive prenatal test that looks at cell-free DNA in the mother's blood to detect Down syndrome. Participants give blood between…
Sponsor: Sequenom, Inc. • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
Can AI predict your lifespan from a short video?
Diagnosis Recruiting nowResearchers are building AI models that score standard physical and cognitive screening tests from video and audio, and that predict results a person did not obtain. The study enrolls adults 18 and older and follows them for life, linking records to a long-term aging study to che…
Sponsor: Longevity Metrics, Inc. • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
Two proteins could give african clinics an early warning for dangerous pregnancy complication
Diagnosis Recruiting nowPreeclampsia is a serious high blood pressure condition that can develop during pregnancy and is a leading cause of death for mothers and babies in Africa. Doctors struggle to predict which women with high blood pressure will become severely ill because current tests are not accu…
Sponsor: Africa Clinical Research Network (ACRN) • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
Monthly HIV prevention pill could replace daily dose
Prevention Recruiting nowThis phase 3 trial tests MK-8527, a once-monthly oral pill, to prevent HIV-1 infection in women. About 4580 HIV-negative women will take either MK-8527 monthly or a daily PrEP pill (Truvada) to see which works better and is safer. The goal is to offer a more convenient prevention…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Could everyday supplements turn back the clock on aging?
Prevention Recruiting nowThis trial tests whether two natural supplements—quercetin (from foods like apples and onions) and coenzyme Q10 (a substance your body makes)—can reduce inflammation and improve metabolic health in older adults. Over 12 weeks, participants aged 50 to 75 who are sedentary will tak…
Sponsor: Applied Science & Performance Institute • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Mindfulness and wearable tech tested to prevent dangerous pregnancy condition
Prevention Recruiting nowThis study will test if mindfulness training, with or without a wearable biosensor watch, can help prevent preeclampsia in pregnant women at moderate to high risk. 90 women will be split into three groups: mindfulness plus the watch, mindfulness alone, or standard prenatal care. …
Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Could a Vitamin-Like pill stop prediabetes from becoming diabetes?
Prevention Recruiting nowThis phase II trial tests whether a special form of nicotinic acid (a B vitamin) can reverse prediabetes and prevent type 2 diabetes. About 390 adults with prediabetes will take either a low or high dose of the drug or a placebo daily for 26 weeks, along with lifestyle advice. Th…
Phase 2 • Sponsor: University Hospital Schleswig-Holstein • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Could a weekly shot stop diabetes after pregnancy diabetes?
Prevention Recruiting nowThis study tests whether the drug semaglutide can prevent type 2 diabetes in women who had gestational diabetes and now have high blood sugar after pregnancy. About 252 women will receive either semaglutide or a placebo for several months. The goal is to see if the drug lowers th…
Phase 3 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Prevention
Last updated Sep 17, 2026 00:00 UTC
-
Broccoli compound put to the test against melanoma
Prevention Recruiting nowResearchers are testing whether sulforaphane, a substance found in broccoli and other cruciferous vegetables, can prevent melanoma in people who have multiple atypical moles and a prior history of melanoma. Participants take sulforaphane or a placebo by mouth. The trial measures …
Phase 2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Prevention
Last updated Sep 17, 2026 00:00 UTC
-
Can exercise shield pregnant women from preeclampsia?
Prevention Recruiting nowResearchers are testing whether exercise during pregnancy can reduce the risk and severity of preeclampsia, a dangerous condition marked by high blood pressure. The trial enrolls 224 healthy women at risk for preeclampsia who are less than 16 weeks pregnant. Participants take par…
Sponsor: East Carolina University • Aim: Prevention
Last updated Sep 13, 2026 00:00 UTC
-
Prisons as HIV prevention hubs: can opioid treatment reach more people behind bars?
Prevention Recruiting nowResearchers at Yale University are studying how to expand opioid agonist therapy (OAT) in prisons and probation systems in Tajikistan, Kyrgyzstan, Moldova, and Georgia. OAT uses medicines like methadone or buprenorphine to treat opioid dependence and can lower HIV transmission am…
Sponsor: Yale University • Aim: Prevention
Last updated Sep 12, 2026 00:00 UTC
-
Can cottonseed oil improve cholesterol? trial tests common cooking oil against similar blends
Prevention Recruiting nowResearchers are testing whether daily cottonseed oil improves cholesterol and blood fat levels compared with oils that have a similar fat makeup. The study includes 90 adults aged 25 to 75 who have elevated cholesterol or excess weight. Participants drink a breakfast shake contai…
Sponsor: University of Georgia • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
Can removing a baby tooth or widening the jaw save kids from surgery?
Prevention Recruiting nowAbout 2 to 3 in 100 children have an upper adult canine tooth that gets stuck in the roof of the mouth instead of coming down. Dentists often remove the baby canine to try to guide the adult tooth into place, but the evidence for this is weak. This trial compares removing the bab…
Sponsor: Göteborg University • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
A lens that could let cataract patients see near and far without glasses
Symptom relief Recruiting nowCataracts cloud the eye's lens and blur vision, and presbyopia makes it hard to focus up close after age 50. Researchers are testing an intraocular lens with a virtual aperture optic, implanted during cataract surgery, to see if it improves vision at distance, intermediate, and n…
Sponsor: Z Optics, Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Brain pacemaker tweak could help stroke and tremor patients speak and swallow better
Symptom relief Recruiting nowThis study looks at whether adjusting deep brain stimulation (DBS) can improve movement, speech, and swallowing in people already implanted with DBS for conditions like tremor, stroke, or traumatic brain injury. Researchers will test hand dexterity, grip strength, facial movement…
Sponsor: Jorge Gonzalez-Martinez • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Exercise with or without compression: a new hope for leg swelling?
Symptom relief Recruiting nowThis study looks at whether doing resistance exercises (like leg presses) can reduce swelling in the lower legs of people with lymphedema. It also checks if wearing compression garments during exercise makes a difference. Thirty-six adults with lower limb lymphedema will exercise…
Sponsor: Carsten Bogh Juhl • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a cancer drug calm the nosebleeds of a rare bleeding disorder?
Symptom relief Recruiting nowHereditary hemorrhagic telangiectasia (HHT) causes tangled blood vessels that lead to frequent, hard-to-stop nosebleeds and low hemoglobin. Researchers are testing whether intravenous bevacizumab, given once or twice a year after nasal electrocoagulation, reduces nosebleed severi…
Phase 2 • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a Weight-Loss drug ease rett syndrome?
Symptom relief Recruiting nowThis Phase 3 trial tests whether fenfluramine (Fintepla) can reduce behavioral and emotional symptoms in people with Rett syndrome. About 200 participants will receive either the drug or a placebo for 14 weeks. The study measures changes in behavior, sleep, and overall condition …
Phase 3 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New therapy aims to help kids with speech disorder speak in phrases
Symptom relief Recruiting nowThis study tests a speech therapy called DTTC-Connect for children aged 3 to 12 with childhood apraxia of speech, a disorder that makes it hard to say words clearly. The therapy focuses on helping children move from saying single words to speaking in phrases. Sixty-eight children…
Sponsor: New York University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can video games calm anxious teens?
Symptom relief Recruiting nowResearchers are testing whether playing video games can reduce anxiety in adolescents aged 11 to 15 with elevated anxiety symptoms. The trial compares an action game designed to boost attention control, a casual puzzle game, and no game at all. Teens play at home online for six w…
Sponsor: School of Health Sciences Geneva • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Tiny One-Way valves for emphysema under close watch in japan
Symptom relief Recruiting nowResearchers in Japan are observing 140 people with severe emphysema who receive Zephyr Endobronchial Valves, tiny one-way valves placed in the lungs to reduce hyperinflation. The surveillance follows participants for 12 months across up to 20 centers. The main goal is to measure …
Sponsor: Pulmonx Corporation • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could a common anxiety drug help autistic youth? new trial aims to find out.
Symptom relief Recruiting nowThis study tests whether buspirone, a medication used for anxiety, is safe and effective for autistic youth aged 7 to 17 who also have anxiety disorders. Researchers will measure changes in anxiety symptoms over 16 weeks. The goal is to see if this drug can ease anxiety in this s…
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Three shots, one wrist: which injection best eases carpal tunnel?
Symptom relief Recruiting nowCarpal tunnel syndrome happens when the median nerve gets squeezed at the wrist, causing numbness, tingling, and pain in the hand. This study compares three ultrasound-guided injections for adults with mild to moderate cases: hyaluronic acid, corticosteroid, and 5% glucose. Sixty…
Early phase 1 • Sponsor: Tanta University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can an old blood vessel drug shorten labour when waters break at term?
Symptom relief Recruiting nowWhen a woman's waters break at term but labour has not started, doctors often use oxytocin to get contractions going. This trial tests whether adding a single intravenous dose of papaverine, a drug that relaxes smooth muscle, helps oxytocin work faster. Two hundred women with ter…
Sponsor: Wolfson Medical Center • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a group program teach teens to cope before therapy starts?
Symptom relief Recruiting nowResearchers at Penn State are testing whether the BaSICS program reduces anxiety, depression, and suicide risk in 11- to 14-year-olds from low-income families who are waiting for mental health services. The program teaches coping skills, healthy identity development, and collecti…
Sponsor: Penn State University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Coloring books in the ER: a simple fix for long waits?
Symptom relief Recruiting nowThis study tests whether giving coloring activities (nature scenes, geometric shapes, word searches, or free drawing) to adults waiting in the emergency department can lower their self-reported pain and anxiety. Researchers will measure changes using standard questionnaires. If e…
Sponsor: Stony Brook University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Horseback therapy may help Parkinson's patients move better
Symptom relief Recruiting nowThis pilot study tests whether hippotherapy, a type of physical therapy using the natural movement of a horse, can improve mobility, gait, balance, and quality of life in people with Parkinson's disease. Participants will be randomly assigned to receive either hippotherapy sessio…
Sponsor: Klinik Valens • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Ear-Zapping device may quiet lupus pain and fatigue
Symptom relief Recruiting nowResearchers are testing whether a handheld device that stimulates the vagus nerve through the skin can reduce musculoskeletal pain and fatigue in people with systemic lupus erythematosus. Eighteen participants will use the device for five minutes daily for 28 days, with some rece…
Phase 2 • Sponsor: Northwell Health • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New device aims to help stroke survivors move their arms again
Symptom relief Recruiting nowThis pilot study tests whether a device called IVS3 is tolerable and easy to use for arm recovery in people who had a stroke at least 6 months ago. The device uses mirrored video to create the illusion that the affected arm is moving. Researchers will track how many sessions part…
Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
New Identity-Based therapy aims to beat standard CBT for young adults
Symptom relief Recruiting nowThis study tests a new type of talk therapy called Identity-Based Transdiagnostic Therapy (IBTT) for young adults with anxiety or depression. It compares IBTT to a well-known therapy called the Unified Protocol (CBT-based). The goal is to see if IBTT is more engaging and effectiv…
Sponsor: University of Barcelona • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could a gentle zap to the brain ease Parkinson's symptoms?
Symptom relief Recruiting nowThis study will test whether a gentle, non-invasive brain stimulation technique called tDCS can improve verbal fluency, thinking, and motor control in people with Parkinson's disease. Twenty participants aged 50-90 with Parkinson's and a verbal fluency deficit will receive the st…
Sponsor: The University of Texas at Dallas • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Tai chi via zoom tested as depression remedy for older HIV patients
Symptom relief Recruiting nowThis study tests whether doing tai chi/qigong over Zoom twice a week for 12 weeks can reduce depressive symptoms in people aged 50-75 living with HIV. About 326 participants will be randomly assigned to either tai chi or a health education class. Researchers will track mood, hear…
Sponsor: Florida International University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Sleep sounds may boost brain power and mood in anxious young adults
Symptom relief Recruiting nowThis study tests whether playing gentle sounds during deep sleep can improve thinking and emotional control in young adults (ages 18-25) with anxiety, depression, and sleep problems. Participants will spend two nights in a sleep lab, once with tones and once without, and complete…
Sponsor: Michelle Stepan • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Zapping tremors: radiation may offer new hope for Parkinson's and essential tremor patients
Symptom relief Recruiting nowThis study follows 60 people with essential tremor or Parkinson's tremor whose symptoms aren't well-controlled by medication. After receiving stereotactic radiosurgery—a precise dose of radiation to a small brain area—participants fill out questionnaires about their quality of li…
Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Alcoholism drug may boost vision in eye disease patients
Symptom relief Recruiting nowThis study looks at whether disulfiram (Antabuse), a drug used for alcohol use disorder, can improve vision in people with retinal degeneration (like macular degeneration or retinitis pigmentosa). Researchers believe it may calm overactive cells in the retina. The study involves …
Phase 1 • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can the plastic in clear aligners change how much they hurt?
Symptom relief Recruiting nowClear aligners straighten teeth with removable plastic trays, but different materials may cause different levels of pain and irritation. This trial compares two common plastics, TPU and PETG, to see which one patients find more comfortable. About 34 people with mild to moderate c…
Sponsor: CMH Lahore Medical College and Institute of Dentistry • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can home exercise and mindfulness help people with rare brain diseases walk and sleep better?
Symptom relief Recruiting nowResearchers are testing whether a home-based program combining adapted exercise and mindfulness training can improve walking ability and sleep quality in people with rare neurodegenerative diseases such as leukodystrophy, ataxia, and adrenomyeloneuropathy. The study enrolls about…
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
A new gel aims to fade dark Spots—Will it deliver a brighter complexion?
Symptom relief Recruiting nowThis trial tests whether a depigmenting gel cream called Blancy Pro can reduce facial hyperpigmentation, including dark spots and melasma. Forty women aged 30 to 60 will apply the product daily for 90 days. Researchers will measure skin lightening using a colorimeter and clinical…
Sponsor: Brainfarma Industria Química e Farmacêutica S/A • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Hip surgery pain targeted with nerve block in new trial
Symptom relief Recruiting nowResearchers are testing whether a nerve block called a PENG block reduces pain after periacetabular osteotomy, a major hip realignment surgery. In the study, 90 adults scheduled for this surgery receive either ropivacaine, a local anesthetic, or a saline placebo injected around s…
Phase 4 • Sponsor: Matias Vested • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New drug combo aims to ease dystonia symptoms
Symptom relief Recruiting nowThis phase 2 trial tests whether VIM0423, a combination of two drugs, can reduce symptoms of isolated dystonia (a movement disorder causing muscle spasms). About 100 adults aged 18-65 with dystonia in at least two body areas will receive either VIM0423 or a placebo. Researchers w…
Phase 2 • Sponsor: Vima Therapeutics • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Sound waves aim to ease stuttering in early trial
Symptom relief Recruiting nowThis study tests whether low-intensity focused ultrasound (LIFU), a gentle sound wave technique, can safely improve speech fluency in people who stutter. Twenty adults who stutter will receive LIFU or a sham treatment, and researchers will measure changes in stuttering severity a…
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New shot aims to ease depression and anxiety in cancer and chronic disease patients
Symptom relief Recruiting nowThis study tests whether a single injection of RE104 can reduce symptoms of depression or mixed depression and anxiety in people with adjustment disorder caused by a serious medical illness like cancer, ALS, multiple sclerosis, Parkinson's disease, or idiopathic pulmonary fibrosi…
Phase 2 • Sponsor: Reunion Neuroscience Inc • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
CBD trial aims to ease sanfilippo syndrome symptoms
Symptom relief Recruiting nowThis study tests whether cannabidiol (CBD) can safely improve behavior, mood, sleep, and daily function in people with Sanfilippo syndrome, a rare genetic disorder. Thirty-five participants will receive either CBD or a placebo, then switch after a break. Caregivers will report on…
Phase 2/3 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Could ditching diets during pregnancy improve weight gain and mood?
Symptom relief Recruiting nowResearchers at San Diego State University are testing an 8-week online program that teaches intuitive eating principles to pregnant women with obesity. The program includes weekly video modules and workbook exercises, with optional office hours. The study will compare participant…
Sponsor: San Diego State University • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
One laser, many skin fixes? trial tests 1550nm device on scars and wrinkles
Symptom relief Recruiting nowResearchers are testing a 1550nm non-ablative fractional laser on adults with skin concerns such as acne scars, wrinkles, and dark spots. The trial enrolls about 200 people aged 18 to 70. Participants receive laser treatment, then answer questionnaires about their experience. Der…
Sponsor: AVAVA, Inc. • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Sound waves aimed at the brain could tame seizures
Symptom relief Recruiting nowThis early study tests a device that uses low-intensity focused ultrasound to calm overactive brain areas in people with drug-resistant temporal lobe epilepsy. Eight adults will receive up to three 10-minute ultrasound sessions. Researchers will track side effects and check if se…
Phase 1/2 • Sponsor: NaviFUS Corporation • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can talk therapy and symptom tracking ease the trauma of leukemia?
Symptom relief Recruiting nowThis study tests a program called EASE that combines psychological support with regular symptom checks and early access to palliative care. Researchers want to see if it reduces traumatic stress and physical symptoms in people newly diagnosed with acute leukemia. Half of the 266 …
Sponsor: Canadian Cancer Trials Group • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can a nudge toward healthy habits boost an online depression and anxiety program?
Symptom relief Recruiting nowThis trial tests whether adding personalized feedback makes an ultra-brief online program more effective for adults with depression and anxiety. The program, called Things You Do, teaches skills to increase healthy actions like meaningful activities, healthy thinking, and social …
Sponsor: University of Regina • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Brain training through implanted electrodes aims to quiet Parkinson's tremors
Symptom relief Recruiting nowResearchers are testing whether people with Parkinson's disease, epilepsy, or essential tremor can use visual neurofeedback to change abnormal brain activity linked to their symptoms. Participants already scheduled for deep brain stimulation surgery use their implanted electrodes…
Sponsor: ETH Zurich • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Can a tuned brain implant sharpen thinking in Parkinson's?
Symptom relief Recruiting nowMany people with Parkinson's disease develop problems with thinking and memory, and few treatments help. This trial tests whether deep brain stimulation delivered at a specific rhythm, called theta frequency, can improve working memory. Participants already have a stimulator impl…
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Could a wakefulness drug beat fatigue in IBD patients?
Symptom relief Recruiting nowThis study tests whether modafinil, a drug used for sleep disorders, can reduce severe fatigue in adults with inactive inflammatory bowel disease (IBD). Sixty participants will take either modafinil or a placebo for 8 weeks, starting at 100 mg daily with possible dose increases. …
Phase 2/3 • Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Two surgeries, one goal: easing crippling muscle tightness in kids
Symptom relief Recruiting nowChildren and teens with spastic or dystonic quadriplegia from cerebral palsy often need surgery to control severe muscle tightness that interferes with comfort, movement, and care. Doctors at Boston Children's Hospital are tracking outcomes for two approaches: implanted baclofen …
Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Old drug showdown: can benzhexol match procyclidine for Parkinson's tremor?
Symptom relief Recruiting nowResearchers are comparing two anticholinergic medicines, benzhexol and procyclidine, to see whether they ease tremor similarly in adults with tremor-predominant Parkinson's disease. About 88 people aged 40 to 70 who already take levodopa will be randomly assigned to add one of th…
Sponsor: safia bano • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Desert plant tested against Clozapine's weighty side effects
Symptom relief Recruiting nowPeople with treatment-resistant schizophrenia often take clozapine, a drug that can cause serious weight gain and metabolic problems. This pilot study tests whether a daily infusion made from the leaves of the Nitraria retusa plant can reduce those side effects. Thirty patients w…
Sponsor: Faculty of Medicine, Sousse • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Switching to a nebulizer may help COPD patients who get no relief from inhalers
Symptom relief Recruiting nowResearchers are testing whether COPD patients who report no symptom relief from their handheld maintenance inhalers do better when switched to nebulized versions of similar drugs. The trial enrolls about 120 people with severe COPD who have used a single handheld inhaler for at l…
Phase 4 • Sponsor: COPD Foundation • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Does the order of bone grafting change how well dental implants take?
Symptom relief Recruiting nowResearchers compare two ways of sequencing bone grafting during sinus lift and dental implant placement in the upper jaw. One sequence places the implant before packing bone graft; the other packs the graft first, then drills for the implant. Both use a customized surgical guide …
Sponsor: Cairo University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
New pacing technique aims to outperform standard therapy for heart failure
Symptom relief Recruiting nowResearchers are testing whether a pacing technique called left bundle branch area pacing, guided by detailed imaging and electrical data, can improve outcomes for people with heart failure and left bundle branch block. The trial enrolls 100 adults with non-ischemic cardiomyopathy…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Lower back nerve block tested to cut pain after fibroid surgery
Symptom relief Recruiting nowResearchers are testing whether a quadratus lumborum nerve block reduces pain after laparoscopic myomectomy, a surgery to remove uterine fibroids while keeping the uterus. The block is a temporary anesthetic injection into a lower back muscle. In this double-blind, randomized tri…
Phase 4 • Sponsor: Joseph Findley MD • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can adding Shoulder-Blade training boost neck pain relief?
Symptom relief Recruiting nowResearchers are testing two physical therapy approaches for adults aged 40 to 60 with chronic neck pain and confirmed cervical spondylosis. Both groups do deep neck flexor training guided by a pressure biofeedback device, and one group also adds shoulder-blade stabilization exerc…
Sponsor: Ibadat International University, Islamabad • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Scalpel vs sound waves: two carpal tunnel surgeries go head to head
Symptom relief Recruiting nowCarpal tunnel syndrome happens when a nerve in the wrist gets squeezed, causing pain, numbness, and weakness in the hand. Open surgery has long been the standard fix, but a newer minimally invasive method uses ultrasound to guide the release through a much smaller opening. This s…
Sponsor: AUVA General Trauma Hospital Salzburg • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can intensive speech therapy rewire speech in children with rare genetic conditions?
Symptom relief Recruiting nowResearchers are testing whether four weeks of intensive motor speech therapy can improve speech accuracy in children who have childhood apraxia of speech along with a rare genetic condition. The study enrolls up to 20 children aged 3 to 16. Each child receives 12 sessions of eith…
Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can tailored acupuncture help untangle PCOS?
Symptom relief Recruiting nowResearchers are testing whether a personalized acupuncture program combined with lifestyle coaching can improve insulin resistance in women with polycystic ovary syndrome (PCOS). The trial enrolls 210 women aged 18 to 40 with a BMI of 25 to 40. Participants receive acupuncture se…
Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can trained peer mentors ease the mental toll of IBD?
Symptom relief Recruiting nowAdults with inflammatory bowel disease often face psychological distress, especially during transitions like a new diagnosis, a flare, or surgery. Researchers are testing IBD Strong Peer, a program where trained peer mentors provide emotional support through up to 10 virtual call…
Sponsor: Jennifer Jones • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a massive data registry crack the code of Parkinson's and related brain diseases?
Knowledge-focused Recruiting nowResearchers are building a large database of cognitive, behavioral, lifestyle, and genetic information from people with neurodegenerative diseases such as Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. The goal is to find biomarkers that help do…
Sponsor: Vincent Mok • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
NIH launches massive hunt to solve medical mysteries for thousands
Knowledge-focused Recruiting nowThis study aims to diagnose people with severe, undiagnosed conditions that have baffled doctors. Up to 20,000 participants will undergo advanced genetic testing and clinical exams at multiple research centers. The goal is to provide answers, discover new diseases, and improve ca…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists launch national study to track immune weakness linked to severe COVID
Knowledge-focused Recruiting nowThis study follows 500 adults in France who have either a genetic defect or autoantibodies that weaken their type I interferon immune response. Researchers will collect blood samples and health data over 1 to 4 years to track infections, autoimmune diseases, and cancers. The goal…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Could a dye reveal hidden scarring in Crohn's patients?
Knowledge-focused Recruiting nowThis study tests a new imaging method using a special dye (FAPI) to detect bowel scarring in people with Crohn's disease. Scarring affects up to half of patients and often leads to surgery, but current tests can't spot it early. The study will involve 30 adults starting biologic …
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Reading the Brain's signals to predict who benefits from deep brain stimulation
Knowledge-focused Recruiting nowDeep brain stimulation uses implanted electrodes to send electrical pulses to specific brain regions, and doctors are still working out how to tune it for each patient. This study records brain activity while adults with neurological or psychiatric conditions perform cognitive an…
Sponsor: Centre Hospitalier St Anne • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can what you eat help sickle cell? new study investigates diet and symptoms
Knowledge-focused Recruiting nowThis study looks at how diet and eating habits affect the health of adults with sickle cell disease. Researchers will interview participants about their food intake and behaviors, and collect blood and urine samples. The goal is to understand links between nutrition and symptoms …
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Massive study aims to unlock secrets of movement disorders
Knowledge-focused Recruiting nowThis natural history study is collecting information from up to 4,000 people with movement disorders (like Parkinson's disease or tremor) and their family members. Participants undergo exams, blood tests, and imaging, but receive no new treatments. The goal is to gather data that…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New brain scans aim to spot inflammation in Alzheimer's and Parkinson's
Knowledge-focused Recruiting nowThis study uses special PET scans to measure inflammation in the brains of people with Alzheimer's, Parkinson's, ALS, and other neurodegenerative diseases. Researchers will compare these scans to those from healthy volunteers to see if inflammation levels differ. The goal is to d…
Phase 1 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can a Vitamin-Like pill boost fat burning on a keto diet?
Knowledge-focused Recruiting nowThis study looks at how a supplement called nicotinamide riboside (NR) and a low-carb, high-fat 'ketogenic' diet affect the way the body burns fat and uses energy. Researchers will measure changes in metabolism in 100 overweight or obese adults. Participants will eat a standard d…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Massive study aims to unlock genetic secrets of movement disorders
Knowledge-focused Recruiting nowThis study aims to understand the link between genes and symptoms in people with inherited movement disorders. Researchers will study up to 2,500 participants, including patients and their family members, to identify new disease-causing genes and improve diagnosis. The goal is to…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Gene hunt in peru: could ancestry hold key to autoimmune diseases?
Knowledge-focused Recruiting nowThis study aims to uncover genetic changes that cause autoimmune diseases in people native to Peru. Researchers will collect blood, urine, and stool samples from 300 participants, including patients with conditions like lupus and rheumatoid arthritis, their family members, and he…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Heartburn drug under the microscope: registry tracks thousands of pregnancies
Knowledge-focused Recruiting nowResearchers are running an observational registry to study whether vonoprazan, an oral drug for heartburn and acid reflux, is safe to take during pregnancy. The study follows women aged 15 to 50 who took vonoprazan while pregnant and compares their outcomes with women who did not…
Sponsor: Phathom Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study uses genetic sequencing to solve mysterious childhood diseases
Knowledge-focused Recruiting nowThis study aims to find genetic causes of rare diseases in children aged 2 to 18 who live outside the United States and have limited access to genetic testing. Researchers will collect blood, saliva, or cheek swab samples from affected children and their family members. The goal …
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Researchers track Insulin-Making cells in type 1 diabetes over years
Knowledge-focused Recruiting nowThis study follows people who previously took part in type 1 diabetes trials to see how long their bodies continue to produce insulin. Researchers will also look at how immune system changes relate to insulin production. The goal is to gather information that could lead to better…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study checks drug levels in breast milk for nursing moms
Knowledge-focused Recruiting nowThis study looks at how much of the drug bimekizumab passes into breast milk. Researchers will collect milk samples from 20 breastfeeding mothers with conditions like psoriasis or arthritis over several weeks. The goal is to understand potential exposure for nursing infants, not …
Phase 1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists scan brains to unravel why effort hurts in chronic fatigue
Knowledge-focused Recruiting nowThis study uses functional MRI to see how the brain processes unpleasant sensations like pain and physical effort in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) compared to healthy volunteers. Researchers will apply mild heat and ask participants to sq…
Early phase 1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New ulcerative colitis drug put through drug interaction test
Knowledge-focused Recruiting nowThis early-phase study is testing whether afimkibart, an experimental drug for ulcerative colitis, changes how the body processes common medications like caffeine, warfarin, and omeprazole. About 25 people with moderate to severe active ulcerative colitis will receive afimkibart …
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists zap brain during surgery to uncover movement secrets
Knowledge-focused Recruiting nowThis study looks at how deep brain stimulation (DBS) changes movement in people with conditions like Parkinson's disease or essential tremor. About 60 people scheduled for DBS surgery will have extra temporary electrodes placed on the brain to measure muscle activity during stimu…
Sponsor: Jorge Gonzalez-Martinez • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Lupus drug anifrolumab under pregnancy safety spotlight
Knowledge-focused Recruiting nowThis study is tracking 500 pregnant women with lupus to see if the drug anifrolumab is linked to birth defects or pregnancy loss. Researchers will compare women who took anifrolumab during early pregnancy to those who did not. The goal is to gather real-world safety data, not to …
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists launch deep dive into rare genetic condition behind chronic inflammation
Knowledge-focused Recruiting nowThis study aims to better understand trisomy 8 mosaicism, a rare genetic condition where some cells have an extra copy of chromosome 8, and its link to autoinflammatory disease (TRIAD). Researchers will follow affected individuals and their healthy relatives over time, collecting…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can a simple questionnaire reveal why some cystic fibrosis patients skip physiotherapy?
Knowledge-focused Recruiting nowResearchers are translating the AdT-Physio scale into French and testing it in 121 adults with cystic fibrosis. The scale asks 15 questions about how often patients do their physiotherapy and what they believe about the treatment and their therapist. Participants also fill out qu…
Sponsor: Pole Sante Grace de Dieu • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Simple skin test may spot Parkinson's risk years early
Knowledge-focused Recruiting nowThis study is testing whether a skin biopsy can detect abnormal proteins linked to Parkinson's disease in people with essential tremor, a common movement disorder. Researchers will follow 300 participants aged 50-85 for two years to see who develops Parkinson's. The goal is to fi…
Sponsor: CND Life Sciences • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Massive study aims to unlock secrets of parathyroid diseases
Knowledge-focused Recruiting nowThis study follows up to 3,000 people who have, are at risk for, or are related to someone with a parathyroid disorder. Researchers will collect medical records, questionnaires, and samples like blood and saliva to learn what causes these conditions and how they change over time.…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists launch major study to unravel mysteries of rare lung infections
Knowledge-focused Recruiting nowThis study aims to learn more about non-tuberculous mycobacterial (NTM) infections, which cause repeated lung and other organ infections. Researchers will study up to 1,000 participants to understand the genetics, symptoms, and best treatments for these infections. The study also…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can tissue clues predict which Crohn's patients relapse after surgery?
Knowledge-focused Recruiting nowResearchers are building a tool to predict which Crohn's disease patients will have their disease return after intestinal surgery. The study follows 250 people who undergo intestinal resection as part of routine care, collecting leftover surgical tissue, clinical data, and blood …
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Major study tracks rare muscle disease to pave way for future treatments
Knowledge-focused Recruiting nowThis observational study aims to better understand primary mitochondrial myopathy, a rare muscle disease. Researchers will follow 1300 patients and healthy controls, measuring muscle strength, balance, and daily function over time. The goal is to develop and validate tools to tra…
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists track rare eye disease to pave way for future treatments
Knowledge-focused Recruiting nowThis study follows 25 people aged 10 and older with Stargardt-like macular dystrophy (STDG3), a rare inherited eye disease that causes vision loss. Over three years, researchers will measure changes in the retina using eye exams, imaging, and vision tests. The goal is to understa…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
2,000 volunteers to help unlock secrets of metabolic syndrome and prediabetes
Knowledge-focused Recruiting nowThis study will follow 2,000 adults with metabolic syndrome or prediabetes over time to understand how these conditions progress and lead to complications. Researchers will track health records, nutrition, and physical function to find key factors that affect long-term outcomes. …
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Blood platelets may hold clues to HIV's hidden hideouts
Knowledge-focused Recruiting nowThis study investigates whether platelets—tiny blood cells involved in clotting—interact with HIV-infected immune cells in ways that affect the virus's ability to persist despite treatment. Researchers will collect blood samples from 90 adults with HIV who have had undetectable v…
Sponsor: Tourcoing Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New study tracks teen gaze to fight nearsightedness
Knowledge-focused Recruiting nowThis observational study looks at whether different eyeglass prescriptions change how close teenagers hold objects during everyday tasks. It includes 100 adolescents aged 12-17, both with and without myopia. Participants wear motion-capture and eye-tracking gear while performing …
Sponsor: Essilor International • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Pregnancy hormone hCG may hold clues to bone and gland health
Knowledge-focused Recruiting nowResearchers are studying whether blood levels of luteinizing hormone (LH) and human chorionic gonadotropin (hCG) are linked to the presence, severity, and long-term outcomes of endocrine disorders such as osteoporosis, thyroid disease, and adrenal gland problems. The study enroll…
Sponsor: Martin Blomberg Jensen • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Brain scans probe why some Parkinson's patients freeze Mid-Step
Knowledge-focused Recruiting nowResearchers at National Taiwan University Hospital are studying how the brain combines visual information with movement in people who have Parkinson's disease. They will compare 21 people with freezing of gait, 21 without it, and 21 healthy adults of similar age. Participants com…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists hunt for genes behind rare eye conditions
Knowledge-focused Recruiting nowThis study aims to uncover the genetic causes of a group of eye conditions called MAC (microphthalmia, anophthalmia, and uveal coloboma), which can lead to vision loss or blindness. Researchers will collect DNA samples from 600 people—both those with MAC and their close relatives…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Rare disease study seeks clues for future treatments
Knowledge-focused Recruiting nowThis study tracks the natural course of fucosidosis, a rare genetic disorder, in up to 57 people. It collects medical history and ongoing health data without giving any experimental treatment. The goal is to better understand the disease and help design future therapies.
Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Donated tissue could reveal how HHT blood vessel tangles form
Knowledge-focused Recruiting nowResearchers at University Hospital Essen are studying donated tissue from people with hereditary hemorrhagic telangiectasia (HHT), a genetic condition that causes abnormal blood vessel tangles called telangiectasias. The study compares tissue with and without these malformations,…
Sponsor: University Hospital, Essen • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists seek brain clues to impulsive and compulsive behaviors
Knowledge-focused Recruiting nowThis observational study aims to understand why some people are more impulsive or compulsive than others. Researchers will use brain scans, genetic tests, and behavioral surveys in 1,100 participants aged 6 to 80, including those with ADHD, OCD, autism, and conduct disorder. The …
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists hunt for hidden genes behind rare disorders
Knowledge-focused Recruiting nowThis study aims to identify the genetic causes of rare, undiagnosed disorders by using genome sequencing. Researchers will analyze the DNA of up to 2,000 participants, including affected individuals and their family members. The goal is to discover new disease-causing genes and i…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists launch major study to unravel salivary gland mysteries
Knowledge-focused Recruiting nowThis study aims to learn more about diseases that affect the salivary glands, which produce saliva. Researchers will collect medical data, blood, saliva, and tissue samples from people with these conditions, their relatives, and healthy volunteers. The goal is to better understan…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Global registry aims to map the full course of Charcot-Marie-Tooth disease
Knowledge-focused Recruiting nowResearchers are building a global registry to collect patient-reported surveys, genetic test results, and medical records from people with Charcot-Marie-Tooth disease and related inherited neuropathies. The study is open to children and adults with a confirmed or suspected diagno…
Sponsor: Hereditary Neuropathy Foundation • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists probe immune cell shifts in ICU patients to unlock sepsis secrets
Knowledge-focused Recruiting nowThis study examines how a type of immune cell called gamma delta T cells adapt and function in critically ill patients, both with and without sepsis. Researchers will compare these cells in healthy people, non-septic ICU patients, and septic ICU patients. The goal is to understan…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New study seeks to uncover links between ALS and dementia
Knowledge-focused Recruiting nowThis study screens 360 adults with neurodegenerative disorders like ALS, frontotemporal dementia, and progressive supranuclear palsy. Researchers will use medical history, physical exams, memory tests, movement analysis, MRI scans, and other tests to find common features and diff…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Sound waves shed light on nerve and muscle health
Knowledge-focused Recruiting nowThis study uses ultrasound, a safe imaging technique that uses sound waves, to get detailed pictures and measurements of nerves and muscles. Researchers aim to collect normal values from healthy adults and compare them with data from people who have neuromuscular disorders. The g…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists hunt for genetic clues to mysterious immune diseases
Knowledge-focused Recruiting nowThis study aims to find the genetic causes of inherited immune problems that affect white blood cells called lymphocytes. Researchers will review medical records and collect blood samples from up to 5,000 people with suspected immune disorders, as well as their relatives. The goa…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New study aims to better measure pain in NF1 patients
Knowledge-focused Recruiting nowThis study works to improve questionnaires that measure pain, daily activities, and physical function for people with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas. Participants aged 5 and older will give feedback on existing surveys through group discussions or…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Six biologics put to the test in Real-World asthma and COPD care
Knowledge-focused Recruiting nowResearchers are observing how six biologics that target Type 2 inflammation perform in adults with asthma or COPD during routine care in China. The study follows 538 participants for 12 months to measure flare-ups, lung function, symptom control, and safety. It also collects bloo…
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Eye fluid clues may unlock why wet AMD treatment fails for some
Knowledge-focused Recruiting nowThis study aims to find out why 20-40% of people with wet age-related macular degeneration (AMD) don't respond well to standard anti-VEGF injections. Researchers will collect fluid from inside the eye of 117 patients and compare those who respond well to treatment with those who …
Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dig into why skin tumors grow in rare disease
Knowledge-focused Recruiting nowThis study looks at why people with tuberous sclerosis, a rare genetic condition, develop non-cancerous skin tumors. Researchers will examine up to 400 adults, perform skin exams, and take small tissue samples (biopsies) from tumors. The goal is to identify the cells and genetic …
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Brain waves reveal how we stay upright: new study links visual attention to balance
Knowledge-focused Recruiting nowThis study investigates how the brain uses visual attention to help maintain balance. Healthy adults aged 18 to 35 will perform a visual attention task while their brain activity is recorded with EEG and their balance is measured. The goal is to understand the neural connections …
Sponsor: Istanbul Gedik University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dig into skin healing mysteries in immune disorders
Knowledge-focused Recruiting nowThis study aims to understand how the immune system and skin healing are connected in people with primary immunodeficiency, psoriasis, or eczema, as well as in healthy volunteers. Researchers will collect skin biopsies, blood samples, and optional skin swabs to analyze microbes a…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
HIV hiding spots revealed in treatment pause study
Knowledge-focused Recruiting nowThis study aims to understand where HIV hides in the body when people stop their daily antiretroviral therapy (ART) for a short time. Fifty adults with HIV will either stay on ART or pause it for up to 90 days. Researchers will use PET/CT scans and take small tissue samples from …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches study to map brain changes in kids with rare genetic disorders
Knowledge-focused Recruiting nowThis study aims to understand how the brain develops in children with Williams syndrome or 7q11.23 duplication syndrome, compared to healthy children. Researchers will use MRI scans and cognitive tests to track changes over time. The goal is to learn how these genetic variations …
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists launch deep dive into rare liver disease PSC
Knowledge-focused Recruiting nowThis study aims to understand what causes primary sclerosing cholangitis (PSC), a rare chronic liver disease. About 143 adults with PSC will provide blood, saliva, urine, stool, and tissue samples, plus undergo imaging and procedures like colonoscopy and liver biopsy. No treatmen…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track rare family condition to uncover hidden clues about blood disorder
Knowledge-focused Recruiting nowThis study follows about 50 members of a family with a rare inherited condition called familial hypereosinophilia, where high levels of a type of white blood cell can damage the heart and nerves. Researchers will track participants over many years with yearly checkups, blood test…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive heart study seeks 5,000 volunteers to uncover hidden risks
Knowledge-focused Recruiting nowThis study aims to learn more about heart and blood vessel diseases by observing people who have them or are at risk. Researchers will collect samples and perform tests like imaging and stress tests on up to 5,000 participants, including healthy volunteers and relatives of affect…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive gene hunt aims to unlock secrets of immune disorders
Knowledge-focused Recruiting nowThis study is looking for the genes that cause certain immune system problems. Researchers want to understand why some people get sick and others don't, even in the same family. Up to 5,000 people with immune disorders and their relatives will give blood or cheek cell samples for…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive study aims to unlock secrets of rare inflammatory diseases
Knowledge-focused Recruiting nowThis study is for people with certain autoinflammatory diseases (like NOMID, DIRA, CANDLE, SAVI, and others) and their healthy relatives. Researchers want to learn more about what causes these diseases and how they affect the body over time. Participants will have medical tests a…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches major screening study to unravel mysteries of immune weakness
Knowledge-focused Recruiting nowThis study screens up to 2,000 people who have or may have immune disorders that make them prone to infections, along with their healthy relatives. Researchers will use medical history, physical exams, blood tests, and genetic testing to better understand these conditions. The go…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dig into skin bugs to unlock eczema secrets
Knowledge-focused Recruiting nowThis study looks at the tiny organisms living on our skin—like bacteria and fungi—and how they might differ in people with eczema (atopic dermatitis). Researchers will collect skin samples from healthy volunteers and patients aged 2 to 40 with moderate to severe eczema, as well a…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Researchers launch major study to unravel cholesterol mysteries
Knowledge-focused Recruiting nowThis study aims to learn more about lipid disorders—conditions that affect fats like cholesterol in the blood. Researchers will observe up to 2,000 people with abnormal cholesterol levels to better understand how these disorders develop and how to diagnose them. Participants will…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists watch thyroid conditions unfold in 2,500 patients
Knowledge-focused Recruiting nowThis study follows up to 2,500 people with thyroid problems like hyperthyroidism, hypothyroidism, or Graves' disease. Researchers will track how these conditions develop over time using standard medical tests and genetic samples. The goal is to better understand the natural histo…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists watch immune system in action to unlock IBD mysteries
Knowledge-focused Recruiting nowThis study aims to learn how the immune system controls inflammation in the gut for people with Crohn's disease or ulcerative colitis. Up to 1,000 participants aged 0 to 75 will receive standard medical care and may provide blood, tissue, or white blood cell samples. No experimen…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Lupus secrets revealed: major study tracks disease over time
Knowledge-focused Recruiting nowThis study aims to learn more about how lupus (SLE) develops and changes over time by observing patients and their relatives. Up to 2000 people aged 3 and older with known or suspected lupus, along with their family members, will provide medical history, blood and urine samples, …
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists probe how eczema drugs alter skin microbes
Knowledge-focused Recruiting nowThis study examines how common eczema treatments, including antibiotics and bleach baths, change the types and amounts of bacteria on the skin. Researchers will compare people with eczema to healthy volunteers. The goal is to understand the skin microbiome better, not to test a n…
Phase 2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Stem cells harvested for lab tests in immune disorder gene therapy quest
Knowledge-focused Recruiting nowThis study collects blood stem cells from adults aged 18-40 with DOCK8 deficiency, LAD-1, or GATA2 deficiency. Participants receive daily injections of G-CSF for 5 days to move stem cells into the blood, then undergo a single leukapheresis procedure to collect them. The cells are…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists harvest cells to grow mini retinas in lab
Knowledge-focused Recruiting nowThis study collects skin, hair, blood, urine, or saliva samples from people with certain eye diseases (like macular degeneration) and from healthy volunteers. Researchers will turn these samples into stem cells in the lab to study how the diseases develop and to test potential ne…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches major study to unravel genetic metabolic mysteries
Knowledge-focused Recruiting nowThis study aims to better understand and treat people with certain inherited metabolic or genetic disorders. Researchers will use standard medical tests like blood work and imaging to diagnose and care for participants, who may also join other related studies. The goal is to expa…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can tracking MADD's natural course unlock better care?
Knowledge-focused Recruiting nowThis study follows people with Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) over time to learn how the condition progresses and affects daily life. Researchers will collect health data and patient feedback to identify patterns and potential markers of the disease. The goal i…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists probe immune System's role in chronic disease
Knowledge-focused Recruiting nowThis study looks at how the body's innate immune system responds to certain environmental exposures by measuring inflammation markers in blood. Researchers will collect blood samples from up to 725 healthy volunteers aged 18-45 to analyze how specific genes and proteins react. Th…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Rare bone disease under the microscope: what causes melorheostosis?
Knowledge-focused Recruiting nowThis study follows adults with melorheostosis, a rare disease that causes bone thickening, pain, and joint problems. Researchers will track how the disease progresses over time, collect genetic samples from patients and their relatives, and look for biomarkers. The goal is to bet…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can your genes predict eye damage from a common arthritis drug?
Knowledge-focused Recruiting nowThis study looks at whether certain genes make some people more likely to develop eye damage from the drug Plaquenil, which is used for autoimmune diseases like lupus and rheumatoid arthritis. Researchers will compare people who have had eye damage from Plaquenil with those who h…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Girls' period patterns under the microscope: a quest to decode healthy puberty
Knowledge-focused Recruiting nowThis study follows healthy girls ages 8-14 and teens with irregular periods to learn how their menstrual cycles become regular after their first period. Researchers also include girls at risk for PCOS and compare them to women with and without PCOS. The goal is to understand norm…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists seek tissue samples to unlock HIV and cancer mysteries
Knowledge-focused Recruiting nowThis study collects blood, bone marrow, and tissue samples from people with HIV, KSHV, or certain cancers to help researchers learn more about these diseases. Participants must be 18 or older and may have HIV, KSHV, or related conditions. No treatment is given; the goal is to gat…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
The question after preventive mastectomy: would women do it again?
Knowledge-focused Recruiting nowResearchers at an Italian hospital are asking women who carry BRCA1/2 gene variants and chose risk-reducing mastectomy to describe their experience in an online survey. The survey covers why they chose surgery, which procedures and reconstructions they had, complications, sensati…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive study aims to unlock secrets of food allergies
Knowledge-focused Recruiting nowThis study looks at the causes and effects of food allergies and related conditions like eczema and eosinophilic esophagitis. Researchers will collect blood, skin, and genetic samples from up to 1,800 people over many years. The goal is to find biomarkers and pathways that explai…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Lupus drug anifrolumab under safety microscope: does it raise infection or cancer risk?
Knowledge-focused Recruiting nowThis study watches over 3,000 adults with moderate-to-severe lupus to see if the drug anifrolumab increases the risk of serious infections or cancer compared to standard treatments. No new medicine is given—researchers simply analyze health records from people already prescribed …
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists seek clues to rare cancer syndrome in 5,000-Person study
Knowledge-focused Recruiting nowThis study aims to learn more about Li-Fraumeni syndrome (LFS), a genetic condition that raises the risk of several cancers. Researchers will study up to 5,000 people with LFS or related cancer histories to find new genes, understand how the TP53 gene works, and identify factors …
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
50,000 Alzheimer's patients join global study to unlock disease secrets
Knowledge-focused Recruiting nowThis international observational study will follow 50,000 people with Alzheimer's disease or related dementias for many years. Researchers will collect real-world data from routine doctor visits to track how the disease progresses and how treatments are used and tolerated. The go…
Sponsor: Stichting International Registry for Alzheimer's Disease and other Dementias Foundation • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Rare cancer syndrome under the microscope: what families need to know
Knowledge-focused Recruiting nowThis study follows people with a rare genetic condition called DICER1 syndrome, which raises the risk of certain childhood cancers like pleuropulmonary blastoma. Researchers will collect medical histories, genetic samples, and tissue from up to 1,500 participants and their relati…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Bedside test may end guesswork in nerve pain treatment
Knowledge-focused Recruiting nowThis study aims to see if a quick bedside sensory test can predict which painkiller—pregabalin, duloxetine, or a placebo—works best for people with nerve pain in their feet. About 190 adults with diabetic, chemotherapy-related, or idiopathic nerve pain will try each treatment for…
Phase 2 • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Blood cell harvest could fuel future immune disease cures
Knowledge-focused Recruiting nowThis study collects blood stem cells and immune cells from healthy volunteers and patients with primary immune deficiencies or blood disorders. The cells are used in the lab to develop new gene and cell therapies. Up to 850 adults aged 18-70 will participate. The goal is to advan…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists launch Long-Term study to unravel mysterious liver disease
Knowledge-focused Recruiting nowThis study is observing 400 people aged 12 and older who have noncirrhotic portal hypertension (NCPH) or are at risk for it. NCPH is a liver condition that increases blood pressure in the liver's blood vessels without causing cirrhosis, and often has no early symptoms. Researcher…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Eye scans as a window to the body: study probes retinal imaging across diseases
Knowledge-focused Recruiting nowResearchers at the University of Miami are studying whether advanced eye imaging devices can reveal useful information about the eye in health and disease. The study has two parts: one observes the eyes of healthy people and people with conditions such as multiple sclerosis, dry …
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches study to uncover link between infections and mitochondrial disease
Knowledge-focused Recruiting nowThis study at the National Institutes of Health looks at how infections can worsen symptoms in people with mitochondrial disease, a group of disorders that affect energy production in cells. Researchers will evaluate participants' immune systems through blood tests, physical exam…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches massive study to unlock HIV's secrets through blood
Knowledge-focused Recruiting nowThis study aims to learn more about how HIV infects cells and affects the immune system by collecting blood samples from up to 2,419 adults, both with and without HIV. Researchers will analyze these samples to compare genetic and protein differences. The goal is to better underst…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive study seeks answers for rare inherited nerve diseases
Knowledge-focused Recruiting nowThis study aims to learn more about rare inherited disorders that affect the brain, spinal cord, muscles, and nerves. Researchers will collect medical history, perform exams, and run genetic tests on up to 3,500 participants. No new treatments are tested; the goal is to better un…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
NIH launches major study to unlock secrets of rare bone diseases
Knowledge-focused Recruiting nowThis study aims to collect information and bone samples from up to 1,000 people with bone or mineral disorders, such as tumor-induced osteomalacia or familial tumoral calcinosis. Participants receive standard medical evaluations and may provide bone tissue from surgery or a biops…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Cured of cushing as a kid? scientists want to track your health for years
Knowledge-focused Recruiting nowThis study looks at the long-term health of people who were cured of Cushing disease before age 21. Researchers want to understand how past high cortisol levels affect the body and mind years later. Participants will complete surveys and have check-ups every 5 years. The goal is …
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists hunt for better ways to spot hidden adrenal tumors
Knowledge-focused Recruiting nowThis study aims to improve how doctors find and understand pheochromocytomas and paragangliomas, rare tumors that can cause dangerous high blood pressure. Researchers will use advanced imaging scans and genetic testing in up to 3,000 participants to learn more about these tumors.…
Phase 1 • Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists hunt for gene behind rare kidney cancer syndrome
Knowledge-focused Recruiting nowThis study aims to uncover the genetic causes of hereditary leiomyomatosis renal cell cancer (HLRCC), a condition that can lead to painful skin bumps, uterine fibroids, and kidney tumors. Researchers will study people with known or suspected HLRCC and their family members to iden…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Could an existing drug treat sickle cell? researchers launch blood sample hunt
Knowledge-focused Recruiting nowThis study collects blood samples from 250 adults with sickle cell disease, sickle cell trait, or healthy red blood cells. Researchers will use these samples to screen thousands of compounds, including FDA-approved drugs, to find ones that stop red blood cells from sickling. The …
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track rare genetic disorder to unlock its secrets
Knowledge-focused Recruiting nowThis study follows 600 people with GATA2 deficiency, a genetic disorder affecting the immune system and other body systems. Researchers aim to understand the full range of health problems it causes and why it affects people differently. Participants will have yearly check-ups for…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a photo help diagnose a rare brain disorder?
Knowledge-focused Recruiting nowThis study looks at facial features of males aged 2 to 40 with creatine transporter deficiency (CTD), a genetic disorder that causes intellectual disability, seizures, and behavioral issues. Researchers will examine photos of participants to see if they share common facial traits…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Sickle cell study aims to uncover disease patterns
Knowledge-focused Recruiting nowThis study follows up to 3,500 people with sickle cell disease to learn more about how the condition progresses and what complications arise. Participants receive their usual medical care outside the hospital and visit the clinic for check-ups and research tests. No experimental …
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Banking blood and bone marrow to decode plasma cell disorders
Knowledge-focused Recruiting nowResearchers at Peking University First Hospital are building a prospective cohort of 2,000 people with plasma cell disorders, including multiple myeloma, amyloidosis, and related conditions. Participants give blood, bone marrow, and urine samples before and after treatment, and t…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Cystic fibrosis diabetes: do gut hormones and genes hold the key?
Knowledge-focused Recruiting nowResearchers at Children's Hospital of Philadelphia are studying why people with cystic fibrosis develop diabetes. They will collect blood or saliva samples from 550 children and adults with CF to look at genes linked to type 2 diabetes, including TCF7L2. The team will compare ins…
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Tiny study could unlock secrets of genetic heart failure
Knowledge-focused Recruiting nowThis study follows 10 Chinese adults who have a specific gene mutation (BAG3) linked to dilated cardiomyopathy, a condition where the heart becomes enlarged and weak. Researchers will track changes in heart function, symptoms, and biomarkers over time to better understand how the…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Brain scans may reveal how kids respond to anxiety treatment
Knowledge-focused Recruiting nowThis study looks at how the brains of children with anxiety disorders work differently from healthy children. Researchers will use brain scans and thinking tasks to track changes over a year, before and after standard treatments like therapy or medication. The goal is to find pat…
Phase 2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Massive study aims to uncover cancer secrets in rare bone marrow diseases
Knowledge-focused Recruiting nowThis natural history study follows up to 4,000 people with inherited bone marrow failure syndromes (IBMFS) and their families to learn why they are prone to certain cancers. Researchers will track health over time, collect genetic samples, and look for clues that separate those w…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track rare immune disease to unlock its secrets
Knowledge-focused Recruiting nowThis study follows people with autoimmune lymphoproliferative syndrome (ALPS) and their relatives over many years. Researchers will collect blood and tissue samples, track symptoms, and study genetics to better understand why the immune system attacks the body. The goal is to lea…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists track rare brain diseases to unlock clues for future treatments
Knowledge-focused Recruiting nowThis study follows people with rare genetic disorders that cause harmful substances to build up in the body, leading to brain damage. Researchers will monitor up to 200 participants over time using exams, surveys, and lab tests. The goal is to better understand how these diseases…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Inside the eye: new study aims to personalize myopia care for kids
Knowledge-focused Recruiting nowThis study looks at the structure of children's eyes using MRI and standard eye exams. The goal is to understand why some kids respond better to myopia treatments than others. By collecting detailed images and measurements from 100 children, researchers hope to pave the way for m…
Sponsor: Essilor International • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Lupus drug in breast milk: new study aims to find out
Knowledge-focused Recruiting nowThis study tracks 16 breastfeeding mothers with lupus who are taking anifrolumab. Researchers will measure how much of the drug appears in breast milk and in the mother's and baby's blood. The goal is to understand potential exposure and effects on the breastfed infant.
Phase 4 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Your wisdom teeth could help science: study seeks tissue samples
Knowledge-focused Recruiting nowThis study collects wisdom teeth and surrounding tissue that are normally thrown away after oral surgery. Researchers will use these samples to learn more about oral health and disease. Up to 3,000 people aged 16 to 50 who need their wisdom teeth removed can join. The study also …
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Rare gene study aims to unlock kidney cancer risks
Knowledge-focused Recruiting nowThis study looks at a rare inherited condition called Birt-Hogg-Dube (BHD) syndrome, which raises the risk of kidney cancer. Researchers will collect blood, saliva, and tissue samples from up to 950 participants to find the genes involved and understand how kidney tumors grow. Th…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dive deep into the roots of a mysterious lung disease
Knowledge-focused Recruiting nowThis study aims to understand how lymphangioleiomyomatosis (LAM) damages the lungs at the cellular and genetic level. Researchers will follow up to 2,000 participants, including women with LAM and healthy volunteers, using advanced imaging and lab tests. The goal is to find the p…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists launch major study to unravel rare bone disease
Knowledge-focused Recruiting nowThis study follows up to 500 people with polyostotic fibrous dysplasia or McCune-Albright syndrome to learn how these conditions change over time. Researchers will collect medical data and tissue samples to better understand the disease. The goal is to improve future diagnosis an…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dive deep into endocrine tumors to unlock molecular secrets
Knowledge-focused Recruiting nowThis study enrolls people with endocrine tumors (such as thyroid, parathyroid, adrenal, or pancreatic tumors) who are scheduled for surgery or biopsy. Researchers collect samples of the tumor, nearby healthy tissue, blood, and urine to analyze genetic and molecular changes. The g…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New study tracks safety of enzyme therapy in babies with rare genetic disease
Knowledge-focused Recruiting nowThis study follows up to 10 children under 2 years old with acid sphingomyelinase deficiency (ASMD) who are already receiving olipudase alfa (Xenpozyme®) as part of their routine care. Researchers will monitor side effects and immune responses over 1 to 3 years. No new treatment …
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New study aims to close gaps in cancer care for black patients
Knowledge-focused Recruiting nowThis study is for Black adults newly diagnosed with gastrointestinal cancer. It focuses on ensuring patients receive proper biomarker testing and evidence-based care, helping them find and join clinical trials if they choose, and providing easy-to-understand information about the…
Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Scientists decode gut proteins to unlock Crohn's secrets
Knowledge-focused Recruiting nowThis study looks at proteins and bacteria in the gut of people with Crohn's disease compared to healthy individuals. Researchers will analyze samples from colonoscopies to understand what goes wrong in Crohn's. The goal is to find new ways to diagnose and treat the disease. 40 ad…
Sponsor: Weizmann Institute of Science • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
10,000 kidneys under the microscope: registry maps IgA Nephropathy's course
Knowledge-focused Recruiting nowResearchers in China are enrolling people with biopsy-confirmed primary IgA nephropathy into a long-term registry. Participants are followed once a year, with baseline and follow-up details recorded in a database. The study tracks deaths from any cause and heart-related deaths, p…
Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Massive global registry launched to unlock secrets of gaucher disease
Knowledge-focused Recruiting nowThis study is a long-term registry that follows over 1,200 people with Gaucher disease worldwide. It collects real-world data on how the disease progresses and how different treatments, including velaglucerase alfa, work over time. No new drugs are being tested; instead, particip…
Sponsor: Shire • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
First human doses of experimental drug ARO-033 begin safety testing
Knowledge-focused Recruiting nowThis study is the first time the experimental drug ARO-033 is being given to humans. Its main goal is to check the safety and tolerability of single and multiple doses in healthy adult volunteers. Researchers will also measure how the drug moves through the body. This is an early…
Phase 1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Scientists launch Decade-Long quest to unravel rare stroke disorder
Knowledge-focused Recruiting nowThis study follows 155 adults with CADASIL, a genetic condition that narrows small blood vessels and raises the risk of strokes and dementia, over nine years. Researchers will use brain scans, blood tests, and other exams to track how the disease changes blood vessels and thinkin…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
New european registry aims to unlock mysteries of rare breast disease
Knowledge-focused Recruiting nowThis study is creating a European registry for people with idiopathic granulomatous mastitis (IGM), a rare inflammatory breast condition that causes pain, redness, and abscesses. Researchers will collect information from 1,000 participants to better understand symptoms, treatment…
Sponsor: European Breast Cancer Research Association of Surgical Trialists • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Scientists watch and learn: no treatment, just tracking blood cancers over time
Knowledge-focused Recruiting nowThis study follows up to 1,000 adults with certain slow-growing blood cancers (CLL, SLL, LPL, WM) to track how the diseases change over time. Participants have regular check-ups and blood draws every 6 to 24 months, and may also have optional biopsies or scans for research. No tr…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Diabetes study aims to uncover hidden links between diet and physical decline
Knowledge-focused Recruiting nowThis observational study will follow 2000 adults with type 2 diabetes to see how their eating habits, body composition, and grip strength change over time. Researchers hope to identify patterns that could help improve care. Participants must be 18 or older and able to complete ba…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Can we map the course of a rare mitochondrial disease?
Knowledge-focused Recruiting nowThis global study follows people with POLG-related disorders, a group of rare mitochondrial conditions, to understand how the disease progresses over time. By observing clinical changes in up to 300 participants of all ages, researchers aim to identify key milestones that could s…
Sponsor: The POLG Foundation • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Millions of unpaid caregivers: study tracks hidden health toll
Knowledge-focused Recruiting nowThis study follows 2,800 unpaid caregivers of people with chronic conditions like diabetes or inherited disorders. Researchers will survey and interview caregivers over up to 5 years to track changes in their health, stress, and social support. The goal is to understand how careg…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Tracking the long road after gene therapy and transplant for blood disorders
Knowledge-focused Recruiting nowResearchers at St. Jude Children's Research Hospital are following people with hemoglobin disorders who have received a stem cell transplant or gene therapy. The study enrolls up to 200 participants who had or plan to have one of these treatments within 15 years. It collects rout…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Real-Time glucose data may boost healthy habits in prediabetes
Knowledge-focused Recruiting nowThis study tests whether people with prediabetes and obesity change their eating and activity habits when they can see their glucose levels in real time versus when the data is hidden. Thirty-four adults will wear a continuous glucose monitor during both an open and a blinded pha…
Sponsor: University of Primorska • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Eye scans probe how cataract surgery shifts the vitreous gel
Knowledge-focused Recruiting nowResearchers at the University of Trieste are studying how the vitreous gel inside the eye changes after cataract surgery. They will take detailed OCT scans of 15 adults before and after the procedure, focusing on the back of the vitreous and where it meets the retina. By comparin…
Sponsor: University of Trieste • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
New study tracks safety of eplontersen in patients with liver transplants
Knowledge-focused Recruiting nowThis observational study monitors the long-term safety of eplontersen, a treatment for transthyretin amyloidosis, in patients who have had a liver transplant or have severe liver impairment. Researchers will track side effects, lab changes, and serious health events in about 320 …
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Hormone tests may reveal who benefits most from acne drug
Knowledge-focused Recruiting nowResearchers at Biruni University are studying whether baseline blood levels of three hormones (DHEAS, FSH, and LH) are linked to how well adult women with moderate to severe acne respond to the drug isotretinoin. The trial enrolls 64 women aged 18 and older who are starting syste…
Sponsor: Biruni University • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
20-Year study to track rare bone marrow diseases
Knowledge-focused Recruiting nowThis study follows people with acquired or inherited bone marrow failure for up to 20 years to learn how the diseases and treatments affect the body over time. Participants, aged 2 and older, will have regular check-ups and tests every 1 to 3 years. The goal is to better understa…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Banking blood, skin and spinal fluid to decode Parkinson's
Knowledge-focused Recruiting nowResearchers at the Luxembourg Institute of Health run a long-term observational study that gathers clinical, genetic, and digital data plus biological samples from people with Parkinson's disease and healthy volunteers. Participants include adults with typical Parkinson's or atyp…
Sponsor: Luxembourg Institute of Health • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
New drug study aims to understand how liver disease affects medication
Knowledge-focused Recruiting nowThis early-stage study will test a drug called saroglitazar magnesium in 6 adults with moderate liver scarring (cirrhosis) caused by cholestatic liver disease. The main goal is to see how the drug moves through the body and if it is safe when taken every other day. Participants w…
Phase 1 • Sponsor: Zydus Therapeutics Inc. • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Massive Real-World database aims to map how chronic diseases interact
Knowledge-focused Recruiting nowOPERA is a large observational database that collects health records from people treated for chronic conditions such as HIV, liver disease, inflammatory bowel disease, heart disease, rheumatic disease, and neurodegenerative disease. Researchers use the records to study how these …
Sponsor: Epividian • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Can some children with a pointed skull skip major surgery?
Knowledge-focused Recruiting nowTrigonocephaly is a condition where a baby's skull fuses too early along the forehead, giving the head a pointed shape. Doctors often operate to relieve pressure on the growing brain, but some children may do just as well without surgery. This study follows children aged 0 to 8 w…
Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Tiny biochip could reveal sickle cell severity
Knowledge-focused Recruiting nowResearchers are testing a microfluidic device called the SCD Biochip to measure how red and white blood cells stick to proteins under normal and low oxygen conditions. They will study blood samples from people with sickle cell disease, including HbSS and HbSC types, and compare t…
Sponsor: University Hospitals Cleveland Medical Center • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Hunting the hidden genes that decide who gets porphyria attacks
Knowledge-focused Recruiting nowAcute intermittent porphyria (AIP) is an inherited disorder that can cause sudden, severe attacks, but not everyone who carries the gene gets sick. Researchers at Mount Sinai are collecting blood, saliva, and urine samples from about 150 people in AIP families, including affected…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Do Ultra-Processed meals make you eat faster and feel less full?
Knowledge-focused Recruiting nowResearchers at Ariel University are studying how the level of food processing and nutritional quality affect how much people eat, how fast they eat, how full they feel, and their blood sugar. Forty adults in Israel with a body mass index between 20 and 40 will eat three laborator…
Sponsor: Ariel University • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
5,000 heartbeats under the microscope: registry tracks arrhythmia care
Knowledge-focused Recruiting nowResearchers at the Heart Center Bad Berka run a registry that collects data on adults treated for heart rhythm problems. The registry follows people who receive medication, procedures such as ablation, or implanted cardiac devices. It tracks how safe and effective these treatment…
Sponsor: Zentralklinik Bad Berka • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Magnetic pulses to the brain: can they speed up reading?
Knowledge-focused Recruiting nowResearchers at Georgia State University are studying how transcranial magnetic stimulation (TMS) affects reading speed and accuracy. About 50 adults with typical reading skills will receive either excitatory, inhibitory, or sham stimulation to a brain region called the supramargi…
Sponsor: Georgia State University • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC